10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the quarterly period ended June 27, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to

Commission File Number: 001-38879

BEYOND MEAT, INC.

(Exact name of registrant as specified in its charter)

Delaware	26-4087597
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)

119 Standard Street

El Segundo, CA 90245

(Address, including zip code, of principal executive offices)

(866) 756-4112

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value	BYND	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒     No   ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☐
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐   No  ☒

As of August 10, 2020, the registrant had 62,444,717 shares of common stock, $0.0001 par value per share, outstanding.

TABLE OF CONTENTS
	Page
Part I. Financial Information
Item 1. Financial Statements (Unaudited):	1
Condensed Consolidated Balance Sheets	1
Condensed Consolidated Statements of Operations	3
Condensed Consolidated Statements of Comprehensive Loss	4
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)	5
Condensed Consolidated Statements of Cash Flows	6
Notes to Unaudited Condensed Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3. Quantitative and Qualitative Disclosures About Market Risk	48
Item 4. Controls and Procedures	50
Part II. Other Information
Item 1. Legal Proceedings	51
Item 1A. Risk Factors	60
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	60
Item 3. Defaults Upon Senior Securities	60
Item 4. Mine Safety Disclosures	61
Item 5. Other Information	61
Item 6. Exhibits	62
Exhibit Index	62
Signatures	63

i

Note Regarding Forward-Looking Statements

This report includes forward-looking statements within the meaning of the federal securities laws. We have based these forward-looking statements largely on our current opinions, expectations, beliefs, plans, objectives, assumptions and projections about future events and financial trends affecting the operating results and financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:

•the effects of the coronavirus (“COVID-19”) pandemic, including on our supply chain, the demand for our products, and, in particular in our foodservice channel, our product and channel mix, our manufacturing facilities and operations, our ability to expand and produce in new geographic markets or the timing of such expansion efforts, the pace and success of new product introductions, and on overall economic conditions and consumer confidence and spending levels;

•the impact of adverse and uncertain economic conditions in the U.S. and international markets;

•estimates of our expenses, future revenues, capital expenditures, capital requirements and our needs for additional financing;

•our ability to effectively manage our growth;

•the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, such as the COVID-19 pandemic;

•our estimates of the size of our market opportunities;

•our ability to effectively expand our manufacturing and production capacity;

•our ability to accurately forecast demand for our products and manage our inventory;

•variations in product selling prices and costs, and the mix of products sold;

•our ability to successfully enter new geographic markets, manage our international expansion and comply with any applicable laws and regulations;

•the effects of increased competition from our market competitors and new market entrants;

•the success of our marketing initiatives and the ability to grow brand awareness, maintain, protect and enhance our brand, attract and retain new customers and grow our market share;

•our ability to attract, maintain and effectively expand our relationships with key strategic foodservice partners;

•our ability to attract and retain our suppliers, distributors, co-manufacturers and customers;

•our ability to procure sufficient high quality, raw materials to manufacture our products;

•the availability of pea protein that meets our standards;

•our ability to diversify the protein sources used for our products;

•the volatility associated with ingredient and packaging costs;

•real or perceived quality or health issues with our products or other issues that adversely affect our brand and reputation;

•changes in the tastes and preferences of our consumers;

•our ability to accurately predict consumer taste preferences, trends and demand and successfully introduce and commercialize new products and improve existing products, including in new geographic markets;

•significant disruption in, or breach in security of our information technology systems and resultant interruptions in service and any related impact on our reputation;

•the attraction and retention of qualified employees and key personnel and our ability to maintain our corporate culture as we continue to grow;

ii

•the effects of natural or man-made catastrophic events particularly involving our or any of our co-manufacturers’ manufacturing facilities or our suppliers’ facilities;

•the impact of marketing campaigns aimed at generating negative publicity regarding our products, brand and the plant-based industry category;

•the effectiveness of our internal controls;

•changes in laws and government regulation affecting our business, including the U.S. Food and Drug Administration (“FDA”) and the U.S. Federal Trade Commission (“FTC”) governmental regulation, and state, local and foreign regulation;

•new or pending legislation, or changes in laws, regulations or policies of governmental agencies or regulators, both in the U.S. and abroad, affecting plant-based meat, the labeling or naming of our products, or our brand name;

•the financial condition of, and our relationships with our suppliers, co-manufacturers, distributors, retailers, and foodservice customers, and their future decisions regarding their relationships with us;

•the ability of our suppliers and co-manufacturers to comply with food safety, environmental or other laws or regulations;

•seasonality;

•the sufficiency of our cash and cash equivalents to meet our liquidity needs and service our indebtedness;

•economic conditions and the impact on consumer spending;

•outcomes of legal or administrative proceedings;

•our, our suppliers’ and our co-manufacturers’ ability to protect our proprietary technology, intellectual property and trade secrets adequately;

•the impact of tariffs and trade wars; and

•the risks discussed in Part I, Item 1A, “Risk Factors,” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”) on March 19, 2020 (the “2019 10-K”), Part II, Item 1A, “Risk Factors” included herein, and those discussed in other documents we file from time to time with the SEC.

In some cases, you can identify forward-looking statements by the use of words such as “believe,” “may,” “will,” “will continue,” “could,” “will likely result,” “estimate,” “continue,” “anticipate,” “intend,” “plan,” “predict,” “project,” “expect,” “potential” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. These forward-looking statements are based on our current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those anticipated or implied in the forward-looking statements.

This report also contains estimates and other statistical data obtained from independent parties and by us relating to market size and growth and other data about our industry and ultimate consumers. The number of retail and foodservice outlets are derived from data through June 27, 2020. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates and data.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date of this report. You should not put undue reliance on any forward-looking statements. We assume no obligation to publicly update or revise any forward-looking statements because of new information, future events, changes in assumptions or otherwise, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

As used herein, the terms “Beyond Meat,” “we,” “us,” “our” and the “Company” refer to Beyond Meat, Inc., a Delaware corporation, including its consolidated subsidiaries unless the context otherwise requires.

“Beyond Meat,” “Beyond Burger,” “Beyond Beef,” “Beyond Sausage,” “Beyond Breakfast Sausage,” “Beyond Chicken,” “Beyond Fried Chicken,” “Beyond Meatball,” the Caped Steer Logo, “GO BEYOND,” “Eat What You Love,” “The Cookout Classic,” “The Future of Protein” and “The Future of Protein Beyond Meat” and

iii

design are registered or pending trademarks of Beyond Meat, Inc. in the United States and, in some cases, in certain other countries. All other brand names or trademarks appearing in this report are the property of their respective holders. Solely for convenience, the trademarks and trade names contained herein are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.

iv

Part I. Financial Information

ITEM I. FINANCIAL STATEMENTS

BEYOND MEAT, INC.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(unaudited)
	June 27, 2020		December 31, 2019
Assets
Current assets:
Cash and cash equivalents	$	222,334	$	275,988
Accounts receivable	45,986		40,080
Inventory	143,033		81,596
Prepaid expenses and other current assets	17,990		5,930
Total current assets	$	429,343	$	403,594
Property, plant, and equipment, net	70,286		47,474
Operating lease right-of-use assets	13,793		—
Other non-current assets, net	4,552		855
Total assets	$	517,974	$	451,923
Liabilities and Stockholders’ Equity:
Current liabilities:
Accounts payable	$	51,567	$	26,923
Wages payable	2,024		1,768
Accrued bonus	1,416		4,129
Current portion of operating lease liabilities	2,367		—
Accrued expenses and other current liabilities	8,829		3,805
Short-term borrowings under revolving credit facility and bank term loan	—		11,000
Current portion of finance lease liabilities	72		72
Total current liabilities	$	66,275	$	47,697
Long-term liabilities:
Revolving credit facility	$	50,000	$	—
Operating lease liabilities, net of current portion	11,604		—
Long-term portion of bank term loan, net	—		14,637
Equipment loan, net	—		4,932
Finance lease obligations and other long-term liabilities	185		567
Total long-term liabilities	$	61,789	$	20,136
Commitments and Contingencies (Note 10)
(continued on the next page)

1

BEYOND MEAT, INC.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(unaudited)
	June 27, 2020		December 31, 2019
Stockholders’ equity:
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding	$	—	$	—
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 62,425,640 and 61,576,494 shares issued and outstanding at June 27, 2020 and December 31, 2019, respectively	6		6
Additional paid-in capital	540,576		526,199
Accumulated deficit	(150,505)		(142,115)
Accumulated other comprehensive loss	(167)		—
Total stockholders’ equity	$	389,910	$	384,090
Total liabilities and stockholders’ equity	$	517,974	$	451,923

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

BEYOND MEAT, INC.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share data)

(unaudited)

	Three Months Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net revenues	$	113,338	$	67,251	$	210,412	$	107,457
Cost of goods sold	79,687		44,510		139,070		73,945
Gross profit	33,651		22,741		71,342		33,512
Research and development expenses	6,016		4,212		12,210		8,710
Selling, general and administrative expenses	34,292		15,515		61,607		26,692
Restructuring expenses	1,509		847		3,882		1,241
Total operating expenses	41,817		20,574		77,699		36,643
(Loss) income from operations	(8,166)		2,167		(6,357)		(3,131)
Other expense, net:
Interest expense	(569)		(741)		(1,274)		(1,474)
Remeasurement of warrant liability	—		(11,744)		—		(12,503)
Other, net	(1,454)		898		(744)		1,039
Total other expense, net	(2,023)		(11,587)		(2,018)		(12,938)
Loss before taxes	(10,189)		(9,420)		(8,375)		(16,069)
Income tax expense	16		21		15		21
Net loss	$	(10,205)	$	(9,441)	$	(8,390)	$	(16,090)
Net loss per share available to common stockholders—basic and diluted	$	(0.16)	$	(0.24)	$	(0.14)	$	(0.69)
Weighted average common shares outstanding—basic and diluted	62,098,861		39,081,359		61,904,360		23,206,203

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

BEYOND MEAT, INC.

Condensed Consolidated Statements of Comprehensive Loss

(In thousands)

(unaudited)

	Three Months Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net loss	$	(10,205)	$	(9,441)	$	(8,390)	$	(16,090)
Other comprehensive loss, net of tax:
Foreign currency translation loss, net of tax	(167)		—		(167)		—
Comprehensive loss, net of tax	$	(10,372)	$	(9,441)	$	(8,557)	$	(16,090)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

BEYOND MEAT, INC.

Condensed Consolidated Statements of Convertible Preferred Stock and

Stockholders’ Equity (Deficit)

(In thousands, except share data)

(unaudited)

	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total
	Shares	Amount
Balance at December 31, 2019	61,576,494	$	6	$	526,199	$	(142,115)	$	—	$	384,090
Net income	—	—		—		1,815		—		1,815
Issuance of common stock under equity incentive plans, net	280,883	—		1,002		—		—		1,002
Share-based compensation for equity classified awards	—	—		5,074		—		—		5,074
Balance at March 28, 2020	61,857,377	$	6	$	532,275	$	(140,300)	$	—	$	391,981
Net loss	—	—		—		(10,205)		—		(10,205)
Issuance of common stock under equity incentive plans, net	568,263	—		1,590		—		—		1,590
Share-based compensation for equity classified awards	—	—		6,711		—		—		6,711
Foreign currency translation adjustment	—	—		—		—		(167)		(167)
Balance at June 27, 2020	62,425,640	$	6	$	540,576	$	(150,505)	$	(167)	$	389,910

	Preferred Stock				Common Stock			Additional Paid-in Capital		Accumulated Deficit		Total
	Shares		Amount		Shares	Amount
Balance at December 31, 2018	41,562,111		$	199,540	6,951,350	$	1	$	7,921	$	(129,672)	$	(121,750)
Net loss	—		—		—	—		—		(6,649)		(6,649)
Issuance of common stock under equity incentive plans	—		—		169,583	—		366		—		366
Share-based compensation for equity classified awards	—		—		—	—		855		—		855
Balance at March 30, 2019	41,562,111		$	199,540	7,120,933	$	1	$	9,142	$	(136,321)	$	(127,178)
Net loss					—	—		—		(9,441)		(9,441)
Issuance of common stock pursuant to the IPO, net of issuance costs of $4.9 million	—		—		11,068,750	1		252,452		—		252,453
Issuance of common stock upon conversion of convertible preferred stock	(41,562,111)		(199,540)		41,562,111	4		199,536		—		199,540
Issuance of common stock upon exercise of common stock warrants	—		—		214,875	—		—		—		—
Reclassification of warrant liability to additional paid-in capital upon closing of the initial public offering	—		—		—	—		14,421		—		14,421
Issuance of common stock under equity incentive plans	—		—		200,852	—		167		—		167
Share-based compensation for equity classified awards	—		—		—	—		1,823		—		1,823
Balance at June 29, 2019	$	—	$	—	60,167.521	$	6	$	477,541	$	(145,762)	$	331,785

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

BEYOND MEAT, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
	Six Months Ended
	June 27, 2020		June 29, 2019
Cash flows from operating activities:
Net loss	$	(8,390)	$	(16,090)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,855		3,957
Non-cash lease expense	1,193		—
Share-based compensation expense	13,535		2,678
Loss on sale of fixed assets	183		—
Amortization of debt issuance costs	93		78
Loss on extinguishment of debt	1,538		—
Change in preferred and common stock warrant liabilities	—		12,503
Net change in operating assets and liabilities:
Accounts receivable	(5,907)		(21,762)
Inventories	(61,437)		(12,438)
Prepaid expenses and other assets	(12,192)		(2,131)
Accounts payable	21,564		9,799
Accrued expenses and other current liabilities	818		1,028
Operating lease liabilities	(1,188)		—
Long-term liabilities	—		12
Net cash used in operating activities	$	(44,335)	$	(22,366)
Cash flows from investing activities:
Purchases of property, plant and equipment	$	(26,031)	$	(7,502)
Proceeds from sale of fixed assets	—		232
Purchases of property, plant and equipment held for sale	(2,288)		(3,121)
Payment of security deposits	(9)		(487)
Net cash used in investing activities	$	(28,328)	$	(10,878)
Cash flows from financing activities:
Proceeds from issuance of common stock pursuant to the initial public offering, net of issuance costs	$	—	$	255,448
Proceeds from revolving credit facility	50,000		—
Debt issuance costs	(1,183)		—
Debt extinguishment costs	(1,200)		—
Repayment of revolving credit line	(6,000)		—
Repayment of term loan	(20,000)		—
Repayment of equipment loan	(5,000)		—
Principal payments under finance lease obligations	(34)		(21)
Proceeds from exercise of stock options	3,824		533
Payments of minimum withholding taxes on net share settlement of equity awards	(1,231)		—
Net cash provided by financing activities	$	19,176	$	255,960
(continued on the next page)

6

BEYOND MEAT, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
	Six Months Ended
	June 27, 2020		June 29, 2019
Net (decrease) increase in cash and cash equivalents	$	(53,487)	$	222,716
Effect of exchange rate changes on cash	(167)		—
Cash and cash equivalents at the beginning of the period	275,988		54,271
Cash and cash equivalents at the end of the period	$	222,334	$	276,987
Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest	$	1,265	$	1,445
Taxes	$	15	$	21
Non-cash investing and financing activities:
Non-cash additions to property, plant and equipment	$	4,499	$	1,003
Offering costs, accrued not yet paid	$	—	$	578
Non-cash additions to property, plant and equipment held for sale	$	—	$	646
Operating lease right-of-use assets obtained in exchange for lease liabilities	$	2,632	$	—
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering	$	—	$	14,421
Conversion of convertible preferred stock to common stock upon initial public offering	$	—	$	199,540
Note receivable from sale of assets held for sale	$	5,158	$	—
(concluded)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1. Introduction

The Company

Beyond Meat, Inc., a Delaware corporation (including its consolidated subsidiaries unless the context otherwise requires, the “Company”), is one of the fastest growing food companies in the United States, offering a portfolio of revolutionary plant-based meats. The Company builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating the Company’s plant-based meat products.

The Company’s primary production facilities are located in Columbia, Missouri, and research and development and administrative offices are located in El Segundo, California. In addition to its own production facilities, the Company uses co-manufacturers in various locations in the United States, Canada and the Netherlands. On January 14, 2020, the Company registered its new subsidiary, Beyond Meat EU B.V., in the Netherlands. On April 28, 2020, the Company registered its new subsidiary, Beyond Meat (Jiaxing) Food Co., Ltd., in the Zhejiang Province in China. In the three months ended June 27, 2020, the Company acquired its first manufacturing facility in Europe located in Enschede, the Netherlands. This facility is expected to be operational by the end of 2020. In addition, in June 2020 the Company announced the official opening of a new co-manufacturing facility to be used for Beyond Meat production built by the Company’s distributor in the Netherlands.

The Company sells to a variety of customers in the retail and foodservice channels throughout the United States and internationally primarily through distributors who purchase, store, sell, and deliver the Company’s products. In addition, the Company sells directly to customers in the retail and foodservice channels who handle their own distribution. As of June 27, 2020, approximately 96% of the Company’s long-lived assets were located in the United States.

COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. The global spread and unprecedented impact of COVID-19 continues to create significant volatility, uncertainty and economic disruption. In the three months ended June 27, 2020, the Company’s operations in its facilities, and its financial results including net revenues, gross profit, gross margin and operating expenses were negatively impacted by COVID-19. The extent of COVID-19’s effect on the Company’s operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. As a result, it is not currently possible to ascertain the overall impact of COVID-19 on the Company’s business. While the ultimate health and economic impact of the COVID-19 pandemic is highly uncertain, the Company expects that its business operations and results of operations, including its net revenues, gross profit, gross margin, earnings and cash flows, will be adversely impacted for at least the balance of 2020.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements include all adjustments

8

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

necessary, which are of a normal and recurring nature, for the fair presentation of the Company’s financial position and of the results of operations and cash flows for the periods presented. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2020 or for any other interim period or for any other future fiscal year. These condensed consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on March 19, 2020 (the “2019 10-K”). The condensed balance sheet as of December 31, 2019 has been derived from the audited financial statements at that date. There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2019 10-K, except as noted below.

Principles of Consolidation

The condensed consolidated financial statements for the periods ended June 27, 2020 include the accounts of the Company and its subsidiaries. All inter-company balances and transactions have been eliminated.

Management’s Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include trade promotion accruals; useful lives of property, plant and equipment; valuation of deferred tax assets; valuation of inventory; incremental borrowing rate used to determine operating lease right-of-use assets and operating lease liabilities; assessment of contract-based factors, asset-based factors, entity-based factors and market-based factors to determine the lease term impacting right-of-use assets and lease liabilities; and the valuation of the fair value of stock options used to determine share-based compensation expense. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.

Property, Plant and Equipment

Property, plant and equipment are carried at cost less accumulated depreciation and are depreciated using the straight-line method over the following estimated useful lives:

Land	Not amortized
Buildings	30 years
Leasehold improvements	Shorter of lease term or estimated useful life
Furniture and fixtures	3 years
Manufacturing equipment	5 to 10 years
Research and development equipment	5 to 10 years
Software and computer equipment	3 years
Vehicles	5 years

Leasehold improvements are depreciated on a straight-line basis over the lesser of the estimated useful life of the asset or the remaining lease term. When assets are sold or retired, the asset and related accumulated depreciation are removed from the respective account balances and any gain or loss on disposal is included in loss from operations. Expenditures for repairs and maintenance are charged directly to expense when incurred. See Note 6.

9

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Foreign Currency

The Company’s foreign entities use their local currency as the functional currency. For these entities, the Company translates net assets into U.S. dollars at period end exchange rates, while revenue and expense accounts are translated at average exchange rates prevailing during the periods being reported. Resulting currency translation adjustments are included in accumulated other comprehensive loss and foreign currency transaction gains and losses are included in other, net. Transaction gains and losses on long-term intra-entity transactions are recorded as a component of other comprehensive loss. Transactions denominated in a currency other than the reporting entity’s functional currency may give rise to transaction gains and losses that impact the Company’s results of operations.

Unrealized translation losses, net of tax, reported as cumulative translation adjustments through other comprehensive loss were $0.2 million as of June 27, 2020. Foreign currency transaction gains included in other, net were $0.1 million during the three and six months ended June 27, 2020.

Fair Value of Financial Instruments

The fair value measurement accounting guidance creates a fair value hierarchy to prioritize the inputs used to measure fair value into three categories. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement, where Level 1 is the highest and Level 3 is the lowest.

The three levels are defined as follows:

•Level 1—Unadjusted quoted prices in active markets accessible by the reporting entity for identical assets or liabilities. Active markets are those in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

•Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which significant value drivers are observable.

•Level 3—Valuations derived from valuation techniques in which significant value drivers are unobservable.

The Company’s financial instruments include cash equivalents, accounts receivable, accounts payable, and accrued expenses, for which the carrying amounts approximate fair value due to the short-term maturity of these financial instruments. Based on the borrowing rates currently available to the Company for debt with similar terms, the carrying value of the Company’s revolving credit facility approximates fair value as well.

The Company had no financial instruments measured at fair value on a recurring basis as of June 27, 2020 and December 31, 2019, other than the liability classified share-settled obligation to one of the Company’s executive officers as discussed in Note 9 which represents a Level 1 financial instrument. There was no change in the fair value of the liability-classified share-settled obligation in the three and six months ended June 27, 2020. There were no transfers of financial assets or liabilities into or out of Level 1, Level 2 or Level 3 for the three and six months ended June 27, 2020.

Prior to the IPO, the stock warrant liability was measured at fair value using Level 3 inputs upon issuance and at each reporting date. Inputs used to determine the estimated fair value of the warrant liability as of the valuation date included expected term of the warrants, the risk-free interest rate, volatility, and the fair value of underlying shares.

10

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

The following table sets forth a summary of the changes in the fair value of the preferred and common stock warrant liabilities:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Beginning balance	$	—	$	2,677	$	—	$	1,918
Fair value of warrants issued during the period	—		—		—		—
Change in fair value of warrant liability	—		11,744		—		12,503
Reclassification of warrant liability to additional paid-in capital in connection with the IPO	—		(14,421)		—		(14,421)
Ending balance	$	—	$	—	$	—	$	—

The Company remeasured and reclassified the common stock warrant liability to additional paid-in-capital in connection with the IPO. The final re-measurement of the preferred stock warrant was based upon the publicly available stock price on the conversion date. Subsequent to the closing of the IPO, all outstanding warrants to purchase shares of common stock were cashless exercised and no warrants were outstanding as of June 29, 2019.

Revenue Recognition

Revenue is recognized at the point in which the performance obligation under the terms of a contract with the customer have been satisfied and control has transferred. The Company’s performance obligation is typically defined as the accepted purchase order, or the contract, with the customer which requires the Company to deliver the requested products at agreed upon prices at the time and location of the customer’s choice. The Company does not offer warranties or a right to return on the products it sells except in the instance of a product recall.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for fulfilling the performance obligation. Sales and other taxes the Company collects concurrent with the sale of products are excluded from revenue. The Company's normal payment terms vary by the type and location of its customers and the products offered. The time between invoicing and when payment is due is not significant. None of the Company's customer contracts as of June 27, 2020 contains a significant financing component.

The Company routinely offers sales discounts and promotions through various programs to its customers and consumers. These programs include rebates, temporary on shelf price reductions, buy-one-get-one-free programs, off invoice discounts, retailer advertisements, product coupons and other trade activities. Provision for discounts and incentives are recorded in the same period in which the related revenues are recognized. At the end of each accounting period, the Company recognizes a liability for estimated sales discounts that have been incurred but not paid which totaled $4.7 million and $1.6 million as of June 27, 2020 and December 31, 2019, respectively. The offsetting charge is recorded as a reduction of revenues in the same period when the expense is incurred.

The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. The incremental cost to obtain contracts was not material.

11

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Presentation of Net Revenues by Channel

Effective January 1, 2020, the Company began presenting net revenues by geography and distribution channel as follows:

Distribution Channel	Description
U.S. Retail	Net revenues from retail sales to the U.S. market
U.S. Foodservice	Net revenues from restaurant and foodservice sales to the U.S. market
International Retail	Net revenues from retail sales to international markets, including Canada
International Foodservice	Net revenues from restaurant and foodservice sales to international markets, including Canada

Net revenues from sales to the Canadian market, previously included with net revenues from sales to the U.S. market, have been reclassified to International net revenues. Prior period amounts have been recast to conform to the current period presentation. The foregoing change in presentation had no impact on the Company’s net revenues, results of operations or cash flows.

Effective January 1, 2020, the Company also eliminated the presentation of net revenues by platform as it is no longer material to an understanding of the Company's financial results. Previously, the Company presented net revenues by platform for its “ready-to-cook” or fresh platform, and “ready-to-heat” or frozen platform. Gross revenues from sales of products in the Company's frozen platform were 5.5% of gross revenues in the year ended December 31, 2019, as compared to 16.3% of gross revenues in the year ended December 31, 2018.

The following table presents the Company’s net revenues by channel:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net revenues:
U.S.:
Retail	$	90,040	$	30,531	$	139,963	$	49,992
Foodservice	6,486		16,504		29,117		25,338
U.S. net revenues	96,526		47,035		169,080		75,330
International:
Retail	9,572		3,589		15,524		3,707
Foodservice	7,240		16,627		25,808		28,420
International net revenues	16,812		20,216		41,332		32,127
Net revenues	$	113,338	$	67,251	$	210,412	$	107,457

One distributor accounted for approximately 16% of the Company’s gross revenues in the three months ended June 27, 2020; and two distributors accounted for approximately 22% and 20%, respectively, of the Company’s gross revenues in the three months ended June 29, 2019. One distributor accounted for approximately 14% of the Company’s gross revenues in the six months ended June 27, 2020; and two distributors accounted for approximately 22% and 21%, respectively, of the Company’s gross revenues in the six months ended June 29, 2019. No other distributor or customer accounted for more than 10% of the Company’s gross revenues in the three and six months ended June 27, 2020 and June 29, 2019.

Shipping and Handling Costs

Outbound shipping and handling costs included in selling, general and administrative (“SG&A”) expenses in the three months ended June 27, 2020 and June 29, 2019 were $3.2 million and $2.6 million,

12

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

respectively. Outbound shipping and handling costs included in SG&A expenses in the six months ended June 27, 2020 and June 29, 2019 were $4.8 million and $3.9 million, respectively.

Recently Adopted Accounting Pronouncements

As an “emerging growth company” (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company will no longer qualify as an EGC as of the end of the fiscal year ending December 31, 2020, when it becomes a Large Accelerated Filer under Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Therefore, the Company has elected to use the adoption dates applicable to public companies beginning in the first quarter of 2020 and the adoption dates for the new accounting pronouncements disclosed below have been evaluated under such premise.

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842) (“ASU 2016-02”), which requires lessees to record most leases on their balance sheets but recognize the expenses on their income statements in a manner similar to Accounting Standards Codification (“ASC”) 840, “Leases” (“ASC 840”). ASU 2016-02 requires that a lessee recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term.

On January 1, 2020, the Company adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840. The Company also elected the package of practical expedients permitted under the transition guidance within ASU 2016-02, which among other things, permits the Company to not reassess under the new standard the Company’s prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight practical expedient or the practical expedient pertaining to land easements, the latter not being applicable to the Company. As part of this adoption, the Company elected not to record operating right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. Payments on those leases will be recognized on a straight-line basis through the Company’s condensed consolidated statements of operations over the lease term. The Company also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets. See Note 4.

On March 12, 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). The amendments in ASU 2020-04 provide temporary optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions to ease the potential accounting and financial reporting burden associated with transitioning away from reference rates that are expected to be discontinued, including the London Interbank Offered Rate (LIBOR). ASU 2020-04 is effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of ASU 2020-04 has not had and is not expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

New Accounting Pronouncements

On December 18, 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes (Topic 740)” (“ASU 2019-12”). ASU 2019-12 eliminates the need for an organization to analyze whether the following apply in a given period (1) exceptions to the incremental approach for intra-period tax allocation, (2) exceptions to accounting for basis differences when there are ownership changes in foreign investments, and (3) exceptions in interim period income tax accounting for year-to-date losses that exceed anticipated losses. ASU 2019-12 also is designed to improve financial statement preparers’ application of income tax-related guidance and simplify GAAP for (1) franchise taxes that are partially based on income, (2) transactions with a government that result in a step-up in the tax basis of goodwill, (3) separate financial statements of legal entities that are not subject to tax, and (4) enacted changes in

13

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

tax laws in interim periods. For public business entities, the amendments in ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption of the amendments is permitted, including adoption in any interim period for public business entities for periods for which financial statements have not yet been issued. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. ASU 2019-12 is effective for the Company beginning on January 1, 2021. Adoption of ASU 2019-12 is not expected to result in any material changes to the way the tax provision is prepared and is not expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

Note 3. Restructuring

In May 2017, management approved a plan to terminate the Company’s exclusive supply agreement (the “Agreement”) with one of its co-manufacturers, due to non-performance under the Agreement and on May 23, 2017, the Company notified the co-manufacturer of its decision to terminate the Agreement. In the three months ended June 27, 2020 and June 29, 2019, the Company recorded $1.5 million and $0.8 million, respectively, in restructuring expenses related to this dispute, which consisted primarily of legal and other expenses. In the six months ended June 27, 2020 and June 29, 2019, the Company recorded $3.9 million and $1.2 million, respectively, in restructuring expenses related to this dispute, which consisted primarily of legal and other expenses. See Note 10 for further information. As of June 27, 2020 and December 31, 2019, the Company had $2.3 million and $1.1 million, respectively, in accrued and unpaid restructuring expenses.

Note 4. Leases

Leases are classified as either finance leases or operating leases based on criteria in ASC 842. The Company has operating leases for its corporate offices including its Manhattan Beach Innovation Center where the Company’s research and development facility is located, its manufacturing facilities, warehouses and vehicles, and finance leases for certain of the Company’s equipment. Such leases generally have original lease terms between two and 11 years, and often include one or more options to renew. Some leases also include early termination options, which can be exercised under specific conditions. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company currently considers its renewal options to be reasonably certain to be exercised. The Company does not have residual value guarantees or material restrictive covenants associated with its leases.

On January 1, 2020, the Company adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840.

Operating lease assets represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments at lease commencement. The Company calculates the present value of its operating leases using an estimated incremental borrowing rate, which requires judgment. The Company estimates the incremental borrowing rate for each operating lease based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. Certain leases contain variable payments, which are expensed as incurred and not included in the Company’s operating lease right-of-use assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance on the Company’s corporate, research and development, and manufacturing facilities and warehouse leases and are excluded from the present value of the Company’s lease obligations.

14

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Previously designated capital leases under ASC 840 are now considered finance leases under ASC 842. The Company calculates the present value of its finance leases using the interest rate implicit in the lease agreement.

Upon adoption of ASU 2016-02, the Company recognized operating lease right-of-use assets of $11.9 million adjusted for $0.3 million previously recorded as deferred rent and $0.2 million previously recorded as prepaid rent on the Company’s condensed consolidated balance sheets. The Company also recorded $1.4 million in current operating lease liabilities and $10.6 million in operating lease liabilities, net of current portion.

As part of this adoption, the Company elected to not record operating lease right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.

The components of lease expense were as follows:

(in thousands)	Statement of Operations Location	Three Months Ended June 27, 2020		Six Months Ended June 27, 2020
Operating lease cost:
Lease cost	Cost of goods sold	$	468	$	652
Lease cost	Research and development expenses	158		283
Lease cost	Selling, general and administrative expenses	161		273
Variable lease cost (1)	Cost of goods sold	1		7
Operating lease cost		$	788	$	1,215
Short-term lease cost	Selling, general and administrative expenses	$	111	$	175
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	$	20	$	38
Interest on lease liabilities	Interest expense	3		7
Finance lease cost		$	23	$	45
Total lease cost		$	922	$	1,435

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

15

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Supplemental balance sheet information as of June 27, 2020 related to leases are as follows:

(in thousands)	Balance Sheet Location	June 27, 2020
Assets
Operating leases	Operating lease right-of-use assets	$	13,793
Finance leases, net	Property, plant and equipment, net	249
Total lease assets		$	14,042
Liabilities
Current:
Operating lease liabilities	Current portion of operating lease liabilities	$	2,367
Finance lease liabilities	Current portion of finance lease liabilities	72
Long-term:
Operating lease liabilities	Operating lease liabilities, net of current portion	11,604
Finance lease liabilities	Finance lease obligations and other long-term liabilities	185
Total lease liabilities		$	14,228

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2020:

	June 27, 2020
(in thousands)	Operating Leases		Finance Leases
Remainder of 2020	$	1,335	$	43
2021	2,737		80
2022	2,664		71
2023	2,181		58
2024	1,395		30
2025	1,281		—
Thereafter	3,914		—
Total undiscounted future minimum lease payments	15,507		282
Less imputed interest	(1,536)		(25)
Total discounted future minimum lease payments	$	13,971	$	257

Weighted average remaining lease terms and weighted average discount rates were:

	June 27, 2020
	Operating Leases		Finance Leases
Weighted average remaining lease term (years)	7.4		3.7
Weighted average discount rate	2.9	%	5.4	%

16

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

A schedule of the future minimum rental commitments under the Company’s capital lease agreements and non-cancelable operating lease agreements with an initial or remaining term in excess of one year as of December 31, 2019, in accordance with ASC 840 were as follows:

(in thousands)	Capital Lease Obligations		Operating Lease Obligations
2020	$	86	$	1,878
2021	80		1,813
2022	71		1,817
2023	58		1,840
2024	30		1,353
Thereafter	—		5,167
Total minimum lease payments			$	13,868
Total minimum lease payments	$	325
Less: imputed interest (4.1% to 15.9%)	(34)
Total capital lease obligations	$	291
Less: current portion of capital lease obligations	(72)
Long-term capital lease obligations	$	219

Note 5. Inventories

Major classes of inventory were as follows:

(in thousands)	June 27, 2020		December 31, 2019
Raw materials and packaging	$	80,848	$	36,884
Work in process	13,326		17,958
Finished goods	48,859		26,754
Total	$	143,033	$	81,596

17

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Note 6. Property, Plant and Equipment

Property, plant, and equipment are stated at cost and finance lease assets are included. A summary of property, plant, and equipment as of June 27, 2020 and December 31, 2019, is as follows:

(in thousands)	June 27, 2020		December 31, 2019
Manufacturing equipment	$	51,559	$	37,939
Research and development equipment	9,643		8,933
Leasehold improvements	8,000		7,620
Building	1,600		—
Finance leases	287		1,108
Software	358		274
Furniture and fixtures	461		433
Vehicles	378		210
Land	1,120		—
Assets not yet placed in service	23,149		11,666
Total property, plant and equipment	$	96,555	$	68,183
Accumulated depreciation and amortization	(26,269)		(20,709)
Property, plant and equipment, net	$	70,286	$	47,474

Depreciation and amortization expense for the three months ended June 27, 2020 and June 29, 2019, was $3.3 million and $2.1 million, respectively. Of the total depreciation and amortization expense in the three months ended June 27, 2020 and June 29, 2019, $2.5 million and $1.4 million, respectively, were recorded in cost of goods sold, $0.7 million and $0.6 million, respectively, were recorded in research and development expenses, and $0.1 million and $12,000, respectively, were recorded in SG&A expenses in the Company’s condensed consolidated statements of operations.

Depreciation and amortization expense for the six months ended June 27, 2020 and June 29, 2019, was $5.9 million and $4.0 million, respectively. Of the total depreciation and amortization expense in the six months ended June 27, 2020 and June 29, 2019, $4.4 million and $2.8 million, respectively, were recorded in cost of goods sold, $1.4 million and $1.1 million, respectively, were recorded in research and development expenses, and $0.1 million and $22,000, respectively, were recorded in SG&A expenses, in the Company’s condensed consolidated statements of operations.

The Company no longer has any assets that meet the criteria for assets held for sale as of June 27, 2020. Amounts previously classified as assets held for sale were sold for amounts that approximated book value for which a note receivable of $5.2 million was recorded, of which $3.4 million is included in prepaid expenses and other current assets and $1.8 million is included in other non-current assets, net in the Company’s condensed consolidated balance sheet as of June 27, 2020.

Note 7. Debt

On April 21, 2020, the Company entered into a $150 million five-year secured revolving credit agreement (“2020 Credit Agreement”) by and among the Company, the lenders party thereto (the “Lenders”) and JPMorgan Chase Bank, N.A., as the administrative agent (the “Administrative Agent”). JPMorgan Chase Bank, N.A. and Silicon Valley Bank acted as joint bookrunners and joint lead arrangers under the 2020 Credit Agreement. The 2020 Credit Agreement includes an accordion feature for up to an additional $200 million. Capitalized terms used below but not defined have the meanings ascribed to such terms in the 2020 Credit Agreement.

18

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Concurrently with the effectiveness of the 2020 Credit Agreement, on April 21, 2020, the Company terminated the SVB Credit Facilities (a revolving credit facility and a term loan facility with Silicon Valley Bank) and the Equipment Loan Facility (an equipment loan from Structural Capital), and incurred an aggregate of $1.2 million of termination, prepayment, and related fees in connection with such terminations.

Amounts available under the 2020 Credit Agreement are for working capital needs, for general corporate purposes and to refinance certain existing indebtedness, as the Company deems necessary. Borrowings under the 2020 Credit Agreement will bear interest, at the Company’s option, calculated according to an Alternate Base Rate or LIBO Rate, as the case may be, plus an applicable margin. Until the delivery to the Administrative Agent of the Company’s consolidated financial information for the fiscal quarter ending September 30, 2020, the applicable margin shall be 1.5% per annum for Alternate Base Rate loans and 2.5% per annum for LIBO Rate loans. Thereafter, the applicable margin for Alternate Base Rate loans will range from 1.25% to 1.75% per annum, and the applicable margin for LIBO Rate loans will range from 2.25% to 2.75% per annum, in each case, based on the Company’s total leverage ratio at the end of each quarter.

The Company is required to pay an unused commitment fee of 0.375% per annum, which shall accrue at the applicable rate on the daily amount of the undrawn portion of the commitment of each Lender. Letters of credit issued under the 2020 Credit Agreement are subject to customary letter of credit fees. The Company’s obligations under the 2020 Credit Agreement are secured by substantially all of its assets, subject to customary exceptions set forth in the 2020 Credit Agreement. In addition, to the extent the Company forms or acquires any domestic subsidiaries, such domestic subsidiaries will be required to guarantee the Company’s obligations under the 2020 Credit Agreement and provide a security interest over substantially all of their assets.

The 2020 Credit Agreement contains customary representations, warranties and covenants for a transaction of this type, including maintenance of (i) a maximum total leverage ratio of 3.00 to 1.00 and (ii) a minimum fixed charge coverage ratio of 1.25 to 1.00, in each case, tested on the last day of each fiscal quarter. The 2020 Credit Agreement also provides for customary events of default, including (among others) nonpayment, covenant defaults, breaches of representations or warranties, bankruptcy and insolvency events and a change of control. If an event of default occurs, the Administrative Agent shall, at the request of, or may, with the consent of, the required Lenders, declare the obligations under the 2020 Credit Agreement immediately due and payable and the commitments of the Lenders may be terminated. For certain events of default relating to insolvency, the commitments of the Lenders are automatically terminated and all outstanding obligations become due and payable.

The Company’s debt balances are detailed below:

(in thousands)	June 27, 2020		December 31, 2019
Revolving credit facility	$	50,000	$	—
Revolving credit line (SVB)	—		6,000
Term loan facility	—		20,000
Equipment financing loan	—		5,000
Debt issuance costs	—		(431)
Total debt outstanding	$	50,000	$	30,569
Less: current portion of long-term debt	—		11,000
Long-term debt	$	50,000	$	19,569

The Company records debt issuance costs on the revolving credit facility in other non-current assets, net in the accompanying condensed consolidated balance sheet as of June 27, 2020. Debt issuance costs on the revolving credit line and term loan, net of amortization, were recorded as a reduction of carrying value of the debt in the accompanying condensed consolidated balance sheet as of December

19

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

31, 2019. Debt issuance costs, net of amortization, totaled $1.2 million and $0.4 million as of June 27, 2020 and December 31, 2019, respectively. Debt issuance costs are amortized as interest expense over the term of the loan for which amortization of $57,000 and $20,000 was recorded during the three months ended June 27, 2020 and June 29, 2019, respectively, and $93,000 and $78,000 was recorded during the six months ended June 27, 2020 and June 29, 2019, respectively.

In the three months ended June 27, 2020 and June 29, 2019, the Company incurred $0.4 million and $0.5 million, respectively, in interest expense related to its bank credit facilities. In the six months ended June 27, 2020 and June 29, 2019, the Company incurred $0.9 million and $1.1 million, respectively, in interest expense related to its bank credit facilities. In the three months ended June 27, 2020 and June 29, 2019, the Company recorded $0.1 million and $0.2 million, respectively, in interest expense related to the Equipment Loan Facility. In the six months ended June 27, 2020 and June 29, 2019, the Company recorded $0.2 million and $0.3 million, respectively, in interest expense related to the Equipment Loan Facility.

The interest rate on the revolving credit facility under the 2020 Credit Agreement at June 27, 2020 was 3.5%. The Company is subject to compliance with the financial covenants in the 2020 Credit Agreement commencing with the fiscal quarter ending September 26, 2020.

Note 8. Stockholders’ Equity

As of June 27, 2020, the Company’s shares consisted of 500,000,000 authorized shares of common stock, par value $0.0001 per share, of which 62,425,640 shares of common stock were issued and outstanding, and 500,000 authorized shares of preferred stock, par value $0.0001 per share, of which no shares were issued and outstanding.

As of December 31, 2019, the Company’s shares consisted of 500,000,000 authorized shares of common stock, par value $0.0001 per share, of which 61,576,494 shares were issued and outstanding, and 500,000 authorized shares of preferred stock, par value $0.0001 per share, of which no shares were issued and outstanding.

The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock.

20

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Note 9. Share-Based Compensation

In 2019, the Company’s 2011 Equity Incentive Plan was amended, restated and re-named the 2018 Equity Incentive Plan (“2018 Plan”), and the remaining shares available for issuance under the 2011 Plan were added to the shares reserved for issuance under the 2018 Plan. As of January 1, 2020, the maximum aggregate number of shares that may be issued under the 2018 Plan increased to 16,626,877 shares.

As of June 27, 2020 and December 31, 2019, there were 4,562,663 and 5,170,976 shares, respectively, issuable under stock options outstanding, 287,439 and 149,004 shares, respectively, issuable under unvested RSUs outstanding, 6,722,897 and 5,864,738 shares, respectively, issued for stock option exercises, RSU settlement, and restricted stock grants, and 5,060,728 and 3,297,638 shares, respectively, available for grants under the 2018 Plan.

Stock Options

Following are the assumptions used in the Black-Scholes valuation model for options granted during the periods shown below:

	Three Months Ended		Six Months Ended
	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Risk-free interest rate	0.5%	2.3%	0.7%	2.3%
Average expected term (years)	7.0	6.0	7.0	6.0
Expected volatility	55.0%	55.0%	55.0%	55.0%
Dividend yield	—	—	—	—

Option grants to new employees in the six months ended June 27, 2020 and June 29, 2019 vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting monthly over the remaining three-year period, subject to continued employment through the vesting date. Option grants to continuing employees in the six months ended June 27, 2020 vest monthly over a 48-month period, subject to continued employment through the vesting date. Option grants to continuing employees in the six months ended June 29, 2019 vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting monthly over the remaining three-year period, subject to continued employment through the vesting date.

The following table summarizes the Company’s stock option activity during the six months ended June 27, 2020:

	Number of Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value (in thousands)(1)
Outstanding at December 31, 2019	5,170,976	$	14.28	7.5	$	329,879
Granted	251,170	$	97.72	—	$	—
Exercised	(825,965)	$	4.63	—	$	91,606
Cancelled/Forfeited	(33,518)	$	34.47	—	$	—
Outstanding at June 27, 2020	4,562,663	$	20.47	7.2	$	556,534
Vested and exercisable at June 27, 2020	2,470,346	$	7.84	6.0	$	331,568
Vested and expected to vest at June 27, 2020	3,932,836	$	15.73	6.9	$	497,871

__________

(1) Aggregate intrinsic value is calculated as the difference between the value of common stock on the transaction date and the exercise price multiplied by the number of shares issuable under the stock option.

21

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

During the three months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $3.6 million and $1.2 million, respectively, of share-based compensation expense related to options issued to employees and nonemployees. During the six months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $6.6 million and $1.8 million, respectively, of share-based compensation expense related to options issued to employees and nonemployees. The share-based compensation expense is included in cost of goods sold, research and development expenses, and SG&A expenses in the Company’s condensed consolidated statements of operations.

As of June 27, 2020, there was $15.7 million in unrecognized compensation expense related to nonvested stock option awards which is expected to be recognized over a weighted average period of 2.4 years.

Restricted Stock Units

RSU grants to new employees in the six months ended June 27, 2020 and June 29, 2019 vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting quarterly over the remaining three years of the award, subject to continued employment through the vesting date. RSU grants in the six months ended June 27, 2020 to continuing employees vest quarterly over 16 quarters, subject to continued employment through the vesting date. RSU grants to consultants in the six months ended June 27, 2020 vest quarterly over 8 quarters, subject to continued service through the vesting date. An RSU grant to a nonemployee brand ambassador in the six months ended June 27, 2020 vests 50% upon grant with the remainder vesting quarterly over 4 quarters commencing on October 1, 2020, subject to continued service through the vesting date.

The following table summarizes the Company’s RSU activity during the six months ended June 27, 2020:

	Number of Shares	Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2019	149,004	$	132.82
Granted	180,774	$	102.51
Vested(1)	(34,245)	$	137.82
Cancelled/Forfeited	(8,094)	$	—
Unvested at June 27, 2020	287,439	$	113.40

________

(1) Includes 8,902 shares of common stock that were withheld to cover taxes on the release of vested RSUs and became available for future grants pursuant to the 2018 Plan.

During the three months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $2.7 million and $89,000, respectively, of share-based compensation expense related to RSUs. During the six months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $4.3 million and $89,000, respectively, of share-based compensation expense related to RSUs. The share-based compensation expense is included in cost of goods sold, research and development expenses, and SG&A expenses in the Company’s condensed consolidated statements of operations.

As of June 27, 2020, there was $12.2 million in unrecognized compensation expense related to unvested RSUs which is expected to be recognized over a weighted average period of 2.2 years.

Share-Settled Obligation

Share-based compensation expense in the three and six months ended June 27, 2020 includes $0.9 million and $1.8 million, respectively, for a liability classified, share-settled obligation to an executive officer related to a sign-on award pursuant to the terms of the executive officer’s offer letter dated August 1, 2019 with the Company. There was no such expense in the three and six months ended June 29, 2019.

22

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

The share-based compensation expense related to this share-settled obligation is included in SG&A expenses in the Company’s condensed consolidated statements of operations. The liability classified award is considered unearned until the requirements for issuance of the shares are met and is included in accrued expenses and other current liabilities on the Company’s condensed consolidated balance sheets as of June 27, 2020 and December 31, 2019 in the amount of $2.8 million and $1.0 million, respectively. As of June 27, 2020, there was $4.2 million in unrecognized compensation expense related to this share-settled obligation which is expected to be recognized over 1.2 years.

Restricted Stock to Nonemployees

The following table summarizes the Company’s restricted stock activity during the six months ended June 27, 2020:

	Number of Shares of Restricted Stock	Weighted Average Remaining Contractual Life (Years)	Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2019	88,988	1.2	$	19.49
Granted	—	—	$	—
Vested/Released	(48,607)	—	$	19.39
Cancelled/Forfeited	—	—	$	—
Unvested at June 27, 2020	40,381	0.95	$	19.77

As of June 27, 2020, 40,381 shares of restricted stock had been purchased by nonemployee brand ambassadors which remained subject to vesting requirements and repurchase pursuant to restricted stock purchase agreements.

During the three months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $0.4 million and $0.5 million, respectively, of share-based compensation expense related to restricted stock issued to nonemployee brand ambassadors, which is included in SG&A expenses in the Company’s condensed consolidated statements of operations. During each of the six months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $0.8 million of share-based compensation expense related to restricted stock issued to nonemployee brand ambassadors, which is included in SG&A expenses in the Company’s condensed consolidated statements of operations.

As of June 27, 2020, there was $0.8 million in unrecognized compensation expense related to unvested restricted stock, which is expected to be recognized over 0.8 years.

Employee Stock Purchase Plan

As of June 27, 2020, the maximum aggregate number of shares that may be issued under the 2018 Employee Stock Purchase Plan (“ESPP”) was 1,340,325 shares of common stock, including an increase of 536,130 shares effective January 1, 2020 under the terms of the ESPP. The 2018 ESPP is expected to be implemented through a series of offerings under which participants are granted purchase rights to purchase shares of the Company’s common stock on specified dates during such offerings. The administrator has not yet approved an offering under the 2018 ESPP.

Note 10. Commitments and Contingencies

Leases

On March 16, 2020, the Company amended an operating lease for its manufacturing facility in Columbia, Missouri, to extend the lease term for two years to June 30, 2022.

23

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Effective May 22, 2020, the Company amended an operating lease for one of its leased manufacturing facilities to include land adjacent to the facility upon which the landlord will construct a parking lot.

Effective May 26, 2020, the Company entered into an agreement, assignment and assumption of lease and first amendment to lease pursuant to which the Company assumed an operating lease under which the Company is leasing certain real property and a building consisting of approximately 142,317 square feet in Columbia, Missouri, for a term expiring on April 30, 2023 with no renewal options. See Note 4.

Purchase Commitments

On January 10, 2020, the Company and Roquette Frères (“Roquette”) entered into a multi-year sales agreement pursuant to which Roquette will provide the Company with plant-based protein. The agreement expires on December 31, 2022; however it can be terminated after 18 months under certain circumstances. This agreement increases the amount of plant-based protein to be supplied by Roquette in each of 2020, 2021 and 2022 compared to the amount supplied 2019. The plant-based protein sourced under the supply agreement is secured on a purchase order basis regularly, per specified minimum monthly and semi-annual quantities, throughout the term. The Company is not required to purchase plant-based protein in amounts in excess of such specified minimum quantities; however the Company has the option to increase such minimum quantities for delivery in each of 2021 and 2022. The total annual amount purchased each year by the Company must be at least the minimum amount specified in the agreement, which totals in the aggregate $154.1 million over the term of the agreement. The Company also has the right to be indemnified by Roquette in certain circumstances.

As of June 27, 2020, the Company had committed to purchase pea protein inventory totaling $192.4 million, approximately $51.6 million in the remainder of 2020, $82.3 million in 2021, and $58.5 million in 2022.

In addition, as of June 27, 2020, the Company had approximately $17.8 million in purchase order commitments for capital expenditures primarily to purchase machinery and equipment. Payments for these purchases will be due within twelve months.

Litigation

Don Lee Farms

On May 25, 2017, Don Lee Farms, a division of Goodman Food Products, Inc., filed a complaint against the Company in the Superior Court of the State of California for the County of Los Angeles asserting claims for breach of contract, misappropriation of trade secrets, unfair competition under the California Business and Professions Code, money owed and due, declaratory relief and injunctive relief, each arising out of the Company’s decision to terminate an exclusive supply agreement between the Company and Don Lee Farms. The Company denied all of these claims and filed counterclaims on July 27, 2017, alleging breach of contract, unfair competition under the California Business and Professions Code and conversion. In October 2018, the former co-manufacturer filed an amended complaint that added one of the Company’s current contract manufacturers as a defendant, principally for claims arising from the current contract manufacturer’s alleged use of the former co-manufacturer’s alleged trade secrets, and for replacing the former co-manufacturer as one of the Company’s current co-manufacturers. The current contract manufacturer filed an answer denying all of Don Lee Farms’ claims and a cross-complaint against Beyond Meat asserting claims of total and partial equitable indemnity, contribution, and repayment. On March 11, 2019, Don Lee Farms filed a second amended complaint to add claims of fraud and negligent misrepresentation against the Company. On May 30, 2019, the judge denied the Company’s motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On June 19, 2019, the Company filed an answer denying Don Lee Farms' claims.

On January 24, 2020, a writ judge granted Don Lee Farms a right to attach in the amount of $628,689 on the grounds that Don Lee Farms had established a “probable validity” of its claim that the Company owes it money for a small batch of unpaid invoices.  This determination was not made by the trial judge.  The trial judge has yet to determine the legitimacy or merits of Don Lee Farms’ claims.

24

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

On January 27, 2020, Don Lee Farms filed a third amended complaint to add three individual defendants, all of whom are current or former employees of the Company, including Mark Nelson, the Company’s Chief Financial Officer and Treasurer, to Don Lee Farms’ existing fraud and negligent misrepresentation claims alleging that those individuals were involved in the alleged fraud and negligent misrepresentations. On June 23, 2020, the judge denied Beyond Meat and the individual defendants’ motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On July 6, 2020, the Company and the individual defendants filed an answer denying all of Don Lee Farms’ claims, including denying all allegations of fraud and negligent misrepresentation.

On August 11, 2020, the Company filed an amended cross-complaint against Don Lee Farms, its parent Goodman Food Products, Inc. and its owners and employees, Donald, Daniel, and Brandon Goodman. Among other claims, the amended cross-complaint alleges that Don Lee Farms defrauded Beyond Meat, misappropriated its trade secrets, and infringed its trademarks.

The previous trial date, February 8, 2021, was vacated. Trial is currently set for June 14, 2021.

Don Lee Farms is seeking from Beyond Meat, the individual defendants, and the current contract manufacturer unspecified compensatory and punitive damages, declaratory and injunctive relief, including the prohibition of Beyond Meat’s use or disclosure of the alleged trade secrets, and attorneys’ fees and costs. The Company is seeking from Don Lee Farms monetary damages, restitution of monies paid to Don Lee Farms, injunctive relief, including the prohibition of Don Lee Farms’ use or disclosure of Beyond Meat’s trade secrets and the prohibition of Don Lee Farms’ infringing use of Beyond Meat’s trademarks, and attorneys’ fees and costs. The current contract manufacturer is seeking indemnity, contribution, or repayment from the Company of any or all damages that the current contract manufacturer may be found liable to Don Lee Farms, and attorneys’ fees and costs.

The Company believes it was justified in terminating the supply agreement with Don Lee Farms, that the Company did not misappropriate Don Lee Farms’ alleged trade secrets, that the Company is not liable for the fraud or negligent misrepresentation alleged in the third amended complaint, that Don Lee Farms is liable for the conduct alleged in the Company’s amended cross-complaint, and that the Company is not liable to the current contract manufacturer for any indemnity, contribution, or repayment, including for any damages or attorneys’ fees and costs. Conversely, as alleged in the Company’s amended cross-complaint, the Company believes Don Lee Farms misappropriated the Company’s trade secrets, defrauded the Company, and ultimately has infringed the Company’s trademarks.

The Company is currently in the process of litigating this matter and intends to vigorously defend itself and its current and former employees against the claims and to prosecute the Company’s own claims. The Company cannot assure you that Don Lee Farms or the current contract manufacturer will not prevail in all or some of their claims against the Company or the individual defendants, or that the Company will prevail in some or all of its claims against Don Lee Farms. For example, if Don Lee Farms succeeds in the lawsuit, the Company could be required to pay damages, including but not limited to contract damages reasonably calculated at what the Company would have paid Don Lee Farms to produce the Company’s products through 2019, the end of the contract term, and Don Lee Farms could also claim some ownership in the intellectual property associated with the production of certain of the Company’s products or in the products themselves, and thus claim a stake in the value the Company has derived and will derive from the use of that intellectual property after the Company terminated its supply agreement with Don Lee Farms. Based on the Company’s current knowledge, the Company has determined that the amount of any material loss or range of any losses that is reasonably possible to result from this lawsuit is not estimable.

Securities Related Litigation

On January 30, 2020, Larry Tran, a purported shareholder of Beyond Meat, filed a putative securities class action lawsuit in the United States District Court for the Central District of California against Beyond Meat and two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act and is premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to the Company’s public disclosures regarding the

25

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Company’s ongoing litigation with Don Lee Farms during the proposed class period of May 2, 2019 to January 27, 2020. The Court appointed a lead plaintiff and lead counsel on May 18, 2020, and a First Amended Complaint was filed on July 1, 2020. The First Amended Complaint names the same defendants, proposes the same class period, and similarly asserts claims under Sections 10(b) and 20(a) of the Exchange Act premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to the Company’s public disclosures regarding the Company’s ongoing litigation with Don Lee Farms. The Company filed a motion to dismiss on behalf of all defendants on July 31, 2020. The motion to dismiss briefing will be completed by mid-September 2020. The Company believes the claims are without merit and intends to vigorously defend all claims asserted. 

On March 16, 2020, Eric Weiner, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement.  The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 16, 2020, and the securities case brought against the Company. 

On March 18, 2020, Kimberly Brink and Melvyn Klein, purported shareholders of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 18, 2020, and the securities case brought against the Company.

On April 1, 2020, the United States District Court for the Central District of California entered an order consolidating the Weiner action and the Brink action for all purposes and designated the consolidated case In re: Beyond Meat, Inc. Derivative Litigation. On April 13, 2020, the Court entered an order appointing co-lead counsel for the consolidated derivative action. On June 23, 2020, the Court entered an order approving a Joint Stipulation Regarding Stay of Actions. Under the terms of the stay approval order, all proceedings in the consolidated derivative case are stayed until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

On May 27, 2020, Kevin Chew, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act and claims of breaches of fiduciary duty, relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to May 27, 2020. On June 16, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On June 17, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

26

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

On June 17, 2020, James Janolek, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 14(a) and 20(a) of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to June 17, 2020. On July 10, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On July 10, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

TCPA Litigation

On March 18, 2020, Nazrin Massaro filed a putative class action lawsuit in the United States District Court for the Southern District of California against Beyond Meat and People for the Ethical Treatment of Animals, Inc. (“PETA”). The lawsuit asserts claims under the Telephone Consumer Protection Act and alleges that PETA sent unsolicited text message advertisements promoting the Company’s products to the putative class members in violation of consumers’ privacy rights. The lawsuit further alleges that PETA and Beyond Meat arranged for PETA to market Beyond Meat’s products in exchange for monetary contributions from Beyond Meat. The plaintiff seeks injunctive relief and damages on behalf of herself and the putative class members. On May 29, 2020, Beyond Meat moved to dismiss or in the alternative stay this lawsuit, and on June 8, 2020, the plaintiff voluntarily dismissed her claims against Beyond Meat without prejudice. The Company believes the claims asserted in this lawsuit are without merit.

The Company is involved in various other legal proceedings, claims, and litigation arising in the ordinary course of business. Based on the facts currently available, the Company does not believe that the disposition of such matters that are pending or asserted will have a material effect on its financial statements.

Note 11. Income Taxes

For the three months ended June 27, 2020 and June 29, 2019, the Company recorded $16,000 and $21,000, respectively, in income tax expense, in its condensed consolidated statements of operations.

For the six months ended June 27, 2020 and June 29, 2019, the Company recorded $15,000 and $21,000, respectively, in income tax expense in its condensed consolidated statements of operations.

The Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized in the U.S. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against substantially all deferred tax assets. If the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets will be made and the adjustment would have the effect of increasing net income in the period such determination is made. 

As of June 27, 2020, the Company does not have any accrued interest or penalties related to uncertain tax positions. The Company’s policy is to recognize interest and penalties related to uncertain tax positions in income tax expense. The Company is subject to U.S. federal tax authority and U.S. state tax authority examinations for all years with respect to net operating loss and credit carryforwards.

27

BEYOND MEAT, INC.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”).  The CARES Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the U.S. economy and fund a nationwide effort to curtail the effect of COVID-19. While the CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions include removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. 

Due to the recent enactment of the CARES Act, the Company is currently evaluating the impact, if any, that the CARES Act will have on its financial position, results of operations or cash flows. Currently the Company does not expect the enactment of CARES Act will have a material impact on the Company’s financial position, results of operations or cash flows.

Note 12. Net Loss Per Share Available to Common Stockholders

The Company calculates basic and diluted net loss per share available to common stockholders in conformity with the two-class method required for companies with participating securities. Computation of net loss per share available to common stockholders for the three and six months ended June 27, 2020 excludes the dilutive effect of 4,562,663 option shares, 287,439 RSUs and 40,381 unvested restricted stock shares outstanding at June 27, 2020 because their inclusion would be anti-dilutive. Computation of net loss per share available to common stockholders for the three and six months ended June 27, 2020 also excludes adjustments under the two-class method relating to a liability classified, share-settled obligation to an executive officer to deliver a variable number of shares based on a fixed monetary amount because the shares to be delivered are not participating securities as they do not have voting rights and are not entitled to participate in dividends until they are issued. Computation of net loss per share available to common stockholders for the three and six months ended June 29, 2019 excludes the dilutive effect of 6,559,565 potential common shares outstanding at June 29, 2019 because their inclusion would be anti-dilutive.

(in thousands, except share and per share amounts)	Three Months Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Numerator:
Net loss available to common stockholders	$	(10,205)	$	(9,441)	$	(8,390)	$	(16,090)
Denominator:
Weighted average common shares outstanding—basic	62,098,861		39,081,359		61,904,360		23,206,203
Dilutive effect of shares issuable under stock options	—		—		—		—
Dilutive effect of RSUs	—		—		—		—
Dilutive effect of share-settled obligation	—		—		—		—
Weighted average common shares outstanding—diluted	62,098,861		39,081,359		61,904,360		23,206,203
Net loss per share available to common stockholders—basic and diluted	$	(0.16)	$	(0.24)	$	(0.14)	$	(0.69)

28

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part I, Item 1A, “Risk Factors,” of our 2019 Form 10-K and Part II, Item 1A, “Risk Factors” and “Note Regarding Forward-Looking Statements” included in this report and those discussed in other documents we file from time to time with the SEC. The following discussion of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes and other financial information included in this quarterly report and our audited financial statements and notes thereto included in our 2019 10-K. Our historical results are not necessarily indicative of the results to be expected for any future periods and our operating results for the three and six months ended June 27, 2020 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2020 or for any other interim period or for any other future year or period.

Overview

Beyond Meat is one of the fastest growing food companies in the United States, offering a portfolio of revolutionary plant-based meats. We build meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating our plant-based meat products. Our brand commitment, Eat What You Love, represents a strong belief that by eating our plant-based meats, consumers can enjoy more, not less, of their favorite meals, and by doing so help address concerns related to human health, climate change, resource conservation, and animal welfare. The success of our breakthrough innovation model and products has allowed us to appeal to a broad range of consumers, including those who typically eat animal-based meats, positioning us to compete directly in the $1.4 trillion global meat industry.

We sell a range of plant-based products across the three main meat platforms of beef, pork and poultry. As of June 27, 2020, our products were available at approximately 112,000 retail and foodservice outlets in 85 countries worldwide, across mainstream grocery, mass merchandiser, club, convenience store, and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools.

On May 6, 2019, we completed our initial public offering (“IPO”) of common stock, in which we sold 11,068,750 shares. The shares began trading on the Nasdaq Global Select Market on May 2, 2019. The shares were sold at a public offering price of $25.00 per share for net proceeds of approximately $252.4 million, after deducting underwriting discounts and commissions of $19.4 million and issuance costs of approximately $4.9 million payable by us. Upon the closing of the IPO, all outstanding shares of our convertible preferred stock automatically converted into 41,562,111 shares of common stock on a one-for-one basis, and warrants exercisable for convertible preferred stock were automatically converted into warrants exercisable for 160,767 shares of common stock.

On August 5, 2019, we completed our secondary public offering (“Secondary Offering”) of common stock, in which we sold 250,000 shares. The shares were sold at a public offering price of $160.00 per share for net proceeds to us of approximately $37.4 million, after deducting underwriting discounts and commissions of $1.5 million and issuance costs of approximately $1.1 million payable by us. We did not receive any proceeds from the sale of common stock by the selling stockholders in the Secondary Offering.

On January 14, 2020, we registered our new subsidiary, Beyond Meat EU B.V., in the Netherlands. On April 28, 2020, we registered our new subsidiary, Beyond Meat (Jiaxing) Food Co., Ltd., in the Zhejiang Province in China. The condensed consolidated financial statements for the periods ended June 27, 2020 include the accounts of the Company and these subsidiaries. All inter-company balances and transactions have been eliminated.

Our primary production facilities are located in Columbia, Missouri, and research and development and administrative offices are located in El Segundo, California. In addition to our own production facilities, we use

29

co-manufacturers in various locations in the United States, Canada and the Netherlands. In the three months ended June 27, 2020, we acquired our first manufacturing facility in Europe located in Enschede, the Netherlands. This facility is expected to be operational by the end of 2020. In addition, in June 2020 we announced the official opening of a new co-manufacturing facility to be used for Beyond Meat production built by our distributor in the Netherlands.

We operate on a fiscal calendar year, and each interim quarter is comprised of one 5-week period and two 4-week periods, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth fiscal quarters may have more or fewer days included than a traditional 91-day fiscal quarter.

Impact of COVID-19 on Our Business

The COVID-19 pandemic has had, and we expect will continue to have certain negative impacts on our business. As government authorities continue to institute restrictions on commercial operations, while at the same time implementing multi-step policies with the goal of re-opening certain markets, we are working to ensure our compliance while also maintaining business continuity for essential operations in our facilities.

While our manufacturing facilities remain operational, beginning in March 2020 employees at our corporate headquarters began working remotely. For essential activities at our Manhattan Beach Project Innovation Center, we are strictly limiting the number of employees allowed in the building and have implemented physical distancing protocols, mandatory face coverings, temperature screening of all personnel entering the site, and comprehensive preventative hygienic measures to support the health and safety of our employees. We expect our corporate headquarters employees to remain working remotely pending further notice and guidelines from local, state and federal agencies. At our manufacturing facilities, we have implemented a series of physical distancing and hygienic practices to further support the health and safety of our manufacturing employees. Our manufacturing employees are operating at extremely low density; all are being monitored for COVID-19 symptoms, including temperature screening of all personnel entering the site; and are following strict COVID-19 suggested Personal Protective Equipment guidelines per United States Centers for Disease Control and World Health Organization, including mandatory face coverings, increased hand washing and significantly increased sanitation of hard surfaces. All non-essential company-sponsored travel has been suspended and field marketing activities have been curbed due to the COVID-19-related restrictions.

We have established a cross-functional task force that meets regularly and continually monitors and tracks relevant data including guidance from local, national, and international health agencies. This task force works closely with our senior leadership and is instrumental in making critical, timely decisions and is committed to continuing to communicate to our employees as more information is available to share.

We experienced a significant slowdown in our foodservice business beginning in the latter half of March and continuing through the second quarter of 2020 due to the ongoing COVID-19 pandemic as various regions around the world implemented stay-at-home orders, social distancing measures and various restrictions on commercial operations, resulting in the closure or limited operations of many of our foodservice customers. Such closures or scaled back operations have also resulted in delays in tests or launches of our products among our foodservice customers. Additionally, while we were able to increase our total foodservice distribution points globally by approximately 8,000 outlets during the second quarter of 2020, such increase in distribution has not offset decreased demand in the channel due to the conditions described above.

The COVID-19 pandemic had a significant negative impact on our foodservice channel net revenues in the second quarter of 2020 relative to what we experienced in the first quarter of 2020 and we are unable to predict when this negative impact will reverse. For the three months ended June 27, 2020 and March 28, 2020, we generated total foodservice channel net revenues of $13.7 million and $41.2 million, respectively, a decrease of 201%. We continue to partner with our QSR and foodservice customers during this challenging environment, and during the quarter offered promotional programs to many of our foodservice partners to allow them to offer our products to consumers at reduced price points or on other promotional terms. While we are beginning to see some improvement in demand in our foodservice business, the environment remains highly uncertain given the ongoing pandemic and we expect revenues in our foodservice channel will continue to be significantly negatively impacted through at least the remainder of 2020.

30

At the same time, during the second quarter of 2020 we experienced a meaningful increase in retail demand as consumers have shifted toward more at-home consumption. In response to the deterioration in the foodservice business and the significant shift in consumer preferences to retail, during the quarter we re-purposed and re-routed a certain portion of our existing foodservice inventory into retail SKUs. These activities led to increased net revenues in our retail channel and at the same time negatively impacted our gross profit and gross margin in the second quarter of 2020 due to increased expenses associated with such activities and the write-off of unrecoverable portions of the original foodservice inventory items. Following the re-balancing of our finished goods inventory through these efforts, we currently do not anticipate a need for further repacking activity.

Our net revenues in the retail channel increased significantly during the quarter primarily driven by our expansion in total retail outlets, higher sales velocity at existing retail outlets and new product introductions. We also offered promotional and reduced pricing to certain of our retail customers to encourage greater consumer trial amid temporary dislocations in the animal protein market. The resulting change in mix of our distribution channels has been significant. For the year ended December 31, 2019, our U.S. retail and U.S. foodservice channels accounted for approximately 43.4% and 23.6% of our net revenues, respectively. For the quarter ended June 27, 2020, our U.S. retail and U.S. foodservice channels accounted for approximately 79.4% and 5.7% of our net revenues, respectively. For the three months ended June 27, 2020, we generated retail net revenues of $99.6 million, an increase of 191.9%, while foodservice net revenues declined 58.6% compared to the prior-year period.

In response to the COVID-19 pandemic, in the second quarter of 2020 we also launched our Feed A Million + campaign where we, with the support of our brand ambassadors and other partners, pledged to donate and distribute more than one million Beyond Burgers at no cost to food banks, healthcare workers, frontline responders and communities in need across the country. As of June 27, 2020, we have donated more than five million Beyond Burgers and nourishing meals to this cause.

In the second quarter of 2020, we also experienced a significant increase in our inventory balance of $143.0 million compared to $120.7 million at the end of the first quarter of 2020, driven by an increase in raw materials, specifically our core pea protein inputs, which was partially offset by a reduction of our finished goods and work in process inventory levels during the quarter. We source ingredients from multiple suppliers from around the world with our plant-based proteins coming from suppliers in the United States, the EU, China and India. We also maintain inventory positions near our manufacturing operations, as well as floor stock agreements with many of our vendors. With respect to pea protein, given the nature of our contractual commitments, our volume deliveries are front loaded during the year in anticipation of higher demand levels during the summer season. Given that we scaled back our production in response to the COVID-19 pandemic and to reduce our existing finished goods and work in process inventory levels, we have seen an increase in our pea protein stocks. However, in light of the expected shelf life of our pea protein raw materials, we do not believe there is a risk of inventory obsolescence of these raw materials at this time.

It is challenging to estimate the extent of the adverse impact of the COVID-19 pandemic on our results of operations, due to continued uncertainty regarding the duration, magnitude and effects of the COVID-19 pandemic, further spread and resurgences of the disease, potential supply chain or manufacturing disruptions, and the magnitude of reduced customer traffic at our foodservice customers, or the extent to which they may be offset by increased retail demand, increasing consumer awareness of the benefits of plant-based meat products, or potential continued disruptions in the supply of conventional animal proteins. We also are unable to predict whether the increase in demand by our retail customers will continue at the levels experienced in the second quarter of 2020. While the ultimate health and economic impact of the COVID-19 pandemic is highly uncertain, we expect that our business operations and results of operations, including our net revenues, gross profit, gross margin, earnings and cash flows, will be adversely impacted for at least the balance of 2020, including as a result of:

•potential disruption to the supply chain caused by distribution and other logistical issues;

•continued weak demand in the foodservice channel from decreased foot traffic in foodservice establishments and the significant level of demand shift from foodservice to retail business;

31

•increased cost of goods sold and increased promotional programs to our retail and foodservice customers resulting in negative impacts on our gross margins;

•potential disruption or closure of our facilities or those of our suppliers or co-manufacturers due to employee contraction of COVID-19;

•resumption of any expansion plans for our product lines for those quick-service restaurant (“QSR”) customers who are in trial or test phase;

•reduced consumer confidence and consumer spending, (including as a result of lower discretionary income due to unemployment or reduced or limited work as a result of measures taken in response to the pandemic), including spending to purchase our products; and negative trends in consumer purchasing patterns due to consumers’ disposable income, credit availability and debt levels;

•continued foodservice customer closures (including re-closures in the event of one or more resurgences of COVID-19) or further reduced operations;

•our ability to introduce new foodservice products as QSR and other partners look to simplify menu offerings as a result of the pandemic;

•uncertain economic outlook in the U.S. and worldwide;

•uncertainty in the length of recovery time for the U.S. and world economies; and

•disruptions in our ability to expand to new international locations.

We are focused on navigating these recent challenges presented by COVID-19 through offensive measures, such as switching foodservice production lines over to retail products, selling retail value packs and offering aggressive pricing with a strategic opportunity to encourage consumer trials, as well as defensive measures focused on reducing or delaying discretionary spending in areas where effectiveness has been impeded by the pandemic, and streamlining operations, including furloughs and headcount reductions in light of inventory levels, demand shifts and company-wide capacity planning. We expect these actions will continue to negatively impact our gross margins and profitability for the remainder of 2020.

Components of Our Results of Operations and Trends and Other Factors Affecting Our Business

Net Revenues

We generate net revenues primarily from sales of our products to our customers across mainstream grocery, mass merchandiser, club, convenience store, and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Effective January 1, 2020, we began presenting net revenues by geography and distribution channel as follows:

Distribution Channel	Description
U.S. Retail	Net revenues from retail sales to the U.S. market
U.S. Foodservice	Net revenues from restaurant and foodservice sales to the U.S. market
International Retail	Net revenues from retail sales to international markets, including Canada
International Foodservice	Net revenues from restaurant and foodservice sales to international markets, including Canada

Net revenues from sales to the Canadian market, previously included with net revenues from sales to the U.S. market, have been reclassified to International net revenues. Prior period amounts have been recast to conform to the current period presentation. The foregoing change in presentation had no impact on our net revenues, results of operations or cash flows.

Effective January 1, 2020, we also eliminated the presentation of net revenues by platform as it is no longer material to an understanding of our financial results. Previously, we presented net revenues by platform for our

32

“ready-to-cook” or fresh platform, and “ready-to-heat” or frozen platform. Gross revenues from sales of products in our frozen platform were 5.5% of gross revenues in the year ended December 31, 2019, as compared to 16.3% of gross revenues in the year ended December 31, 2018.

The following table presents our 2019 quarterly net revenues by channel (unaudited):

	Three Months Ended
(in thousands)	March 30, 2019		June 29, 2019		September 28, 2019		December 31, 2019
U.S.:
Retail	$	19,461	$	30,531	$	44,170	$	35,221
Foodservice	8,834		16,504		18,359		26,675
U.S. net revenues	28,295		47,035		62,529		61,896
International:
Retail	118		3,589		6,295		5,424
Foodservice	11,793		16,627		23,137		31,159
International net revenues	11,911		20,216		29,432		36,583
Net revenues	$	40,206	$	67,251	$	91,961	$	98,479

The following factors and trends in our business have driven net revenue growth over prior periods and are expected to be key drivers of our net revenue growth, subject to the duration, magnitude and effects of the COVID-19 pandemic:

•increased penetration across our retail channel, including mainstream grocery, mass merchandiser, club, convenience store, and natural retailer channels, and our foodservice channel, including increased desire by foodservice establishments, including large full service restaurants and/or global QSR customers, to add plant-based products to their menus and to highlight these offerings;

•distribution expansion, increased sales velocity, household penetration and repeat buying rates across our channels;

•increased international sales of our products across geographies, markets and channels as we continue to grow our numbers of international customers;

•our continued innovation, including enhancing existing products and introducing new products across our plant-based beef, pork and poultry platforms that appeal to a broad range of consumers, including those who typically eat animal-based meat;

•enhanced marketing efforts as we continue to build our brand and drive consumer adoption of our products, including scaling our GO BEYOND marketing campaign, which seeks to mobilize our ambassadors to welcome consumers to the brand, define the category and remain its leader;

•overall market trends, including growing consumer awareness and demand for nutritious, convenient and high protein plant-based foods; and

•increased production levels as we scale production to meet demand for our products across our distribution channels both domestically and internationally.

In addition to the factors and trends above, we expect the following to positively impact net revenues going forward, subject to the duration, magnitude and effects of the COVID-19 pandemic:

•expansion of our own internal production facilities domestically and abroad to produce our woven proteins, blends of flavor systems and binding systems, and potentially convert our woven proteins into packaged products, while forming additional strategic relationships with co-manufacturers; and

•localized production and third-party partnerships to increase the availability and speed with which we can get our products to customers internationally.

33

We distribute our products internationally, using distributors in 85 countries worldwide as of June 27, 2020. In addition to our own production facilities, we use co-manufacturers in various locations in the United States, Canada and the Netherlands. International net revenues decreased 16.8% in the three months ended June 27, 2020, and increased 28.7% in the six months ended June 27, 2020 as compared to the respective prior-year periods.

As we seek to continue to rapidly grow our net revenues, we face several challenges. The COVID-19 pandemic has continued to spread and has already caused severe global disruptions. The extent of COVID-19’s effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. For example, the impact of COVID-19 on any of our suppliers, co-manufacturers, distributors or transportation or logistics providers may negatively affect the price and availability of our ingredients and/or packaging materials and impact our supply chain. Additionally, if we are forced to scale back hours of production or close our production facilities or our Manhattan Beach Project Innovation Center in response to the pandemic, we expect our business, financial condition and results of operations would be materially adversely affected. In addition, our growth strategy to expand our operations internationally may be impeded. We may also be impacted by decreased customer and consumer demand as a result of event cancellations and social distancing, government-imposed restrictions on public gatherings and businesses, shelter-in place orders and temporary restaurant and retail store closures and operating restrictions. Due to its global spread and unprecedented impact, the pandemic could have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our common stock.

We routinely offer sales discounts and promotions through various programs to customers and consumers. These programs include rebates, temporary on-shelf price reductions, buy-one-get-one-free programs, off-invoice discounts, retailer advertisements, product coupons and other trade activities. In addition, in response to the COVID-19 pandemic, in the second quarter of 2020 we also donated more than five million Beyond Burgers and nourishing meals at no cost to food banks, healthcare workers, frontline responders and communities in need across the country as part of our Feed A Million+ pledge. We anticipate that we will need to continue to offer more trade and promotion discounts to both our retail and foodservice customers, to drive increased consumer trial and in response to the COVID-19 pandemic. The expense associated with these discounts and promotions is estimated and recorded as a reduction in total gross revenues in order to arrive at reported net revenues. We anticipate that these promotional activities will impact our net revenues as well as negatively impact our gross margins and that changes in such activities will impact period-over-period results.

In addition, because we do not have any purchase commitments from our distributors or customers, the amount of net revenues we recognize will vary from period to period depending on the volume, and the channels through which our products are sold, causing variability in our results. 

We expect to face increasing competition across all channels, especially as additional plant-based protein product brands continue to enter the marketplace.

Gross Profit

Gross profit consists of our net revenues less cost of goods sold. Our cost of goods sold primarily consists of the cost of raw materials and ingredients for our products, direct labor and certain supply costs, co-manufacturing fees, in-bound and internal shipping and handling costs incurred in manufacturing our products, plant and equipment overhead, depreciation and amortization expense, as well as the cost of packaging our products. In order to keep pace with demand, we have had to very quickly scale production and we have not always been able to meet all demand for our products. As a result, we have had to quickly expand our sources of supply for our core protein inputs such as pea protein. Our growth has also significantly increased facility and warehouse utilization rates. We intend to continue to increase our production capabilities at our two in-house manufacturing facilities in Columbia, Missouri, while expanding our co-manufacturing capacity and exploring additional production facilities domestically and abroad. In the three months ended June 27, 2020, we acquired our first manufacturing facility in Europe located in Enschede, the Netherlands. This facility is expected to be operational by the end of 2020. In addition, in June 2020 we announced the official opening of a new co-manufacturing facility to be used for Beyond Meat production built by our distributor in the Netherlands. As a

34

result of these expansion initiatives, we expect our cost of goods sold in absolute dollars will continue to increase to support our growth.

In addition, in response to the deterioration in the foodservice business and the significant shift in consumer preferences to retail, during the quarter we re-purposed and re-routed a certain portion of our existing foodservice inventory into retail SKUs. These activities increased our costs of goods sold and negatively impacted our gross profit and gross margin in the second quarter of 2020 due to increased expenses associated with such activities and the write-off of unrecoverable portions of the original foodservice inventory items. Following the re-balancing of our finished goods inventory through these efforts, we currently do not anticipate a need for further repacking activity.

Over the next several years, subject to the duration, magnitude and effects of the COVID-19 pandemic, we continue to expect that gross profit improvements will be delivered primarily through improved volume leverage and throughput, greater internalization and geographic localization of our manufacturing footprint, including co-manufacturing in Canada and the Netherlands, materials and packaging input cost reductions, tolling fee efficiencies, and improved supply chain logistics and distribution costs. We intend to pass some of these cost savings on to the consumer as we pursue our goal to achieve price parity with animal protein in at least one of our product categories by 2024.

We are also working to improve gross margin through ingredient cost savings achieved through scale of purchasing and through expanding our co-manufacturing network and negotiating lower tolling fees. However, in the near term, margin improvements were impacted by repacking costs as we repurposed a certain portion of our existing foodservice inventory into retail SKUs in response to shifts in consumer demand due to COVID-19. Margin improvement may also be impacted by our focus on growing our customer base, volume deleveraging, aggressive pricing strategies and increased discounting, expanding into new geographies and markets, enhancing our production infrastructure, improving our innovation capabilities, enhancing our product offerings and increasing consumer engagement.

Operating Expenses

Research and Development Expenses

Research and development expenses consist primarily of personnel and related expenses for our research and development staff, including salaries, benefits, bonuses, and share-based compensation, scale-up expenses, and depreciation and amortization expense on research and development assets. Our research and development efforts are focused on enhancements to our product formulations and production processes in addition to the development of new products. We expect to continue to invest substantial amounts in research and development, as research and development and innovation are core elements of our business strategy, and we believe they represent a critical competitive advantage for us. We believe that we need to continue to rapidly innovate in order to continue to capture a larger market share of consumers who typically eat animal-based meats. We expect these expenses to increase in absolute dollars, but to decrease as a percentage of net revenues as we continue to scale production.

SG&A Expenses

SG&A expenses consist primarily of selling, marketing and administrative expenses, including personnel and related expenses, share-based compensation, outbound shipping and handling costs, non-manufacturing lease expense, depreciation and amortization expense on non-manufacturing assets and other non-production operating expenses. Marketing and selling expenses include share-based compensation awards to brand ambassadors, advertising costs, costs associated with consumer promotions, product samples and sales aids incurred to acquire new customers, retain existing customers and build our brand awareness. Administrative expenses include the expenses related to management, accounting, legal, IT, and other office functions.

We expect SG&A expenses in absolute dollars to increase as we increase our domestic and international expansion efforts, expand our marketing efforts, and incur costs related to our status as a public company. In response to the COVID-19 pandemic, we expect to undertake measures focused on reducing or delaying discretionary spending in areas where effectiveness has been impeded by the pandemic, and streamlining

35

operations, including furloughs and headcount reductions, in light of inventory levels, demand shifts and company-wide capacity planning.

Restructuring Expenses

In May 2017, management approved a plan to terminate an exclusive supply agreement with one of our co-manufacturers. See “Results of Operations—Three and Six Months Ended June 27, 2020 Compared to Three and Six Months Ended June 29, 2019—Restructuring Expenses” for a discussion of these expenses.

Seasonality

Generally, we expect to experience greater demand for certain of our products during the summer grilling season. As our business continues to grow, we expect to see additional seasonality effects, especially within our retail channel, with revenue contribution from this channel tending to be greater in the second and third quarters of the year. In an environment of uncertainty from the impact of COVID-19, we are unable to assess the ultimate impact on the demand for our products as a result of seasonality.

Results of Operations

The following table sets forth selected items in our condensed consolidated statements of operations for the periods presented:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net revenues	$	113,338	$	67,251	$	210,412	$	107,457
Cost of goods sold	79,687		44,510		139,070		73,945
Gross profit	33,651		22,741		71,342		33,512
Research and development expenses	6,016		4,212		12,210		8,710
Selling, general and administrative expenses	34,292		15,515		61,607		26,692
Restructuring expenses	1,509		847		3,882		1,241
Total operating expenses	41,817		20,574		77,699		36,643
(Loss) income from operations	$	(8,166)	$	2,167	$	(6,357)	$	(3,131)

The following table presents selected items in our condensed consolidated statements of operations as a percentage of net revenues for the periods presented:

	Three Months Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of goods sold	70.3		66.2		66.1		68.8
Gross profit	29.7		33.8		33.9		31.2
Research and development expenses	5.3		6.3		5.8		8.1
Selling, general and administrative expenses	30.3		23.1		29.3		24.8
Restructuring expenses	1.3		1.3		1.8		1.2
Total operating expenses	36.9		30.6		36.9		34.1
(Loss) income from operations	(7.2)	%	3.2	%	(3.0)	%	(2.9)	%

36

Three and Six Months Ended June 27, 2020 Compared to Three and Six Months Ended June 29, 2019

Net Revenues

Net revenues increased by $46.1 million, or 68.5%, and $103.0 million, or 95.8%, in the three and six months ended June 27, 2020, respectively, as compared to the prior-year periods primarily due to an increase in volume sold, partially offset by lower net price per pound driven by our strategic investments in promotional activity intended to encourage greater consumer trial. Growth in volume sold was driven mainly by increased retail channel sales, resulting from distribution gains both domestically and abroad, higher sales velocities at existing retail customers, and contribution from new product introductions, partially offset by lower net price per pound. During the second quarter ended June 27, 2020, increased retail channel sales were partially offset by a reduction in foodservice channel sales as a result of the ongoing COVID-19 pandemic and the impact of widespread domestic and international stay-at-home orders, social distancing measures and various restrictions on commercial operations, resulting in the closure or limited operations of many of our foodservice customers.

The following table presents our net revenues by channel in the second quarter of 2020 as compared to the prior-year period:

	Three Months Ended				Change
(in thousands)	June 27, 2020		June 29, 2019		Amount		%
U.S.:
Retail	$	90,040	$	30,531	$	59,509	194.9	%
Foodservice	6,486		16,504		(10,018)		(60.7)	%
U.S. net revenues	96,526		47,035		49,491		105.2	%
International:
Retail	9,572		3,589		5,983		166.7	%
Foodservice	7,240		16,627		(9,387)		(56.5)	%
International net revenues	16,812		20,216		(3,404)		(16.8)	%
Net revenues	$	113,338	$	67,251	$	46,087	68.5	%

Net revenues from U.S. retail sales in the three months ended June 27, 2020 increased $59.5 million, or 194.9%, primarily due to increases in sales of Beyond Beef, Beyond Burger and Beyond Beef Crumble. U.S. retail sales of Beyond Beef, Beyond Burger and Beyond Beef Crumble in the three months ended June 27, 2020 increased approximately 919%, 205% and 64%, respectively, as compared to the prior-year period. Approximately 4% of the increase in U.S. retail sales was due to the introduction of Beyond Breakfast Sausage at retail during the second quarter of 2020.

Net revenues from U.S. foodservice sales in the three months ended June 27, 2020 decreased $10.0 million, or 60.7%, primarily due to decreases in sales of Beyond Burger, Beyond Beef Crumble and Beyond Sausage due to the impact of COVID-19, partially offset by an increase in sales of Beyond Breakfast Sausage which contributed approximately 29% of U.S. foodservice sales in the second quarter of 2020. Our products were available at approximately 26,000 U.S. retail outlets and 39,000 U.S. foodservice outlets as of June 27, 2020.

Net revenues from international retail sales in the three months ended June 27, 2020 increased $6.0 million, or 166.7%, primarily due to increase in sales of Beyond Beef and Beyond Sausage.

Net revenues from international foodservice sales in the three months ended June 27, 2020 decreased $9.4 million, or 56.5%, primarily due to the impact of COVID-19. Our products were available at approximately 47,000 international retail and foodservice outlets as of June 27, 2020.

37

The following table presents our net revenues by channel in the first half of 2020 as compared to the prior-year period:

	Six Months Ended				Change
(in thousands)	June 27, 2020		June 29, 2019		Amount		%
U.S.:
Retail	$	139,963	$	49,992	$	89,971	180.0	%
Foodservice	29,117		25,338		3,779		14.9	%
U.S. net revenues	169,080		75,330		93,750		124.5	%
International:
Retail	15,524		3,707		11,817		318.8	%
Foodservice	25,808		28,420		(2,612)		(9.2)	%
International net revenues	41,332		32,127		9,205		28.7	%
Net revenues	$	210,412	$	107,457	$	102,955	95.8	%

Net revenues from U.S. retail sales in the six months ended June 27, 2020 increased $90.0 million, or 180.0%, primarily due to increases in sales of Beyond Beef, Beyond Burger, Beyond Sausage and Beyond Beef Crumble. U.S. retail sales of Beyond Beef, introduced at retail in June 2019, increased approximately 1,524% in the six months ended June 27, 2020 as compared to the prior-year period. U.S. retail sales of Beyond Burger, Beyond Sausage and Beyond Beef Crumble increased approximately 191%, 88% and 34%, respectively, as compared to the prior-year period. Approximately 3% of the increase in U.S. retail sales in the six months ended June 27, 2020 was due to the introduction of Beyond Breakfast Sausage at retail during the second quarter of 2020.

Net revenues from U.S. foodservice sales in the six months ended June 27, 2020 increased $3.8 million, or 14.9%, primarily due to sales of Beyond Breakfast Sausage and Beyond Beef, partially offset by decreases in sales of Beyond Burger, Beyond Beef Crumble and Beyond Sausage, primarily due to the impact of COVID-19.

Net revenues from international retail sales in the six months ended June 27, 2020 increased $11.8 million, or 318.8%, primarily due to increases in sales of Beyond Beef, Beyond Burger and Beyond Sausage which in the aggregate accounted for approximately 145% of the increase in international sales from the prior-year period. Net revenues from international foodservice sales in the six months ended June 27, 2020 decreased $2.6 million, or 9.2%, primarily due to the impact of COVID-19.

38

The following table presents consolidated volume of our products sold in pounds for the periods presented:

	Three Months Ended		Change			Six Months Ended		Change
(in thousands)	June 27, 2020	June 29, 2019	Amount	%		June 27, 2020	June 29, 2019	Amount	%
Volume of products sold:
U.S.:
Retail	15,211	4,536	10,675	235.3	%	23,657	7,746	15,911	205.4	%
Foodservice	1,366	2,735	(1,369)	(50.1)	%	5,432	4,182	1,250	29.9	%
International:
Retail	1,882	508	1,374	270.5	%	2,710	524	2,186	417.2	%
Foodservice	1,458	3,717	(2,259)	(60.8)	%	4,770	5,882	(1,112)	(18.9)	%
Volume of products sold	19,917	11,496	8,421	73.3	%	36,569	18,334	18,235	99.5	%

Cost of Goods Sold

	Three Months Ended				Change				Six Months Ended				Change
(in thousands)	June 27, 2020		June 29, 2019		Amount		%		June 27, 2020		June 29, 2019		Amount		%
Cost of goods sold	$	79,687	$	44,510	$	35,177	79.0	%	$	139,070	$	73,945	$	65,125	88.1	%

Cost of goods sold increased by $35.2 million, or 79.0%, to $79.7 million, in the three months ended June 27, 2020 as compared to the prior-year period. Cost of goods sold in the three months ended June 27, 2020 increased to 70.3% of net revenues from 66.2% of net revenues in the prior-year period. Cost of goods sold increased by $65.1 million, or 88.1%, to $139.1 million, in the six months ended June 27, 2020 as compared to the prior-year period. Cost of goods sold in the six months ended June 27, 2020 decreased to 66.1% of net revenues from 68.8% of net revenues in the prior-year period. The dollar increase in cost of goods sold in the three and six months ended June 27, 2020 was primarily due to the increase in the sales volume of our products and included $5.9 million associated with product repacking activities driven by our efforts to repurpose certain foodservice inventory into retail products in the second quarter of 2020 as a result of the sudden shift in consumer demand related to COVID-19. Following these repacking activities, we have rebalanced our mix of finished goods inventory between retail and foodservice products and we currently do not anticipate a need for further repacking activity.

Gross Profit and Gross Margin

	Three Months Ended						Change				Six Months Ended						Change
(in thousands)	June 27, 2020			June 29, 2019			Amount		%		June 27, 2020			June 29, 2019			Amount		%
Gross profit	$	33,651		$	22,741		$	10,910	48.0	%	$	71,342		$	33,512		$	37,830	112.9	%
Gross margin	29.7		%	33.8		%	(410) bps		N/A		33.9		%	31.2		%	270 bps		N/A

Gross profit in the three months ended June 27, 2020 was $33.7 million as compared to gross profit of $22.7 million in the prior-year period, an improvement of $10.9 million, primarily due to the increase in volume of products sold, direct materials and packaging input cost savings, and direct labor and variable cost efficiencies. Gross margin in the three months ended June 27, 2020 declined to 29.7% from 33.8% in

39

the prior-year period. The decline in gross margin in the three months ended June 27, 2020 was primarily due to $5.9 million in costs associated with product repacking activities driven by our efforts to repurpose certain foodservice inventory into retail products in the second quarter of 2020 as a result of the sudden shift in consumer demand related to COVID-19.

Gross profit in the six months ended June 27, 2020 was $71.3 million as compared to gross profit of $33.5 million in the prior-year period, an improvement of $37.8 million. Gross margin in the six months ended June 27, 2020 increased to 33.9% from 31.2% in the prior-year period. The increase in gross profit and the improvement in gross margin were primarily due to the increase in volume of products sold, direct materials and packaging input cost savings, and direct labor and variable cost efficiencies, partially offset by the repacking costs attributable to COVID-19. We include outbound shipping and handling costs within SG&A expenses. As a result, our gross profit and gross margin may not be comparable to other entities that present shipping and handling costs as a component of cost of goods sold.

Research and Development Expenses

	Three Months Ended				Change				Six Months Ended				Change
(in thousands)	June 27, 2020		June 29, 2019		Amount		%		June 27, 2020		June 29, 2019		Amount		%
Research and development expenses	$	6,016	$	4,212	$	1,804	42.8	%	$	12,210	$	8,710	$	3,500	40.2	%

Research and development expenses increased $1.8 million, or 42.8%, and $3.5 million, or 40.2%, in the three and six months ended June 27, 2020, respectively, as compared to the prior-year periods. Research and development expenses decreased to 5.3% and 5.8% of net revenues in the three and six months ended June 27, 2020, respectively, from 6.3% and 8.1% of net revenues, respectively, in the prior-year periods. Research and development expenses in the three and six months ended June 27, 2020 increased primarily due to higher headcount, higher scale-up expenses, higher consulting expenses and higher depreciation and amortization expense compared to the prior-year periods.

SG&A Expenses

	Three Months Ended				Change				Six Months Ended				Change
(in thousands)	June 27, 2020		June 29, 2019		Amount		%		June 27, 2020		June 29, 2019		Amount		%
Selling, general and administrative expenses	$	34,292	$	15,515	$	18,777	121.0	%	$	61,607	$	26,692	$	34,915	130.8	%

SG&A expenses increased $18.8 million, or 121.0%, in the three months ended June 27, 2020. SG&A expenses increased to 30.3% of net revenues in the three months ended June 27, 2020, from 23.1% of net revenues in the prior-year period. The increase was primarily due to $5.4 million in higher share-based compensation expense, $4.8 million in higher salaries and related expenses resulting from higher headcount, $1.6 million in higher expense related to product donations for our Feed A Million+ campaign attributable to COVID-19 relief efforts, $1.3 million in higher broker and distributor commissions, $0.7 million in higher public company-related expenses, $0.7 million in general insurance costs, $0.6 million in higher legal expenses, and continued investment in marketing capabilities.

SG&A expenses increased $34.9 million, or 130.8%, in the six months ended June 27, 2020. SG&A expenses increased to 29.3% of net revenues in the six months ended June 27, 2020, from 24.8% of net revenues in the prior-year period. The increase was primarily due to $10.1 million in higher share-based compensation expense, $8.2 million in higher salaries and related expenses resulting from higher headcount,

40

$2.8 million in higher expense related to product donations for our Feed A Million+ campaign attributable to COVID-19 relief efforts, $2.4 million in higher broker and distributor commissions, $2.0 million in higher legal expenses, $1.2 million in higher public company-related expenses, and continued investment in marketing capabilities. The increase in share-based compensation expense in the three and six months ended June 27, 2020 was primarily due to appreciation in our stock price as well as substantially higher staffing levels versus the prior-year periods.

Restructuring Expenses

As a result of the termination in May 2017 of an exclusive supply agreement with one of our co- manufacturers due to non-performance under the agreement, we recorded restructuring expenses of $1.5 million and $0.8 million in the three months ended June 27, 2020 and June 29, 2019, respectively, and $3.9 million and $1.2 million in the six months ended June 27, 2020 and June 29, 2019, respectively. The restructuring expenses were primarily related to legal and other expenses associated with the dispute. The amount incurred in the six months ended June 27, 2020 includes transition costs associated with our substitution of legal counsel during the first quarter. As of June 27, 2020 and December 31, 2019, there were $2.3 million and $1.1 million, respectively, in accrued and unpaid restructuring expenses representing legal fees. We continue to incur legal fees in connection with our ongoing efforts to resolve this dispute. See Note 3, Restructuring, to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report and Legal Proceedings in Part II, Item 1 of this report.

Total Other Expense, Net

Total other expense, net in each of the three and six months ended June 27, 2020 was $2.0 million, compared to $11.6 million and $12.9 million in the three and six months in the prior-year period. Total other expense, net, in the three and six months ended June 27, 2020 includes interest expense on our debt balances and loss on early extinguishment of debt, partially offset by foreign currency transaction gains and interest income. Total other expense, net in the three and six months ended June 29, 2019 includes interest on our debt balances and expense associated with the remeasurement of our warrant liability, partially offset by interest income.

(Loss) Income from Operations

Loss from operations in the three months ended June 27, 2020 was $8.2 million compared to income from operations of $2.2 million in the prior-year period. Loss from operations in the six months ended June 27, 2020 was $6.4 million compared to $3.1 million in the prior-year period. The increase in loss from operations in the three and six months ended June 27, 2020 was driven by the year-over-year increase in cost of goods sold, higher operating expenses to support increased personnel levels to support the Company’s long-term growth, higher share-based compensation expense, increases in the Company’s marketing initiatives, continued investments in innovation, product donation costs related to the Company’s COVID-19 relief campaign, investments in international expansion initiatives, and higher restructuring expenses, partially offset by the increase in gross profit during the periods.

Net Loss

Net loss was $10.2 million and $8.4 million in the three and six months ended June 27, 2020, respectively, compared to net loss of $9.4 million and $16.1 million in the prior-year periods. The increase in net loss during three months ended June 27, 2020 was primarily the result of higher operating expenses compared to the prior-year period, partially offset by higher gross profit. During the three and six months ended June 27, 2020, net loss included $5.9 million of costs associated with the product repacking activities attributable to COVID-19, $1.6 million in product donation costs related to our COVID-19 relief campaign, and $1.5 million of early debt extinguishment costs associated with our refinanced credit arrangements.

41

Non-GAAP Financial Measures

We use the non-GAAP financial measures set forth below in assessing our operating performance and in our financial communications. Management believes these non-GAAP financial measures provide useful additional information to investors about current trends in our operations and are useful for period-over-period comparisons of operations In addition, management uses these non-GAAP financial measures to assess operating performance and for business planning measures. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies.

“Adjusted EBITDA” is defined as net (loss) income adjusted to exclude, when applicable, income tax expense (benefit), interest expense, depreciation and amortization expense, restructuring expenses, share-based compensation expense, expenses attributable to COVID-19, remeasurement of our warrant liability, and Other, net, including interest income and foreign currency transaction gains and losses.

“Adjusted EBITDA as a % of net revenues” is defined as Adjusted EBITDA divided by net revenues.

We use Adjusted EBITDA and Adjusted EBITDA as a % of net revenues because they are important measures upon which our management assesses our operating performance. We use Adjusted EBITDA and Adjusted EBITDA as a % of net revenues as key performance measures because we believe these measures facilitate internal comparisons of our historical operating performance on a more consistent basis, and also use these measures for our business planning purposes. In addition, we believe Adjusted EBITDA and Adjusted EBITDA as a % of net revenues are widely used by investors, securities analysts, ratings agencies and other parties in evaluating companies in our industry as a measure of our operational performance.

There are a number of limitations related to the use of Adjusted EBITDA rather than net (loss) income, which is the most directly comparable GAAP measure. Some of these limitations are:

•Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated may have to be replaced in the future increasing our cash requirements;

•Adjusted EBITDA does not reflect interest expense, or the cash required to service our debt, which reduces cash available to us;

•Adjusted EBITDA does not reflect income tax payments that reduce cash available to us;

•Adjusted EBITDA does not reflect restructuring expenses that reduce cash available to us;

•Adjusted EBITDA does not reflect expenses attributable to COVID-19 that reduce cash available to us;

•Adjusted EBITDA does not reflect share-based compensation expense and therefore does not include all of our compensation costs;

•Adjusted EBITDA does not reflect Other, net, including investment income and foreign currency transaction gains and losses, that may increase or decrease cash available to us; and

•other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

42

The following table presents the reconciliation of Adjusted EBITDA to its most comparable GAAP measure, net loss, as reported (unaudited):

	Three Months Ended						Six Months Ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Net loss, as reported	$	(10,205)		$	(9,441)		$	(8,390)		$	(16,090)
Income tax expense	16			21			15			21
Interest expense	569			741			1,274			1,474
Depreciation and amortization expense	3,272			2,052			5,855			3,957
Restructuring expenses(1)	1,509			847			3,882			1,241
Share-based compensation expense	7,586			1,823			13,535			2,678
Expenses attributable to COVID-19(2)	7,482			—			8,657			—
Remeasurement of warrant liability	—			11,744			—			12,503
Other, net	1,454			(898)			744			(1,039)
Adjusted EBITDA	$	11,683		$	6,889		$	25,572		$	4,745
Net loss as a % of net revenues	(9.0)		%	(14.0)		%	(4.0)		%	(15.0)		%
Adjusted EBITDA as a % of net revenues	10.3		%	10.2		%	12.2		%	4.4		%

____________

(1)

Primarily comprised of legal and other expenses associated with the dispute with a co-manufacturer with whom an exclusive supply agreement was terminated in May 2017.

(2)

Comprised of $5.9 million in repacking costs attributable to COVID-19 and $1.6 million in product donation costs related to our COVID-19 relief campaign in the three months ended June 27, 2020, and $5.9 million in repacking costs attributable to COVID-19 and $2.8 million in product donation costs related to our COVID-19 relief campaign in the six months ended June 27, 2020. Expenses attributable to COVID-19 in the six months ended June 27, 2020 include $1.2 million in product donation costs related to our COVID-19 relief campaign in the first quarter of 2020, which were not previously included in our Adjusted EBITDA calculation as these were deemed immaterial to our first quarter 2020 financial results. Given the significant increase in COVID-19-related expenses in the second quarter of 2020, and to facilitate better comparison from period to period, management determined that it was appropriate to recast its previous first quarter 2020 Adjusted EBITDA calculation to include these costs.

Liquidity and Capital Resources

Revolving Credit Facility

On April 21, 2020, we entered into a $150 million five-year secured revolving credit agreement (“2020 Credit Agreement”) by and among the Company, the lenders party thereto (the “Lenders”) and JPMorgan Chase Bank, N.A., as the administrative agent (the “Administrative Agent”). JPMorgan Chase Bank, N.A. and Silicon Valley Bank acted as joint bookrunners and joint lead arrangers under the 2020 Credit Agreement. The 2020 Credit Agreement includes an accordion feature for up to an additional $200 million. We incurred debt issuance costs, net of amortization, of $1.2 million in the three months ended June 27, 2020 in connection with the new revolving credit facility. See Note 7 to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.

Concurrently with the effectiveness of the 2020 Credit Agreement, on April 21, 2020, we terminated the $6.0 million revolving credit facility and $20.0 million term loan facility with Silicon Valley Bank (the “SVB Credit Facilities”), and the $5.0 million equipment loan facility with Structural Capital Investments II, LP, as Lender, and Ocean II, PLC, LLC, as collateral agent and administrative agent (the “Equipment Loan Facility”), and incurred an aggregate of $1.2 million of termination, prepayment, and related fees in connection with such terminations.

43

As of June 27, 2020, we had outstanding borrowings of $50.0 million under the revolving credit facility under the 2020 Credit Agreement. The interest rate on outstanding borrowings at June 27, 2020 was 3.5%. We are subject to compliance with the financial covenants in the 2020 Credit Agreement commencing with the fiscal quarter ending September 26, 2020.

Liquidity

Our primary cash needs are for operating expenses, working capital and capital expenditures to support the growth in our business. Prior to our IPO, we financed our operations through private sales of equity securities and through sales of our products. Since our inception and through our IPO, we raised a total of $199.5 million from the sale of convertible preferred stock, including through sales of convertible notes which were converted into preferred stock, net of costs associated with such financings. In connection with our IPO, we sold an aggregate of 11,068,750 shares of our common stock, at a public offering price of $25.00 per share and received approximately $252.4 million in net proceeds.

In connection with the Secondary Offering we sold 250,000 shares of our common stock. The shares were sold at a public offering price of $160.00 per share and we received net proceeds of approximately $37.4 million. We did not receive any proceeds from the sale of common stock by the selling stockholders in the Secondary Offering.

As of June 27, 2020, we had $222.3 million in cash and cash equivalents. We believe that our cash and cash equivalents, cash flow from operating activities and available borrowings under our 2020 Credit Agreement will be sufficient to fund our working capital and meet our anticipated capital requirements for the next 12 months. Our future capital requirements may vary materially from those currently planned and will depend on many factors, including the impact of the COVID-19 global pandemic; the number and characteristics of any additional products or manufacturing processes we develop or acquire to serve new or existing markets; the expenses associated with our marketing initiatives; our investment in manufacturing to expand our manufacturing and production capacity; the costs required to fund domestic and international growth; the scope, progress, results and costs of researching and developing future products or improvements to existing products or manufacturing processes; any lawsuits related to our products or commenced against us, including the costs associated with our current litigation with a former co-manufacturer, the putative class action cases recently brought against us, and the shareholder derivative lawsuits putatively brought on our behalf; the expenses needed to attract and retain skilled personnel; the costs associated with being a public company; the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing intellectual property claims, including litigation costs and the outcome of such litigation; and the timing, receipt and amount of sales of, or royalties on, any future approved products, if any.

Cash Flows

In the six months ended June 27, 2020, approximately $87.4 million in aggregate expenditures to purchase inventory and property, plant and equipment were funded by net borrowings (after extinguishing prior credit facilities) of $17.8 million, $53.5 million of existing cash, and approximately $16.1 million from other operating, investing and financing activities.

The following table presents the major components of net cash flows used in and provided by operating, investing and financing activities for the periods indicated.

	Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019
Cash (used in) provided by:
Operating activities	$	(44,335)	$	(22,366)
Investing activities	$	(28,328)	$	(10,878)
Financing activities	$	19,176	$	255,960

44

Net Cash Used in Operating Activities

In the six months ended June 27, 2020, we recorded net loss of $8.4 million. The primary reason for net cash used in operating activities of $44.3 million was $58.3 million in net cash outflows from changes in our operating assets and liabilities, primarily due to the increase in raw materials inventory resulting from pea protein isolate received pursuant to agreed upon delivery schedules to meet our anticipated product demand. The cash outflows from increase in inventory were partially offset by the increase in accounts payable. Net loss in the six months ended June 27, 2020, included $22.4 million in non-cash expenses primarily comprised of share-based compensation expense and depreciation and amortization expense.

In six months ended June 29, 2019, we incurred a net loss of $16.1 million. The primary reason for net cash used in operating activities of $22.4 million was the $25.5 million in net cash outflows from changes in our operating assets and liabilities, primarily due to increases in accounts receivable and inventory. Net loss in the six months ended June 29, 2019, included $19.2 million in non-cash expenses comprised of change in warrant liability, depreciation and amortization expense, and share-based compensation expense.

Depreciation and amortization expense was $5.9 million and $4.0 million in the six months ended June 27, 2020 and June 29, 2019, respectively.

Net Cash Used in Investing Activities

Net cash used in investing activities primarily relates to capital expenditures to support our growth and investment in property, plant and equipment.

In the six months ended June 27, 2020, net cash used in investing activities was $28.3 million and consisted of $26.0 million in cash outflows for purchases of property, plant and equipment, primarily driven by growth capital production equipment purchases related to our capacity expansion initiatives, international expansion, including the acquisition of a manufacturing facility in Europe located in Enschede, the Netherlands, which is expected to be operational by the end of 2020, and $2.3 million in cash outflows related to property, plant and equipment purchased for sale to co-manufacturers which were sold by the end of the second quarter of 2020.

In the six months ended June 29, 2019, net cash used in investing activities was $10.9 million and consisted of cash outflows for the purchases of property, plant and equipment, primarily for manufacturing facility improvements and manufacturing equipment, $3.2 million in cash outflows related to property, plant and equipment purchased for sale to co-manufacturers and security deposits.

Net Cash Provided by Financing Activities

In the six months ended June 27, 2020, net cash provided by financing activities was $19.2 million primarily from proceeds from a net increase in borrowings on our revolving credit facility and proceeds from stock option exercises, partially offset by debt issuance costs of $1.2 million associated with our new revolving credit facility, early debt extinguishment costs of $1.2 million associated with our refinanced credit arrangements, $1.2 million in payments of minimum withholding taxes on net share settlement of equity awards, and payments under finance lease obligations.

In the six months ended June 29, 2019, net cash provided by financing activities was $256.0 million primarily from the net proceeds of our IPO, and $0.5 million in proceeds from stock option exercises, partially offset by payments under capital lease obligations.

Contractual Obligations and Commitments

There have been no significant changes during the six months ended June 27, 2020 to the contractual obligations disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations set forth in the 2019 10-K, other than the following:

45

Revolving Credit Facility

On April 21, 2020, we entered into the 2020 Credit Agreement. Concurrently with the effectiveness of the 2020 Credit Agreement, on April 21, 2020, we terminated the SVB Credit Facilities and the Equipment Loan Facility, paying off an aggregate of $31.0 million in loan balances. See Note 7 Debt to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.

Leases

On January 1, 2020, we adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840. Upon adoption of ASU 2016-02, we recognized operating lease right-of-use assets of $11.9 million adjusted for $0.3 million previously recorded as deferred rent and $0.2 million previously recorded as prepaid rent on our condensed consolidated balance sheets.

As part of this adoption, we elected to not record operating lease right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. We also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets. Short-term lease payments for the three and six months ended June 27, 2020 totaled $0.1 million and $0.2 million, respectively.

As of June 27, 2020, we had recorded $13.8 million in operating lease right-of-use assets, $2.4 million in current operating lease liabilities and $11.6 million in operating lease liabilities, net of current portion.

During six months ended June 27, 2020, we amended two operating leases for our manufacturing facilities in Columbia, Missouri, one to extend the lease term by two years and another to include land adjacent to the facility upon which the landlord will construct a parking lot. We also assumed an operating lease under which we are leasing certain real property and a building consisting of approximately 142,317 square feet in Columbia, Missouri, for a term expiring on April 30, 2023 with no renewal options. See Note 4, Leases, to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.

Purchase Commitments

On January 10, 2020, we and Roquette Frères (“Roquette”) entered into a multi-year sales agreement pursuant to which Roquette will provide us with plant-based protein. The agreement expires on December 31, 2022; however it can be terminated after 18 months under certain circumstances. This agreement increases the amount of plant-based protein to be supplied by Roquette in each of 2020, 2021 and 2022 compared to the amount supplied 2019. The plant-based protein sourced under the supply agreement is secured on a purchase order basis regularly, per specified minimum monthly and semi-annual quantities, throughout the term. We are not required to purchase plant-based protein in amounts in excess of such specified minimum quantities; however, we have the option to increase such minimum quantities for delivery in each of 2021 and 2022. The total annual amount purchased each year by us must be at least the minimum amount specified in the agreement, which totals in the aggregate $154.1 million over the term of the agreement. We also have the right to be indemnified by Roquette in certain circumstances.

As of June 27, 2020, we had committed to purchase pea protein inventory totaling $192.4 million, approximately $51.6 million in the remainder of 2020, $82.3 million in 2021, and $58.5 million in 2022.

In addition, as of June 27, 2020, we had approximately $17.8 million in purchase order commitments for capital expenditures primarily to purchase machinery and equipment. Payments for these purchases will be due within twelve months. We intend to use cash from operations to fund these purchase commitments.

Off-balance Sheet Arrangements

We do not have any off-balance sheet arrangements or any holdings in variable interest entities.

46

Critical Accounting Policies

In preparing our financial statements in accordance with GAAP, we are required to make estimates and assumptions that affect the amounts of assets, liabilities, revenue, costs and expenses, and disclosure of contingent assets and liabilities that are reported in the financial statements and accompanying disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results may differ from these estimates and assumptions. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.

There have been no material changes in our critical accounting policies during the three months ended June 27, 2020, as compared to those disclosed in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in the 2019 10-K other than as described in Note 2, Summary of Significant Accounting Policies, to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.

Emerging Growth Company Status

We are an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). As an EGC, the JOBS Act allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We will no longer qualify as an EGC as of the end of the fiscal year ending December 31, 2020, when we become a Large Accelerated Filer under Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Therefore, we have elected to use the adoption dates applicable to public companies beginning in the first quarter of 2020. For as long as we continue to be an EGC, we intend to take advantage of certain other exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and exemptions from the requirements of holding non-binding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Recent Accounting Pronouncements

Please refer to Note 2, Summary of Significant Accounting Policies, to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report for a discussion of recently adopted accounting pronouncements and new accounting pronouncements that may impact us.

47

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to certain market risks in the ordinary course of our business, including fluctuations in interest rates, raw material prices, foreign currency exchange fluctuations, and inflation as follows:

Interest Rate Risk

Our cash consists of amounts held by third-party financial institutions. In May 2019, upon closing of our IPO, we adopted an investment policy which has as its primary objective investment activities which preserve principal without significantly increasing risk.

We are subject to interest rate risk in connection with our borrowings under credit facilities. As of June 27, 2020, we had $50.0 million in borrowings on the revolving credit facility under our 2020 Credit Agreement. Borrowings under the 2020 Credit Agreement bear interest, at the Company’s option, calculated according to an Alternate Base Rate or LIBO Rate, as the case may be, plus an applicable margin. Until the delivery to the Administrative Agent of the Company’s consolidated financial information for the fiscal quarter ending September 30, 2020, the applicable margin shall be 1.5% per annum for Alternate Base Rate loans and 2.5% per annum for LIBO Rate loans. Thereafter, the applicable margin for Alternate Base Rate loans will range from 1.25% to 1.75% per annum, and the applicable margin for LIBO Rate loans will range from 2.25% to 2.75% per annum, in each case, based on the Company’s total leverage ratio at the end of each quarter. In addition, we are required to pay an unused commitment fee of 0.375% per annum, which shall accrue at the applicable rate on the daily amount of the undrawn portion of the commitment of each Lender, and fees relating to the issuance of letters of credit.

The interest rate on the revolving credit facility at June 27, 2020 was 3.50%. Based on the average interest rate on our 2020 Credit Agreement and to the extent that borrowings were outstanding, we do not believe that a 1.0% change in the interest rate would have a material effect on our results of operations or financial condition.

Ingredient Risk

We are exposed to risk related to the price and availability of our ingredients because our profitability is dependent on, among other things, our ability to anticipate and react to raw material and food costs. Currently, the main ingredient in our products is pea protein, which we source from the United States, France and Canada. The prices of pea protein and other ingredients we use are subject to many factors beyond our control, such as the number and size of farms that grow yellow peas, the vagaries of these farming businesses, including poor harvests due to adverse weather conditions, natural disasters and pestilence, and changes in national and world economic conditions, including as a result of the COVID-19 pandemic. In addition, we purchase some ingredients and other materials offshore, and the price and availability of such ingredients and materials may be affected by political events or other conditions in these countries or tariffs or trade wars.

During the three and six months ended June 27, 2020, a hypothetical 10% increase or 10% decrease in the weighted-average cost of pea protein, our primary ingredient, would have resulted in an increase of approximately $0.9 million and $1.7 million, respectively, or a decrease of approximately $0.9 million and $1.7 million, respectively, to cost of goods sold. We are working to diversify our sources of supply and intend to enter into long-term contracts to better ensure stability of prices of our raw materials. In the six months ended June 27, 2020, we entered into a multi-year sales agreement with Roquette for the supply of pea protein. See Note 10, Commitments and Contingencies, to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.

Foreign Currency Risk

We are exposed to foreign currency risks that arise from normal business operations. These risks include the translation of local currency balances of foreign subsidiaries, transaction gains and losses associated with intercompany loans with foreign subsidiaries and transactions denominated in currencies other than a location's functional currency. Our foreign entities use their local currency as the functional currency. For these entities, we translate net assets into U.S. dollars at period end exchange rates, while revenue and expense accounts are translated at average exchange rates prevailing during the periods being reported. Resulting currency translation adjustments are included in accumulated other comprehensive loss and foreign currency transaction

48

gains and losses are included in other, net. Transaction gains and losses on long-term intra-entity transactions are recorded as a component of other comprehensive loss. Transactions denominated in a currency other than the reporting entity’s functional currency may give rise to transaction gains and losses that impact our results of operations.

Unrealized translation losses, net of tax, reported as cumulative translation adjustments through other comprehensive loss were $0.2 million as of June 27, 2020. Foreign currency transaction gains included in other, net were $0.1 million during the three and six months ended June 27, 2020.

Inflation Risk

We do not believe that inflation has had a material effect on our business, results of operations, or financial condition. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, results of operations and financial condition.

49

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our principal executive officer and principal financial officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 27, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures 

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected.

50

Part II. Other Information

ITEM 1. LEGAL PROCEEDINGS.

We are subject to various legal proceedings and claims that arise in the ordinary course of our business. The Company establishes an accrued liability for legal matters when those matters present loss contingencies that are both probable and estimable. Although the outcome of these and other claims cannot be predicted with certainty, management is not currently able to estimate the reasonable possible amount of loss or range of loss and does not believe that it is probable that the ultimate resolution of the current matters will have a material adverse effect on our business, financial condition, results of operations or cash flows. However, the final results of any current or future proceeding cannot be predicted with certainty, and until there is final resolution on any such matter that we may be required to accrue for, we may be exposed to loss in excess of the amount accrued. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. 

Don Lee Farms

On May 25, 2017, Don Lee Farms, a division of Goodman Food Products, Inc., filed a complaint against us in the Superior Court of the State of California for the County of Los Angeles asserting claims for breach of contract, misappropriation of trade secrets, unfair competition under the California Business and Professions Code, money owed and due, declaratory relief and injunctive relief, each arising out of our decision to terminate an exclusive supply agreement between us and Don Lee Farms. We denied all of these claims and filed counterclaims on July 27, 2017, alleging breach of contract, unfair competition under the California Business and Professions Code and conversion. In October 2018, Don Lee Farms filed an amended complaint that added ProPortion Foods, LLC (one of Beyond Meat’s current contract manufacturers) as a defendant, principally for claims arising from ProPortion’s alleged use of Don Lee Farms’ alleged trade secrets, and for replacing Don Lee Farms as one of Beyond Meat’s current co-manufacturers. ProPortion filed an answer denying all of Don Lee Farms’ claims and a cross-complaint against Beyond Meat asserting claims of total and partial equitable indemnity, contribution, and repayment. On March 11, 2019, Don Lee Farms filed a second amended complaint to add claims of fraud and negligent misrepresentation against us. On May 30, 2019, the judge denied our motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On June 19, 2019, the Company filed an answer denying Don Lee Farms' claims.

On January 24, 2020, a writ judge granted Don Lee Farms a right to attach in the amount of $628,689 on the grounds that Don Lee Farms had established a “probable validity” of its claim that we owe it money for a small batch of unpaid invoices. This determination was not made by the trial judge. The trial judge has yet to determine the legitimacy or merits of Don Lee Farms’ claims.

On January 27, 2020, Don Lee Farms filed a third amended complaint to add three individual defendants, all of whom are current or former employees of ours, including Mark Nelson, our Chief Financial Officer and Treasurer, to Don Lee Farms’ existing fraud and negligent misrepresentation claims alleging that those individuals were involved in the alleged fraud and negligent misrepresentations. On June 23, 2020, the judge denied Beyond Meat and the individual defendants’ motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On July 6, 2020, the Company and the individual defendants filed an answer denying all of Don Lee Farms’ claims, including denying all allegations of fraud and negligent misrepresentation.

On August 11, 2020, the Company filed an amended cross-complaint against Don Lee Farms, its parent Goodman Food Products, Inc., and its owners and employees, Donald, Daniel, and Brandon Goodman. Among other claims, the amended cross-complaint alleges that Don Lee Farms defrauded Beyond Meat, misappropriated its trade secrets, and infringed its trademarks.

The previous trial date, February 8, 2021, was vacated. Trial is currently set for June 14, 2021.

Don Lee Farms is seeking from Beyond Meat, the individual defendants, and ProPortion unspecified compensatory and punitive damages, declaratory and injunctive relief, including the prohibition of Beyond Meat’s use or disclosure of the alleged trade secrets, and attorneys’ fees and costs. We are seeking from Don Lee Farms monetary damages, restitution of monies paid to Don Lee Farms, injunctive relief, including the

51

prohibition of Don Lee Farms’ use or disclosure of Beyond Meat’s trade secrets and the prohibition of Don Lee Farms’ infringing use of Beyond Meat’s trademarks, and attorneys’ fees and costs. ProPortion is seeking indemnity, contribution, or repayment from us of any or all damages that ProPortion may be found liable to Don Lee Farms, and attorneys’ fees and costs.

We believe we were justified in terminating the supply agreement with Don Lee Farms, that we did not misappropriate Don Lee Farms’ alleged trade secrets, that we are not liable for the fraud or negligent misrepresentation alleged in the third amended complaint, that Don Lee Farms is liable for the conduct alleged in our amended cross-complaint, and that we are not liable to ProPortion for any indemnity, contribution, or repayment, including for any damages or attorneys’ fees and costs. Conversely, as alleged in the Company’s amended cross-complaint, we believe Don Lee Farms misappropriated our trade secrets, defrauded us, and ultimately has infringed our trademarks.

We are currently in the process of litigating this matter and intend to vigorously defend ourselves and our current and former employees against the claims and to prosecute our own claims. We cannot assure you that Don Lee Farms or ProPortion will not prevail in all or some of their claims against us or the individual defendants, or that we will prevail in some or all of our claims against Don Lee Farms. For example, if Don Lee Farms succeeds in the lawsuit, we could be required to pay damages, including but not limited to contract damages reasonably calculated at what we would have paid Don Lee Farms to produce our products through 2019, the end of the contract term, and Don Lee Farms could also claim some ownership in the intellectual property associated with the production of certain of our products or in the products themselves, and thus claim a stake in the value we have derived and will derive from the use of that intellectual property after we terminated our supply agreement with Don Lee Farms. Based on our current knowledge, we have determined that the amount of any material loss or range of any losses that is reasonably possible to result from this lawsuit is not estimable.

Securities Related Litigation

On January 30, 2020, Larry Tran, a purported shareholder of Beyond Meat, filed a putative securities class action lawsuit in the United States District Court for the Central District of California against Beyond Meat and two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act, and is premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to our public disclosures regarding our ongoing litigation with Don Lee Farms during the proposed class period of May 2, 2019 to January 27, 2020. The Court appointed a lead plaintiff and lead counsel on May 18, 2020, and a First Amended Complaint was filed on July 1, 2020. The First Amended Complaint names the same defendants, proposes the same class period, and similarly asserts claims under Sections 10(b) and 20(a) of the Exchange Act premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to the Company’s public disclosures regarding the Company’s ongoing litigation with Don Lee Farms. The Company filed a motion to dismiss on behalf of all defendants on July 31, 2020. The motion to dismiss briefing will be completed by mid-September 2020. We believe the claims are without merit and intend to vigorously defend all claims asserted.

On March 16, 2020, Eric Weiner, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson, and each of our directors, including one former director, who signed our initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to our ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 16, 2020, and the securities case brought against us.

On March 18, 2020, Kimberly Brink and Melvyn Klein, purported shareholders of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson, and each of our directors, including one former director,

52

who signed our initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to our ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 18, 2020, and the securities case brought against us.

On April 1, 2020, the United States District Court for the Central District of California entered an order consolidating the Weiner action and the Brink action for all purposes and designated the consolidated case In re: Beyond Meat, Inc. Derivative Litigation. On April 13, 2020, the Court entered an order appointing co-lead counsel for the consolidated derivative action. On June 23, 2020, the Court entered an order approving a Joint Stipulation Regarding Stay of Actions. Under the terms of the stay approval order, all proceedings in the consolidated derivative case are stayed until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. Based on the early stages of this matter, we are unable to estimate potential losses, if any, related to this lawsuit.

On May 27, 2020, Kevin Chew, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act and claims of breaches of fiduciary duty, relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to May 27, 2020. On June 16, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On June 17, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

On June 17, 2020, James Janolek, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 14(a) and 20(a) of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to June 17, 2020. On July 10, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On July 10, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

TCPA Litigation

On March 18, 2020, Nazrin Massaro filed a putative class action lawsuit in the United States District Court for the Southern District of California against Beyond Meat and People for the Ethical Treatment of Animals, Inc. (“PETA”). The lawsuit asserts claims under the Telephone Consumer Protection Act and alleges that PETA sent unsolicited text message advertisements promoting our products to the putative class members in violation of consumers’ privacy rights. The lawsuit further alleges that PETA and Beyond Meat arranged for PETA to market Beyond Meat’s products in exchange for monetary contributions from Beyond Meat. The plaintiff seeks injunctive relief and damages on behalf of herself and the putative class members. On May 29, 2020, Beyond Meat moved to dismiss or in the alternative stay this lawsuit, and on June 8, 2020, the plaintiff voluntarily dismissed her claims against Beyond Meat without prejudice. We believe the claims asserted in this lawsuit are without merit.

53

ITEM 1A. RISK FACTORS.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, “Risk Factors" in our 2019 Form 10-K, as updated and supplemented below and in subsequent filings. These risk factors could materially harm our business, operating results and financial condition. Additional factors and uncertainties not currently known to us or that we currently consider immaterial also may materially adversely affect our business, financial condition or future results.

The COVID-19 pandemic has had, and we expect will continue to have, certain negative impacts on our business, and such impacts could have a material adverse impact on our business, results of operations, financial condition and cash flows.

On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. The global spread and unprecedented impact of COVID-19 continues to create significant volatility, uncertainty and economic disruption. The pandemic has led governments and other authorities around the world to implement significant measures intended to control the spread of the virus, including shelter-in-place orders, social distancing measures, business closures, quarantines, travel bans, and restrictions and multi-step policies with the goal of re-opening these markets. While some of these restrictions have been lifted or eased in many jurisdictions as the rates of COVID-19 infections have decreased or stabilized, a resurgence of the pandemic in some markets has slowed or halted the reopening process altogether. If COVID-19 infection trends continue to reverse and the pandemic intensifies and expands geographically, its negative impacts on our business, particularly on our net revenues in our foodservice channel, our operating expenses, gross profit and gross margin, our sales could be more prolonged and may become more severe. Even if not required by governments and other authorities, companies are also taking precautions, such as requiring employees to work remotely, imposing travel restrictions, reducing operating hours, imposing operating restrictions and temporarily closing businesses. These continuing restrictions, and future prevention, mitigation measures, and multi-step reopening policies imposed by governments and companies, are likely to continue to have an adverse impact on global economic conditions and consumer confidence and spending (including as a result of lower discretionary income due to unemployment or reduced or limited work as a result of measures taken in response to the pandemic), which could materially adversely affect the supply of as well as the demand for our products, particularly in our foodservice channel, and sustained market turmoil and business disruption could also negatively impact our business, results of operations, financial condition and cash flows.

The COVID-19 pandemic has impacted our business operations and customer and consumer demand. The governors of many states, as well as certain governments abroad, have temporarily closed bars and restaurants, and limited the operations of many of our foodservice customers. Although certain of these restrictions have begun to be lifted pursuant to multi-step reopening plans and carve-outs to these restrictions to allow for carry-out and delivery have enabled certain of our customers to continue to generate business, we have experienced a deterioration in sales to foodservice customers as domestic and international stay-at-home orders became and remained more widespread. For example, for the three months ended June 27, 2020 and March 28, 2020, we generated total foodservice channel net revenue of $13.7 million and $41.2 million, respectively, a decrease of 66.7%. Even after these restrictions are lifted, demand from our foodservice customers may continue to be negatively impacted due to continuing consumer concerns regarding the risk of COVID-19 transmission, decreased consumer confidence and spending, and changes in consumer habits, among other things, and such restrictions may be re-implemented if and when transmission rates increase. It is unclear how long it will take for foodservice demand to return to pre-pandemic levels, if at all.

We have experienced an increase in retail demand as consumers have shifted toward more at-home consumption, and have re-purposed and repackaged a certain portion of our existing foodservice inventory into retail SKUs in response to COVID-19 demand shifts. Nonetheless, we could suffer product inventory losses or markdowns and lost revenue in the event of the loss or a shutdown of a major supplier, co-manufacturer or distributor, disruption of our distribution network, or decreased consumer confidence and spending. We introduced our first ever value-pack retail products in June 2020 and also began to provide heavier discounting on some of our products during the quarter ended June 27, 2020 in response to the pandemic and current disruption in the animal protein market. Although these actions are intended to build brand awareness and increase consumer trials of our products, they have and are likely to continue to have a negative to impact on our gross profit and gross margin in the near term. While we have experienced an increase in demand in our

54

retail channel which offset the decline in sales to our foodservice customers during the quarter ended June 27, 2020, we cannot be assured that such increase in retail demand will continue at these levels, or that such increased sales levels will fully offset the decline in sales to foodservice customers which we expect we will continue to experience with our foodservice customers while COVID-19 restrictions remain in effect.

We source ingredients from multiple suppliers around the world, with our plant-based proteins coming from suppliers in the United States, the European Union, China and India. Currently, the principal ingredient in most of our products is pea protein, which we purchase from four suppliers. The impact of COVID-19 on any of our suppliers, co-manufacturers, distributors or transportation or logistics providers, including problems with their respective businesses, finances, labor matters (including illness or absenteeism in workforce), ability to import raw materials, product quality issues, costs, production, insurance and reputation, may negatively affect the price and availability of our ingredients and/or packaging materials and impact our supply chain. If the disruptions caused by COVID-19 continue for an extended period of time or there are one or more resurgences of COVID-19, our ability to meet the demands of our customers may be materially impacted.

Additionally, we operate two production facilities in Columbia, Missouri where we produce our woven protein. We also operate our Manhattan Beach Project Innovation Center, where our teams of scientists and engineers work to create new products and make improvements to existing products. We have implemented and continue to practice a series of physical distancing and hygienic practices at these facilities. If we are forced to make further modifications, scale back hours of production or close these facilities in response to the pandemic, we expect our business, results of operations, financial condition and cash flows would be materially adversely affected. Moreover, we have transitioned a significant subset of our office-based employee population to a remote work environment in an effort to mitigate the spread of COVID-19, which may exacerbate certain risks to our business, including cybersecurity attacks and risk of phishing due to an increase in the number of points of potential attack, such as laptops and mobile devices (both of which are now being used in increased numbers). In the event that an employee tests positive for COVID-19, we may have to temporarily close one or more of our facilities for cleaning and/or quarantine one or more employees, which could negatively impact our financial results.

Part of our growth strategy includes increasing the number of international customers and expanding into additional geographies. For example, we announced several new partnerships in China during the quarter ended June 27, 2020. We are also exploring adding co-manufacturing partners and production facilities abroad, including in Asia. The timing and success of our international expansion with respect to customers, co-manufacturing partners and/or production facilities, especially in China and other parts of Asia, may be negatively impacted by COVID-19, which could impede our anticipated growth.

Additionally, the COVID-19 pandemic has created significant disruptions in the credit and financial markets, which could adversely affect our ability to access capital on favorable terms or at all. On April 21, 2020, we entered into a $150 million five-year secured revolving credit agreement. However, we may be unable to borrow these funds if a deterioration in our financial condition prohibits us from satisfying certain conditions, including the financial covenants, in the 2020 Credit Agreement, or if one or more lenders refuses or fails to fund its financing commitment to us.

The extent of COVID-19’s effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic (including any resurgences), all of which are uncertain and difficult to predict considering the rapidly evolving landscape. Furthermore, the uncertainty created by COVID-19 significantly increases the difficulty in forecasting operating results and of strategic planning. As a result, it is not currently possible to ascertain the overall impact of COVID-19 on our business. However, the pandemic could have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our common stock. The impact of COVID-19 may also heighten other risks discussed in Part I, Item 1A, “Risk Factors” in our 2019 Form 10-K, and Part II, Item 1A, “Risk Factors” and “Note Regarding Forward-Looking Statements” included in this report.

55

Litigation or legal proceedings could expose us to significant liabilities and have a negative impact on our reputation or business.

From time to time, we may be party to various claims and litigation proceedings. We evaluate these claims and litigation proceedings to assess the likelihood of unfavorable outcomes and to estimate, if possible, the amount of potential losses. Based on these assessments and estimates, we may establish reserves, as appropriate. These assessments and estimates are based on the information available to management at the time and involve a significant amount of management judgment. Actual outcomes or losses may differ materially from our assessments and estimates.

Don Lee Farms

For example, on May 25, 2017, following our termination of our supply agreement with Don Lee Farms, a former co-manufacturer, Don Lee Farms filed a lawsuit against us in California state court claiming, among other things, that we wrongfully terminated the parties’ contract and that we misappropriated their trade secrets principally by sharing with subsequent co-manufacturers the processes for manufacturing our products—processes which they claim to have developed.

On July 27, 2017 we filed a cross-complaint, alleging that Don Lee Farms (1) breached the supply agreement, including by failing to provide salable product, as certain of our products manufactured by Don Lee Farms were contaminated with salmonella and other foreign objects, and that Don Lee Farms did not take appropriate actions to address these issues; (2) engaged in unfair competition in violation of California’s Unfair Competition Law; and (3) unlawfully converted certain Beyond Meat property, including certain pieces of equipment. In October 2018, Don Lee Farms filed an amended complaint that added ProPortion Foods, LLC (one of Beyond Meat’s current contract manufacturers) as a defendant, principally for claims arising from ProPortion’s alleged use of Don Lee Farms’ alleged trade secrets, and for replacing Don Lee Farms as one of Beyond Meat’s current co-manufacturers. ProPortion filed an answer denying all of Don Lee Farms’ claims and a cross-complaint against Beyond Meat asserting claims of total and partial equitable indemnity, contribution, and repayment. On March 11, 2019, Don Lee Farms filed a second amended complaint to add claims of fraud and negligent misrepresentation against us. On May 30, 2019, the judge denied our motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On June 19, 2019, we filed an answer denying Don Lee Farms' claims.

On January 24, 2020, a writ judge granted Don Lee Farms a right to attach in the amount of $628,689 on the grounds that Don Lee Farms had established a “probable validity” of its claim that we owe it money for a small batch of unpaid invoices. This determination was not made by the trial judge. The trial judge has yet to determine the legitimacy or merits of Don Lee Farms’ claims.

On January 27, 2020, Don Lee Farms filed a third amended complaint to add three individual defendants, all of whom are current or former employees of ours, including Mark Nelson, our Chief Financial Officer and Treasurer, to Don Lee Farms’ existing fraud and negligent misrepresentation claims alleging that those individuals were involved in the alleged fraud and negligent misrepresentations. On June 23, 2020, the judge denied Beyond Meat and the individual defendants’ motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On July 6, 2020, the Company and the individual defendants filed an answer denying all of Don Lee Farms’ claims, including denying all allegations of fraud and negligent misrepresentation.

On August 11, 2020, Beyond Meat filed an amended cross-complaint against Don Lee Farms, its parent Goodman Food Products, Inc., and its owners and employees, Donald, Daniel, and Brandon Goodman. Among other claims, the amended cross-complaint alleges that Don Lee Farms defrauded Beyond Meat, misappropriated its trade secrets, and infringed its trademarks.

The previous trial date, February 8, 2021, has been vacated. Trial is currently set for June 14, 2021.

Don Lee Farms is seeking from us, the individual defendants, and ProPortion unspecified compensatory and punitive damages, declaratory and injunctive relief, including the prohibition of our use or disclosure of the alleged trade secrets, and attorneys’ fees and costs. We are seeking from Don Lee Farms monetary damages, restitution of monies paid to Don Lee Farms, injunctive relief, including the prohibition of Don Lee Farms’ use or

56

disclosure of Beyond Meat’s trade secrets and the prohibition of Don Lee Farms’ infringing use of Beyond Meat’s trademarks, attorneys’ fees and costs. ProPortion is seeking indemnity, contribution, or repayment from us of any or all damages that ProPortion may be found liable to Don Lee Farms, and attorneys’ fees and costs.

We believe we were justified in terminating the supply agreement with Don Lee Farms, that we did not misappropriate Don Lee Farms’ alleged trade secrets, that we are not liable for the fraud or negligent misrepresentation alleged in the third amended complaint, that Don Lee Farms is liable for the conduct alleged in our amended cross-complaint, and that we are not liable to ProPortion for any indemnity, contribution, or repayment, including for any damages or attorneys’ fees and costs.

We intend to vigorously defend ourselves and our current and former employees against the claims and prosecute our own. However, we cannot assure you that Don Lee Farms or ProPortion will not prevail in all or some of their claims against us or the individual defendants, or that we will prevail in some or all of our claims against Don Lee Farms. For example, if Don Lee Farms succeeds in the lawsuit, we could be required to pay damages, including but not limited to contract damages reasonably calculated at what we would have paid Don Lee Farms to produce our products through 2019, the end of the contract term, and Don Lee Farms could also claim some ownership in the intellectual property associated with the production of certain of our products or in the products themselves, and thus claim a stake in the value we have derived and will derive from the use of that intellectual property after we terminated our supply agreement with Don Lee Farms. As another example, we also could be required to pay attorneys’ fees and costs incurred by Don Lee Farms or ProPortion.

Securities Related Litigation

On January 30, 2020, Larry Tran, a purported shareholder of Beyond Meat, filed a putative securities class action lawsuit in the United States District Court for the Central District of California against Beyond Meat and two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act and is premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to our public disclosures regarding our ongoing litigation with Don Lee Farms during the proposed class period of May 2, 2019 to January 27, 2020. The Court appointed a lead plaintiff and lead counsel on May 18, 2020, and a First Amended Complaint was filed on July 1, 2020. The First Amended Complaint names the same defendants, proposes the same class period, and similarly asserts claims under Sections 10(b) and 20(a) of the Exchange Act premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to our public disclosures regarding our ongoing litigation with Don Lee Farms. We filed a motion to dismiss on behalf of all defendants on July 31, 2020. The motion to dismiss briefing will be completed by mid-September 2020. We believe the claims are without merit and intend to vigorously defend all claims asserted.

On March 16, 2020, Eric Weiner, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson, and each of our directors, including one former director, who signed our initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to our ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 16, 2020, and the securities case brought against us.

On March 18, 2020, Kimberly Brink and Melvyn Klein, purported shareholders of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson, and each of our directors who signed our initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to our ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 18, 2020, and the securities case brought against us.

57

On April 1, 2020, the United States District Court for the Central District of California entered an order consolidating the Weiner action and the Brink action for all purposes and designated the consolidated case In re: Beyond Meat, Inc. Derivative Litigation. On April 13, 2020, the Court entered an order appointing co-lead counsel for the consolidated derivative action. On June 23, 2020, the Court entered an order approving a Joint Stipulation Regarding Stay of Actions. Under the terms of the stay approval order, all proceedings in the consolidated derivative case are stayed until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. Based on the early stages of this matter, we are unable to estimate potential losses, if any, related to this lawsuit.

On May 27, 2020, Kevin Chew, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson, and each of our directors, including one former director, who signed our initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act and claims of breaches of fiduciary duty, relating to our ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to May 27, 2020. On June 16, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On June 17, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, we are unable to estimate potential losses, if any, related to this lawsuit.

On June 17, 2020, James Janolek, purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of our executive officers, our President and CEO, Ethan Brown, and our Chief Financial Officer and Treasurer, Mark Nelson, and each of our directors, including one former director, who signed our initial public offering registration statement. The lawsuit asserts claims under Sections 14(a) and 20(a) of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to our ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to June 17, 2020. On July 10, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On July 10, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, we are unable to estimate potential losses, if any, related to this lawsuit.

TCPA Litigation

On March 18, 2020, Nazrin Massaro filed a putative class action lawsuit in the United States District Court for the Southern District of California against Beyond Meat and People for the Ethical Treatment of Animals, Inc. (“PETA”). The lawsuit asserts claims under the Telephone Consumer Protection Act and alleges that PETA sent unsolicited text message advertisements promoting our products to the putative class members in violation of consumers’ privacy rights. The lawsuit further alleges that PETA and Beyond Meat arranged for PETA to market Beyond Meat’s products in exchange for monetary contributions from Beyond Meat. The plaintiff seeks injunctive relief and damages on behalf of herself and the putative class members. On May 29, 2020, Beyond Meat moved to dismiss or in the alternative stay this lawsuit, and on June 8, 2020, the plaintiff voluntarily dismissed her claims against Beyond Meat without prejudice. The Company believes the claims asserted in this lawsuit are without merit.

Even when not merited, the defense of these lawsuits may divert our management’s attention, and we may incur significant expenses in defending these lawsuits. The results of litigation and other legal proceedings are inherently uncertain, and adverse judgments or settlements in some of these legal disputes may result in adverse monetary damages, penalties or injunctive relief against us, which could have a material adverse effect on our financial position, cash flows or results of operations. Any claims or litigation, even if fully indemnified or insured, could damage our reputation and make it more difficult to compete effectively or to obtain adequate insurance in the future.

58

Furthermore, while we maintain insurance for certain potential liabilities, such insurance does not cover all types and amounts of potential liabilities and is subject to self-insured retentions, various exclusions as well as caps on amounts recoverable. Even if we believe a claim is covered by insurance, insurers may dispute our entitlement to recovery for a variety of potential reasons, which may affect the timing and, if the insurers prevail, the amount of our recovery.

Covenants in our revolving credit agreement may restrict our operations and the ongoing needs of our business, and if we do not effectively manage our business to comply with these covenants, our liquidity and financial condition could be adversely impacted.

We entered into a five-year secured revolving credit agreement with JPMorgan Chase Bank, N.A. and the lenders party thereto, providing for a $150 million secured revolving line of credit, which includes an accordion feature for up to an additional $200 million. The 2020 Credit Agreement contains various restrictive financial covenants, including, among other things, maintenance of (i) a maximum total leverage ratio of 3.00 to 1.00 and (ii) a minimum fixed charge coverage ratio of 1.25 to 1.00, in each case, on a quarterly basis. The 2020 Credit Agreement also contains certain restrictive covenants, including limitations on incurrence of indebtedness, creation of liens, making acquisitions, loans or other investments, disposition of assets, payment of dividends and other restricted payments, and entering into transactions with affiliates, in each case, subject to certain exceptions. We, therefore, may not be able to engage in any of the foregoing transactions unless we obtain the consent of our lenders or terminate the 2020 Credit Agreement. These restrictions may restrict our current and future operations, particularly our ability to respond to certain changes in our business or industry, or take future actions. Additionally, we may be unable to borrow funds under our 2020 Credit Agreement if we fail to satisfy certain conditions, including compliance with our financial and other restrictive covenants. Pursuant to the 2020 Credit Agreement, we granted the parties thereto a security interest in substantially all of our assets. See Note 7, Debt, to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1 of this report for additional information.

Our ability to meet these restrictive covenants can be impacted by events beyond our control and we may be unable to do so. The 2020 Credit Agreement provides that our breach or failure to satisfy certain covenants constitutes an event of default. The 2020 Credit Agreement also provides for other customary events of default, including (among others) nonpayment, breaches of representations or warranties, bankruptcy and insolvency events and a change of control. Upon the occurrence of an event of default, our lenders could elect to declare all amounts outstanding under its debt agreements to be immediately due and payable and commitments of the lenders may be terminated. In addition, our lenders would have the right to proceed against the assets we provided as collateral pursuant to the 2020 Credit Agreement. If the debt under the 2020 Credit Agreement was to be accelerated, we may not have sufficient cash on hand or be able to sell sufficient collateral to repay it, which would have an immediate adverse effect on our business, liquidity, financial condition and operating results. This could potentially cause us to cease operations and result in a complete loss of your investment in our common stock.

Any changes in, or changes in the interpretation of, applicable laws, regulations or policies of the FDA or U.S. Department of Agriculture, or USDA, state regulators or similar foreign regulatory authorities that relate to the use of the word “meat” or other similar words in connection with plant-based protein products could adversely affect our business, prospects, results of operations or financial condition.

The FDA and the USDA, state regulators or similar foreign regulatory authorities, such as Health Canada or the CFIA, or authorities of the EU or the EU member states, could take action to impact our ability to use the term “meat” or similar words (such as “beef”, “burger” or “sausage”) to describe or advertise our products. In addition, a food may be deemed misbranded if its labeling is false or misleading in any particular way, and the FDA, CFIA, EU member state authorities or other regulators could interpret the use of the term “meat” or any similar phrase(s) to describe our plant-based protein products as false or misleading or likely to create an erroneous impression regarding their composition.

For example, in 2018, the state of Missouri passed a law prohibiting any person engaged in advertising, offering for sale, or sale of food products from misrepresenting a product as meat that is not derived from harvested production livestock or poultry. The state of Missouri Department of Agriculture has clarified its

59

interpretation that products which include prominent disclosure that the product is “made from plants,” or comparable disclosure such as through the use of the phrase “plant-based,” are not misrepresented under the Missouri law. Additional states, including Mississippi, Louisiana, and Georgia, have subsequently passed similar laws, and legislation, that would impose additional requirements on plant-based meat products is currently pending in a number of states. More recently, in late 2019, bills were introduced in both the House and the Senate of the U.S. Congress (titled the Real MEAT Act) that would require the word “imitation” to appear as part of the name of plant-based meat products, and that would give USDA certain oversight over the labeling of plant-based meat products. If these bills gain traction and ultimately become law, it could require us to identify our products as “imitation” in our product labels. Further, the USDA has received a petition from the cattle industry requesting that USDA exclude products not derived from the tissue or flesh of animals that have been harvested in the traditional manner from being labeled and marketed as “meat,” and exclude products not derived from cattle born, raised and harvested in the traditional manner from being labeled and marketed as “beef.” The USDA has not yet responded substantively to this petition but has indicated that the petition is being considered as a petition for a policy change under the USDA’s regulations. We do not believe that USDA has the statutory authority to regulate plant-based products under the current legislative framework. Canadian Food and Drug Regulations also provide requirements for “simulated meat” products, including requirements around composition and naming.

In Europe, the Agriculture Committee of the European Parliament proposed in May 2019 to reserve the use of “meat” and meat-related terms and names for products that are manufactured from the edible parts of animals. It is possible that that this restriction will be adopted at the EU level as of the end of 2020. If adopted, this bill could require a change to our labeling and advertising in the European Union. In June 2020, France adopted a prohibition on using names to indicate foodstuffs of animal origin to describe, market, or promote foodstuffs containing vegetable proteins. An implementing decree is yet to be adopted that will define e.g. the procedures for applications of this prohibition and the sanctions in case of non-compliance. We do not believe that the new French bill complies with the laws of the European Union, in particular the principle of free movement of goods. We also note that this prohibition has not been appropriately notified to the European Commission, and that as a result the prohibition is in principle non-enforceable. Should regulatory authorities take action with respect to the use of the term “meat” or similar terms, such that we are unable to use those terms with respect to our plant-based products, we could be subject to enforcement action or recall of our products marketed with these terms, we may be required to modify our marketing strategy, or require us to identify our products as “imitation” in our product labels, and our business, prospects, results of operations or financial condition could be adversely affected.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Unregistered Sales of Equity Securities

None.

Use of Proceeds from our Initial Public Offering of Common Stock

On May 6 2019, we completed our IPO pursuant to a Registration Statement filed on Form S-1 (File No. 333-228453) and declared effective by the SEC on May 1, 2019.

As previously reported, we received approximately $252.4 million of net proceeds from our IPO. There has been no material change in the planned use of proceeds from our IPO as described in the prospectus filed with the SEC pursuant to Rule 424(b)(4) on May 3, 2019. As of June 27, 2020, we have used $42.3 million of our net proceeds from the IPO to invest in existing and additional manufacturing capacity, $79.0 million to expand our research and development and our sales and marketing capabilities, and $131.1 million for working capital and general corporate purposes.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

60

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

61

ITEM 6. EXHIBITS.

EXHIBIT INDEX
Exhibit No.	Exhibit Description	Incorporated by Reference			Filed Herewith
		Form	Date	Number
3.1	Restated Certificate of Incorporation.	10-Q	6/12/2019	3.1
3.2	Amended and Restated Bylaws.	10-Q	6/12/2019	3.2
4.1	Form of Common Stock Certificate.	S-1/A	3/27/2019	4.1
4.2	Amended and Restated Investors’ Rights Agreement, dated as of October 5, 2018, by and among the Registrant and the other parties thereto.	S-1	11/16/2018	4.2
10.1	Credit Agreement, dated as of April 21, 2020, by and among Beyond Meat, Inc., as the Borrower, the other Loan Parties party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A., as the Administrative Agent.	8-K	4/22/2020	10.1
10.2	Second Lease Amendment, dated as of May 22, 2020, by and between LeMone Family Limited Partnership, LLLP and Beyond Meat, Inc.				X
31.1	Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
31.2	Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
32.2*	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
101	The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended June 27, 2020 formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Loss, (iv) Condensed Consolidated Statements of Preferred Stock and Stockholders' Equity (Deficit), (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.				X
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)				X
_________________
* This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

62

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		BEYOND MEAT, INC.
Date:	August 11, 2020	By:	/s/ Ethan Brown
			Ethan Brown
			President and Chief Executive Officer
			(Principal Executive Officer)

Date:	August 11, 2020	By:	/s/ Mark J. Nelson
			Mark J. Nelson
			Chief Financial Officer and Treasurer
			(Principal Financial and Accounting Officer)

63

EX-10.2

EXHIBIT 10.2 EXECUTION COPY SECOND LEASE AMENDMENT THIS SECOND LEASE AMENDMENT (this “Second Amendment”) is entered into as of the 22nd day of May, 2020 (the “Effective Date”), by and between LeMone Family Limited Partnership, LLLP, a Missouri limited liability limited partnership, hereinafter referred to as “Landlord,” and BEYOND MEAT, INC., a Delaware corporation formerly known as Savage River, Inc., hereinafter referred to as “Tenant”. WHEREAS, Landlord and Tenant entered into a Lease, dated as of October 12, 2017 (the “Original Lease”), pursuant to which Tenant leased from Landlord the real estate and improvements located at 2400 Maguire Boulevard, Columbia, Boone County, Missouri (the “Current Premises”), with the Commencement Date under the Original Lease occurring on August 1, 2018; WHEREAS, the Original Lease was amended by the Lease Amendment, dated April 18, 2018, between Landlord and Tenant (together with the Original Lease, the “Prior Lease”); WHEREAS, RML Investment Properties LLC, a Missouri limited liability company (“RML”), owns land immediately north of and abutting the Current Premises and commonly known as Lot 27, Concorde Office and Industrial Plaza, Plat 14, Boone County, Missouri (the “Raw Land”); WHEREAS, RML and Tenant entered into a Lease, dated May 6, 2019 (the “Raw Land Lease”), pursuant to which Tenant leased from Landlord the Raw Land and deposited with RML the sum of Seven Thousand Dollars ($7,000.00) as security for Tenant’s performance of its obligations under the Raw Land Lease; WHEREAS, RML will, soon after the execution of this Second Amendment by Landlord and Tenant, transfer all of its right, title and interest in and to the Raw Land and the Raw Land Lease to Landlord; WHEREAS, Landlord and Tenant wish to enter into this Second Amendment to increase the size of the Premises, as defined in the Prior Lease, to include the Raw Land and the Additional Improvements (collectively, the “Additional Property”); WHEREAS, Landlord and Tenant have obtained and prepared plans and specifications to construct a parking lot on the Raw Land, which are attached hereto as Exhibit “A” and incorporated herein by this reference (collectively, the “Additional Improvements”); 1

WHEREAS, concurrently with the execution of this Second Amendment, Landlord and Tenant are entering into a Lease Termination Agreement, pursuant to which the Raw Land Lease and each party’s remaining obligations thereunder (other than those expressly surviving expiration or earlier termination thereof) shall terminate, it being acknowledged that the Prior Lease, as amended by this Second Amendment, shall govern Tenant’s leasing from Landlord, and Landlord’s leasing to Tenant, of the Additional Property, and hereinafter the Lease shall refer to the Prior Lease as amended by this Second Amendment; and WHEREAS, the parties desire to enter into this Second Amendment to modify the terms of the Prior Lease as herein set forth. Terms defined in the Prior Lease shall have the same meanings in this Second Amendment. NOW THEREFORE, for and in consideration of the mutual agreements and covenants herein, the parties hereby agree as follows: 1. Conditions Precedent to Effectiveness of Second Amendment. The effectiveness of this Second Amendment is conditioned on the occurrence of each of the following: (1) Landlord owning fee simple title in and to the Additional Property, (2) Landlord being the assignee of RML’s right, title, and interest in and to the Raw Land Lease, including, without limitation, the Seven Thousand Dollar ($7,000) security deposit Tenant submitted to RML thereunder, (3) Landlord and Tenant entering into the Lease Termination Agreement concurrently with this Second Amendment; and (4) Landlord having obtained all necessary building permits to construct the Additional Improvements. If the conditions set forth in the immediately preceding are not satisfied by the date that is forty-five (45) days after the date of this Second Amendment, this Second Amendment shall become automatically terminated, and be of no further force or effect. 2. Certain Amendments to the Prior Lease. 2.1 Recital One of the Prior Lease. The Prior Lease is amended by deleting the first Recital in its entirety and inserting in its place and stead the following: “WHEREAS, Landlord is the owner of certain real estate and improvements located in Columbia, Boone County, Missouri, known as (i) 2400 Maguire Boulevard, Columbia, Boone County, Missouri, and (ii) Lot 27, Concorde Office and Industrial Plaza, Plat 14 (collectively, the “Property”);” 2.2 Section 4 of the Prior Lease. The Prior Lease is amended by deleting Section 4 in its entirety and inserting in its place and stead the following: 2

“4. Rent. (a) During the Lease term, Tenant shall pay monthly rent to Landlord, payable in advance on the first day of each calendar month. Beginning on the first day of the calendar month following the Effective Date of the Second Amendment and the date all conditions precedent set forth in Section 1 of the Second Amendment have been satisfied, Tenant shall pay to Landlord monthly rent for the Premises as follows: (i) Forty-Nine Thousand Two Hundred Eighty-One Dollars ($49,281.00) per month for the remainder of the Second Lease Year; (ii) Fifty-One Thousand Nine Hundred Forty-Nine Dollars ($51,949.00) per month beginning on the first day of the third Lease Year and continuing for the remainder of the Initial Term; (iii) Thirty-Nine Thousand Seven Hundred Twenty-Four Dollars ($39,724.00) per month during the First Option Term; and (iv) Forty-Two Thousand Eighty-Three Dollars ($42,083.00) per month during the Second Option Term.” 2.3 Section 5 of the Prior Lease. The Prior Lease is amended by deleting Section 5 in its entirety and inserting in its place and stead the following: “5. Security Deposit. Landlord and Tenant acknowledge that Landlord has in its possession a security deposit in an amount equal to Fifty-Seven Thousand Dollars ($57,000) as security for performance of all the obligations of Tenant under this Lease, including, without limitation, the payment of all rent and other charges due Landlord under this Lease. In addition to the rights and remedies of Landlord set forth elsewhere in this Lease or otherwise available to Landlord under applicable law, in the event of any default by Tenant under this Lease that remains uncured after written notice and the passing of all applicable cure periods, Landlord shall be entitled to apply said deposit to the obligations of Tenant under this Lease or shall be entitled to expend said security deposit toward the out of pocket costs and expenses incurred by Landlord in connection with remedying any such default by Tenant capable of being remedied by the expenditure of money. Should Landlord so pay or apply said deposit, Tenant shall within five (5) business days of its receipt of Landlord’s written demand, deposit such additional sums with Landlord as may be necessary to restore said deposit to Fifty-Seven Thousand Dollars ($57,000). At the end of the Lease term, provided Tenant is not then in default according to the terms and provisions of 3

this Lease (that remains uncured after written notice of the same and the passing of all applicable cure periods), Landlord shall within thirty (30) days after the end of the Lease term, or upon written demand from Tenant, refund any portion thereof that remains after use of said deposit by Landlord in accordance with the foregoing provisions of this Paragraph, without interest.” 2.1 Section 22 of the Prior Lease. The Prior Lease is amended by deleting Section 22 in its entirety and inserting in its place and stead the following: “If Tenant shall hold over after expiration of the term of this Lease for any cause, Tenant shall be liable for one and one-half times the base rent payable hereunder for the first three (3) months following the end of the Lease term, and double the base rent payable hereunder for the remainder of any such holdover period and shall otherwise be upon the applicable terms and conditions set forth in this Lease.” 3. Construction. 3.1 Upon execution of this Second Amendment, Landlord shall commence construction of the Additional Improvements, and shall substantially complete construction of the Additional Improvements with all reasonable diligence. 3.2 To minimize interference to Tenant’s business operations at, and use of, the Current Premises and the Raw Land during construction of the Additional Improvements, Landlord and Tenant covenant to implement the plan attached hereto as Exhibit “A” and made a part hereof, and otherwise take (or cause to be taken) all action, and to do (or cause to be done) all things reasonably necessary, proper, or advisable in furtherance of minimizing such interference. 3.3 For purposes of this Second Amendment, the Additional Improvements shall be deemed to be “substantially complete” when Landlord has (a) obtained an approval notice from the City of Columbia for the Additional Improvements (temporary or permanent) and (b) completed the Additional Improvements such that Tenant may lawfully use and occupy the Additional Property, for Tenant’s intended purpose, subject to Punch List Items. 3.4 As used in this Second Amendment, “Punch List Items” are those minor items of construction that must be completed or corrected and that will not materially interfere with Tenant’s ability to occupy the Additional Property. Landlord shall notify Tenant upon substantial completion, whereupon the Additional Property shall be delivered to and accepted by Tenant; except, that, Landlord shall complete all Punch List Items as soon thereafter as reasonably practicable. 4

3.5 Landlord and Tenant agree that Tenant is paying the cost to construct the Additional Improvements, including a fee for the general contractor constructing the Additional Improvements (the “Contractor”) equal to eight percent (8%) of the actual construction cost of Additional Improvements, pursuant to the terms and provisions of a construction contract to be entered into between Landlord and Contractor (the “Contract”), which shall include the provisions set forth on Exhibit “B” of this Second Amendment. Prior to Landlord invoicing Tenant, all applications for payment (“Application for Payment”) submitted to Landlord by the Contractor shall be simultaneously submitted to Landlord and Tenant for their review. Within five (5) business days of receipt of an accurate, correct, and complete Application for Payment, Landlord and Tenant must approve or reject such Application for Payment (or portions thereof) using DocuSign, and any such disapproval shall be accompanied with a brief description of the reason (in reasonable detail) for such rejection. The Application for Payment shall be deemed approved if Landlord and Tenant fail to timely approve or disapprove such Application for Payment within such five (5) business day period. All undisputed costs for completion of the Additional Improvements shall be paid by Tenant monthly, within thirty (30) calendar days of invoicing from Landlord. 4. Other Provisions. Except as set forth in this Second Amendment, all other terms and provisions of the Prior Lease shall remain in full force and effect. Any inconsistency between the Prior Lease and this Second Amendment shall be governed by this Second Amendment. This Second Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which, together, shall constitute the same amendment. For purposes of this Second Amendment, signatures by facsimile or electronic PDF shall be binding to the same extent as original signatures. Each signatory of this Second Amendment on behalf of Tenant and Landlord represents that he or she has the full power and authority to execute and deliver the same on behalf of the party hereto for which such signatory is acting. The headings of the paragraphs in this Second Amendment are for reference only and shall not affect the meaning or interpretation of this Second Amendment. Landlord and Tenant acknowledge and reaffirm all of their obligations under the Prior Lease, as the Prior Lease has been amended by this Second Amendment, and agree that any reference made in any other document to the Prior Lease shall mean the Prior Lease as amended by this Second Amendment. The Prior Lease, as hereby amended, may not be further amended except in writing signed by both Landlord and Tenant. If any provisions of this Second Amendment or the Prior Lease, as amended hereby, shall be determined to be illegal or unenforceable, such determination shall not affect any other provision of the Prior Lease or this Second Amendment and all such other provisions shall remain in full force and effect. Landlord and Tenant hereby acknowledge and agree this Second Amendment shall not be construed or interpreted against either party hereto by virtue of the identity of the preparer. 5

5. Binding Effect. The covenants and agreements of this Second Amendment shall be binding upon and inure to the benefit of the parties hereto and their heirs, executors, administrators, legal representatives, successors, and assigns. 6. Attorneys’ Fees. If a party hereto brings an action or suit against the other party hereto to enforce any provisions of this Second Amendment or the Prior Lease, the prevailing party in such action or suit shall be entitled to have and recover from the other party hereto, in addition to damages, equitable or other relief, all costs and expenses of the action or suit and any appeals therefrom, including reasonable attorneys’ fees and court costs and costs of expert witnesses, and fees incurred to enforce any judgment therefrom. 7. No Broker. Each of Landlord and Tenant represent and warrant to each other that neither of them has had any dealings with any real estate broker or agent in connection with the negotiation of this Second Amendment. Landlord and Tenant each hereby agree to indemnify, defend and hold harmless the other against any losses, causes of action, liabilities, damages, claims, demands, costs and expenses (including reasonable attorneys’ fees and costs) incurred, or to be incurred, for any breach of the foregoing warranty by either party hereto regarding any such dealings with any real estate broker or agent. [remainder of page intentionally left blank; signature pages follow] 6

IN WITNESS WHEREOF, this Second Amendment has been executed as of the Effective Date. Landlord: LEMONE FAMILY LIMITED PARTNERSHIP LLLP, a Missouri limited liability limited partnership By: /s/ Sara Maguire LeMone 5/22/20 Name: Sara Maguire LeMone Title: General Partner [signatures continued on following page] SIGNATURE PAGE TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

[signatures continued from preceding page] Tenant: BEYOND MEAT, INC., a Delaware corporation By: /s/ Sanjay Shah 5/20/20 Name: Sanjay Shah Title: COO SIGNATURE PAGE TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

Exhibit “A” Additional Improvements [attached hereto] EXHIBIT “A” TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

Exhibit “B” Provisions to Be Included in the Contract Landlord promptly shall cause the Contract to include each of the following provisions and Landlord shall provide a copy of the fully executed Contract or similar document or agreement evidencing the same: 1. Cost of the Work; General Conditions; Applications for Payment; Audit Rights; Cost Savings. 1.1. The “Cost of the Work” is the amount described as the “Original Scheduled Value” in the Schedule of Values approved by Contractor, Landlord, and Tenant (the “Schedule of Values”). The Cost of the Work shall include the cost of the work and services identified in the Schedule of Values (and as may be modified pursuant to this Paragraph). Notwithstanding anything to the contrary set forth herein or in the Contract, Tenant shall not be obligated to pay as Cost of the Work, any of the following items: (1) the Contractor’s capital expenses, including interest on the Contractor’s capital employed for the work described in the Contract and Plans and Specifications approved by Landlord, Tenant, and Contractor (collectively, the “Contract Documents”, and such work, collectively, the “Work”); (2) costs due to the fault or negligence of the Landlord, the Contractor and/or its Subcontractors and any other person or entity for whose acts the Contractor and/or its Subcontractors may be liable, including, without limitation, the costs of correcting damaged, defective or non-conforming Work, disposal and replacement of materials and equipment incorrectly ordered or supplied; and (3) overhead and general expenses, general conditions and profit other than the “General Conditions” of 2% and the “Contractor’s Mark-up” of 8% set forth on the approved project bid dated January 13, 2020 and revised March 4, 2020, a copy of which is attached hereto as Exhibit “1” and made a part hereof; except, that, “Contractor’s Mark-up” shall exclude any mark-up on General Conditions. Further, notwithstanding anything to the contrary set forth herein or in the Contract, the General Conditions shall not include any cost item that is already accounted for in another line item in the project budget. 1.2. The period covered by each Application for Payment shall be one calendar month ending on the last day of the month. Each Application for Payment shall be accompanied by a lien waiver, executed by each Subcontractor and each materialman or supplier, covering all labor and materials that shall have been paid for in any previous application. Each Application for Payment shall also be accompanied by a partial lien waiver, executed by the Contractor and covering the entire amount of the payment requested by the relevant Application for Payment, effective on payment. In addition, each Application for Payment shall be notarized, if required, and supported by such data substantiating the Contractor’s right to payment as Landlord or Tenant may reasonably require, such as copies of requisitions, invoices or payment applications from Subcontractors and material suppliers. Neither Landlord nor Tenant shall be required to process an Application for Payment until such lien waivers and other requested information are submitted. The Contractor’s Applications for Payment may not include requests for payment of amounts the Contractor does not intend to pay to a Subcontractor or material supplier because of a dispute or other reason. 1.3. Contractor shall permit Landlord and Tenant to audit its books for any purpose of determining the correctness and allowability of charges made pursuant to the Contract, including all items in the Cost of the Work and in any change order (except that these provisions shall not apply to Work contracted on a lump sum basis). Contractor promptly shall produce all data that Landlord or Tenant may request for any such purpose. Contractor shall keep, and shall cause all Subcontractors to keep, such full and detailed accounts as may be necessary to reflect its operations with respect to such charges and extras. Landlord and Tenant and each of their respective agents and employees shall be afforded access at all reasonable times to Contractor’s and (if applicable) Subcontractors’ books, correspondence, instructions, receipts, vouchers, memoranda, and records of all kinds, relating to all Work under the Contract as well as to changes in the Work and extras. In regard to the foregoing and generally, Contractor hereby authorizes the Owner, and shall require all Subcontractors to authorize the Owner, to check directly with its suppliers EXHIBIT “B” TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

of labor and materials the charges for such labor, material, and other items appearing in the Contractor’s bills rendered to the Owner and the balances due on such charges and to obtain sworn statements and waivers of lien from any such suppliers. This provision shall survive for a period of four (4) years after the date the Landlord Improvements are substantially complete. 1.4. If the final Cost of the Work incurred by Contractor on the Project is less than the amount set forth in the Schedule of Values agreed upon by Landlord and Tenant, Tenant shall be entitled to all such savings and Contractor will return to Landlord, for the benefit of Tenant, Cost of the Work saved. 2. Warranties; Condition to Final Payment. 2.1. Contractor warrants to Landlord and Tenant that materials and equipment furnished under the Contract will be of good quality and new unless otherwise required or permitted by Plans and Specifications, that the Work will be free from any defects or deficiencies in workmanship or materials (ordinary wear and tear excepted) and that the Work will conform with the requirements of the Contract Documents. Work not conforming to these requirements, including substitutions not properly approved and authorized, shall be considered defective. The Contractor’s warranty does not cover damage or failure of materials to the extent caused by any abuse, modification, improper or insufficient maintenance or improper operation by the Owner. If required by the Owner, the Contractor shall furnish satisfactory evidence as to the kind and quality of materials and equipment to be employed in the performance of the Work. 2.2. In addition to the warranties set forth in the immediately preceding Paragraph, Contractor represents and warrants to Landlord and Tenant that all Work, materials, and equipment furnished under the Contract shall be free from failure under ordinary usage for a period of one (1) year from the date the Landlord Improvements are substantially complete. All Work not conforming to these standards shall be considered defective. Further, Contractor agrees that all guarantees or warranties of equipment or materials furnished to the Contractor or Subcontractors by any manufacturer or supplier shall be deemed to run to the benefit of, and are hereby assigned to, Landlord (subject to the remainder of this Paragraph). As a condition to final payment for the Work, the Contractor shall deliver to the Landlord two (2) clean, complete and readable copies of all guarantees and warranties on equipment and materials furnished by all manufacturers and suppliers to the Contractor and all Subcontractors, together with duly executed instruments properly assigning the guarantees and warranties to Landlord, and shall also deliver to Landlord two (2) clean, complete and readable copies of as-built drawings, all related manufacturer’s instructions, related maintenance manuals, replacement lists, detailed drawings and any technical requirements necessary to operate and maintain such equipment and materials or needed to maintain the effectiveness of any such warranties. All warranties set forth in this Paragraph and the immediately preceding paragraph shall be assignable to Tenant, and upon Tenant’s written request therefor, shall be assigned to Tenant if and to the extent Tenant is required to repair, maintain, or replace any of the Work pursuant to the applicable provisions of the Lease. 3. Indemnity; Insurance. 3.1. Contractor shall indemnify and hold harmless Landlord, Tenant, and their respective officers, directors, shareholders, partners, employees or agents, from and against claims, damages, losses and expenses, including, without limitation, reasonably attorneys’ fees, arising out of or resulting from performance of the Work, provided that such claim, damage, loss or expense is attributable to bodily injury, sickness, disease or death, or to injury to or destruction of tangible property including loss of use resulting therefrom, but only to the extent caused in whole or in part by the acts or omissions of the Contractor, a Subcontractor, a sub-Subcontractor, materialman, or supplier or anyone directly or indirectly employed by them or anyone for whose acts they may be liable, regardless of whether or not such claim, damage, loss or expense is caused in part by a party indemnified hereunder. Such obligation shall not be construed to negate, abridge, or reduce other rights or obligations of indemnity which would otherwise exist as to a party or person described in this Paragraph. This indemnification shall survive acceptance of the Work and completion of the Contract. In claims against any person or entity indemnified under the terms of the Contract by an employee of the Contractor, a Subcontractor, anyone directly or indirectly employed by them or anyone for whose acts they may be liable, the indemnification obligation under this Contract shall not be limited by a limitation on amount or type of damages, compensation or benefits payable by or for EXHIBIT “B” TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

the Contractor or a Subcontractor under workers or workmen’s compensation acts, disability benefits acts or other employee benefit acts. 3.2. Contractor shall purchase from and maintain in a company or companies lawfully authorized to do business in the State of Missouri and acceptable to Landlord and Tenant such insurance as will protect the Contractor from the following kinds of claims, which may arise out of or result from the Contractor’s operations under the Contract and for which the Contractor may be legally liable, whether such operations be by the Contractor or by a Subcontractor or by anyone directly or indirectly employed by any of them, or by anyone for whose acts any of them may be liable: (1) claims under workers’ or workmen’s compensation, disability benefit and other similar employee benefit acts which are applicable to the Work to be performed; (2) claims for damages because of bodily injury, occupational sickness or disease, or death of the Contractor’s employees; (3) claims for damages because of bodily injury, sickness or disease, or death of any person other than the Contractor’s employees; (4) claims for damages insured by usual personal injury liability coverage; (5) claims for damages, other than to the Work itself, because of injury to or destruction of tangible property, including loss of use resulting therefrom; (6) claims for damages because of bodily injury, death of a person or property damage arising out of ownership, maintenance or use of a motor vehicle; and (7) claims involving contractual liability insurance applicable to the Contractor’s indemnity obligations set forth herein. In addition, Landlord shall carry builder’s risk insurance covering the Landlord Improvements. The coverage and limits of liability contained in the Contractor’s liability insurance required pursuant to this Paragraph shall not be less than (1) Combined single limit for Bodily or Personal Injury and Property Damage of not less than $1,000,000 each occurrence, $2,000,000 annual aggregate for commercial general liability insurance, and (2) $1,000,000 Each accident, $1,000,000 Disease - Policy and $1,000,000 Disease - Each Employee for employer’s liability insurance. All coverage shall be on an occurrence basis. With the exception of workers compensation, insurance coverages required of Contractor by the Contract shall name Landlord and Tenant as additional insureds and shall not be canceled or allowed to expire without thirty (30) days prior written notice to both Landlord and Tenant. The coverage on all such policies required from Contractor pursuant to this Contract shall be primary to any valid and collectible insurance carried by Landlord and Tenant. EXHIBIT “B” TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

Exhibit “1” Approved Bid [to be attached] EXHIBIT “B” TO SECOND AMENDMENT TO LEASE (2400 Maguire Boulevard, Columbia, MO)

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ethan Brown, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Beyond Meat, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)[paragraph omitted in accordance with Exchange Act Rule 13a-14(a)];

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	August 11, 2020	By:	/s/ Ethan Brown
			Ethan Brown
			President and Chief Executive Officer
			(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark J. Nelson, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Beyond Meat, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)[paragraph omitted in accordance with Exchange Act Rule 13a-14(a)];

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	August 11, 2020	By:	/s/ Mark J. Nelson
			Mark J. Nelson
			Chief Financial Officer and Treasurer
			(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Ethan Brown, President and Chief Executive Officer of Beyond Meat, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)the accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended June 27, 2020 (the “Report”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"); and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date:	August 11, 2020	By:	/s/ Ethan Brown
			Ethan Brown
			President and Chief Executive Officer
			(Principal Executive Officer)

This certification shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of Section 18 of the Exchange Act. Such certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark J. Nelson, Chief Financial Officer and Treasurer of Beyond Meat, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)the accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended June 27, 2020 (the “Report”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"); and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date:	August 11, 2020	By:	/s/ Mark J. Nelson
			Mark J. Nelson
			Chief Financial Officer and Treasurer
			(Principal Financial Officer)

This certification shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of Section 18 of the Exchange Act. Such certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

XML

Cover Page - shares	6 Months Ended
	Jun. 27, 2020	Aug. 10, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 27, 2020
Entity File Number	001-38879
Entity Registrant Name	BEYOND MEAT, INC.
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001655210
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-4087597
Entity Address, Address Line One	119 Standard Street
Entity Address, City or Town	El Segundo
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90245
City Area Code	866
Local Phone Number	756-4112
Title of 12(b) Security	Common Stock, $0.0001 par value
Trading Symbol	BYND
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		62,444,717

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 27, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 222,334	$ 275,988
Accounts receivable	45,986	40,080
Inventory	143,033	81,596
Prepaid expenses and other current assets	17,990	5,930
Total current assets	429,343	403,594
Property, plant, and equipment, net	70,286
Property, plant, and equipment, net		47,474
Operating lease right-of-use assets	13,793
Other non-current assets, net	4,552	855
Total assets	517,974	451,923
Current liabilities:
Accounts payable	51,567	26,923
Wages payable	2,024	1,768
Accrued bonus	1,416	4,129
Current portion of operating lease liabilities	2,367
Accrued expenses and other current liabilities	8,829	3,805
Short-term borrowings under revolving credit facility and bank term loan	0	11,000
Current portion of finance lease liabilities	72
Current portion of finance lease liabilities		72
Total current liabilities	66,275	47,697
Long-term liabilities:
Revolving credit facility	50,000	0
Operating lease liabilities, net of current portion	11,604
Long-term portion of bank term loan, net	0	14,637
Equipment loan, net	0	4,932
Finance lease obligations and other long-term liabilities	185	567
Total long-term liabilities	61,789	20,136
Commitments and Contingencies (Note 10)
Stockholders’ equity:
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding	0	0
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 62,425,640 and 61,576,494 shares issued and outstanding at June 27, 2020 and December 31, 2019, respectively	6	6
Additional paid-in capital	540,576	526,199
Accumulated deficit	(150,505)	(142,115)
Accumulated other comprehensive loss	(167)	0
Total stockholders’ equity	389,910	384,090
Total liabilities and stockholders’ equity	$ 517,974	$ 451,923

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 27, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	500,000	500,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	500,000,000	500,000,000
Common stock, issued (in shares)	62,425,640	61,576,494
Common stock, outstanding (in shares)	62,425,640	61,576,494

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Income Statement [Abstract]
Net revenues	$ 113,338	$ 67,251	$ 210,412	$ 107,457
Cost of goods sold	79,687	44,510	139,070	73,945
Gross profit	33,651	22,741	71,342	33,512
Research and development expenses	6,016	4,212	12,210	8,710
Selling, general and administrative expenses	34,292	15,515	61,607	26,692
Restructuring expenses	1,509	847	3,882	1,241
Total operating expenses	41,817	20,574	77,699	36,643
(Loss) income from operations	(8,166)	2,167	(6,357)	(3,131)
Other expense, net:
Interest expense	(569)	(741)	(1,274)	(1,474)
Remeasurement of warrant liability	0	(11,744)	0	(12,503)
Other, net	(1,454)	898	(744)	1,039
Total other expense, net	(2,023)	(11,587)	(2,018)	(12,938)
Loss before taxes	(10,189)	(9,420)	(8,375)	(16,069)
Income tax expense	16	21	15	21
Net loss	$ (10,205)	$ (9,441)	$ (8,390)	$ (16,090)
Net loss per share available to common stockholders—basic and diluted (in dollars per share)	$ (0.16)	$ (0.24)	$ (0.14)	$ (0.69)
Weighted average common shares outstanding—basic and diluted	62,098,861	39,081,359	61,904,360	23,206,203

XML

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (10,205)	$ (9,441)	$ (8,390)	$ (16,090)
Other comprehensive loss, net of tax:
Foreign currency translation loss, net of tax	(167)	0	(167)	0
Comprehensive loss, net of tax	$ (10,372)	$ (9,441)	$ (8,557)	$ (16,090)

XML

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	IPO	Common Stock	Common Stock IPO	Additional Paid-in Capital	Additional Paid-in Capital IPO	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018	41,562,111
Beginning balance at Dec. 31, 2018	$ 199,540
Ending balance (in shares) at Mar. 30, 2019	41,562,111
Ending balance at Mar. 30, 2019	$ 199,540
Beginning balance (in shares) at Dec. 31, 2018			6,951,350
Beginning balance at Dec. 31, 2018	(121,750)		$ 1		$ 7,921		$ (129,672)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(6,649)						(6,649)
Issuance of common stock through equity incentive plans, net (in shares)			169,583
Issuance of common stock under equity incentive plans, net	366				366
Share-based compensation for equity classified awards	855				855
Ending balance (in shares) at Mar. 30, 2019			7,120,933
Ending balance at Mar. 30, 2019	$ (127,178)		$ 1		9,142		(136,321)
Beginning balance (in shares) at Dec. 31, 2018	41,562,111
Beginning balance at Dec. 31, 2018	$ 199,540
Ending balance (in shares) at Jun. 29, 2019	0
Ending balance at Jun. 29, 2019	$ 0
Beginning balance (in shares) at Dec. 31, 2018			6,951,350
Beginning balance at Dec. 31, 2018	(121,750)		$ 1		7,921		(129,672)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(16,090)
Conversion of convertible preferred stock to common stock upon initial public offering	199,540
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering	14,421
Foreign currency translation loss, net of tax	0
Ending balance (in shares) at Jun. 29, 2019			60,167,521
Ending balance at Jun. 29, 2019	$ 331,785		$ 6		477,541		(145,762)
Beginning balance (in shares) at Mar. 30, 2019	41,562,111
Beginning balance at Mar. 30, 2019	$ 199,540
Increase (Decrease) in Temporary Equity
Issuance of common stock upon conversion of convertible preferred stock (in shares)	(41,562,111)
Issuance of common stock upon conversion of convertible preferred stock	$ (199,540)
Ending balance (in shares) at Jun. 29, 2019	0
Ending balance at Jun. 29, 2019	$ 0
Beginning balance (in shares) at Mar. 30, 2019			7,120,933
Beginning balance at Mar. 30, 2019	(127,178)		$ 1		9,142		(136,321)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(9,441)						(9,441)
Issuance of common stock upon initial public offering net of offering costs of $4.9 million (in shares)				11,068,750
Issuance of common stock pursuant to the IPO, net of issuance costs of $4.9 million		$ 252,453		$ 1		$ 252,452
Issuance of common stock upon conversion of convertible preferred stock (in shares)			41,562,111
Conversion of convertible preferred stock to common stock upon initial public offering	199,540		$ 4		199,536
Issuance of common stock upon exercise of common stock warrants (in shares)			214,875
Issuance of common stock upon exercise of common stock warrants	0
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering	14,421				14,421
Issuance of common stock through equity incentive plans, net (in shares)			200,852
Issuance of common stock under equity incentive plans, net	167				167
Share-based compensation for equity classified awards	1,823				1,823
Foreign currency translation loss, net of tax	0
Ending balance (in shares) at Jun. 29, 2019			60,167,521
Ending balance at Jun. 29, 2019	$ 331,785		$ 6		477,541		(145,762)
Beginning balance (in shares) at Dec. 31, 2019	0
Beginning balance (in shares) at Dec. 31, 2019			61,576,494
Beginning balance at Dec. 31, 2019	$ 384,090		$ 6		526,199		(142,115)	$ 0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	1,815						1,815
Issuance of common stock through equity incentive plans, net (in shares)			280,883
Issuance of common stock under equity incentive plans, net	1,002				1,002
Share-based compensation for equity classified awards	5,074				5,074
Ending balance (in shares) at Mar. 28, 2020			61,857,377
Ending balance at Mar. 28, 2020	$ 391,981		$ 6		532,275		(140,300)	0
Beginning balance (in shares) at Dec. 31, 2019	0
Ending balance (in shares) at Jun. 27, 2020	0
Beginning balance (in shares) at Dec. 31, 2019			61,576,494
Beginning balance at Dec. 31, 2019	$ 384,090		$ 6		526,199		(142,115)	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(8,390)
Conversion of convertible preferred stock to common stock upon initial public offering	0
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering	0
Foreign currency translation loss, net of tax	(167)
Ending balance (in shares) at Jun. 27, 2020			62,425,640
Ending balance at Jun. 27, 2020	$ 389,910		$ 6		540,576		(150,505)	(167)
Ending balance (in shares) at Jun. 27, 2020	0
Beginning balance (in shares) at Mar. 28, 2020			61,857,377
Beginning balance at Mar. 28, 2020	$ 391,981		$ 6		532,275		(140,300)	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(10,205)						(10,205)
Issuance of common stock through equity incentive plans, net (in shares)			568,263
Issuance of common stock under equity incentive plans, net	1,590				1,590
Share-based compensation for equity classified awards	6,711				6,711
Foreign currency translation loss, net of tax	(167)							(167)
Ending balance (in shares) at Jun. 27, 2020			62,425,640
Ending balance at Jun. 27, 2020	$ 389,910		$ 6		$ 540,576		$ (150,505)	$ (167)

XML

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Parenthetical) $ in Millions	Jun. 29, 2019 USD ($)
IPO
Deferred offering costs	$ 4.9

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019
Cash flows from operating activities:
Net loss	$ (8,390)	$ (16,090)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,855	3,957
Non-cash lease expense	1,193
Share-based compensation expense	13,535	2,678
Loss on sale of fixed assets	183	0
Amortization of debt issuance costs	93	78
Loss on extinguishment of debt	1,538	0
Change in preferred and common stock warrant liabilities	0	12,503
Net change in operating assets and liabilities:
Accounts receivable	(5,907)	(21,762)
Inventories	(61,437)	(12,438)
Prepaid expenses and other assets	(12,192)	(2,131)
Accounts payable	21,564	9,799
Accrued expenses and other current liabilities	818	1,028
Operating lease liabilities	(1,188)
Long-term liabilities	0	12
Net cash used in operating activities	(44,335)	(22,366)
Cash flows from investing activities:
Purchases of property, plant and equipment	(26,031)	(7,502)
Proceeds from sale of fixed assets	0	232
Purchases of property, plant and equipment held for sale	(2,288)	(3,121)
Payment of security deposits	(9)	(487)
Net cash used in investing activities	(28,328)	(10,878)
Cash flows from financing activities:
Proceeds from issuance of common stock pursuant to the initial public offering, net of issuance costs	0	255,448
Proceeds from revolving credit facility	50,000	0
Debt issuance costs	(1,183)	0
Debt extinguishment costs	(1,200)	0
Repayment of revolving credit line	(6,000)	0
Repayment of term loan	(20,000)	0
Repayment of equipment loan	(5,000)	0
Principal payments under finance lease obligations	(34)
Principal payments under finance lease obligations		(21)
Proceeds from exercise of stock options	3,824	533
Payments of minimum withholding taxes on net share settlement of equity awards	(1,231)	0
Net cash provided by financing activities	19,176	255,960
Net (decrease) increase in cash and cash equivalents	(53,487)	222,716
Effect of exchange rate changes on cash	(167)	0
Cash and cash equivalents at the beginning of the period	275,988	54,271
Cash and cash equivalents at the end of the period	222,334	276,987
Supplemental disclosures of cash flow information:
Interest	1,265	1,445
Taxes	15	21
Non-cash investing and financing activities:
Non-cash additions to property, plant and equipment	4,499	1,003
Offering costs, accrued not yet paid	0	578
Non-cash additions to property, plant and equipment held for sale	0	646
Operating lease right-of-use assets obtained in exchange for lease liabilities	2,632
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering	0	14,421
Conversion of convertible preferred stock to common stock upon initial public offering	0	199,540
Note receivable from sale of assets held for sale	$ 5,158	$ 0

XML

Introduction

6 Months Ended

Jun. 27, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Introduction

Introduction

The Company

Beyond Meat, Inc., a Delaware corporation (including its consolidated subsidiaries unless the context otherwise requires, the “Company”), is one of the fastest growing food companies in the United States, offering a portfolio of revolutionary plant-based meats. The Company builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating the Company’s plant-based meat products.

The Company’s primary production facilities are located in Columbia, Missouri, and research and development and administrative offices are located in El Segundo, California. In addition to its own production facilities, the Company uses co-manufacturers in various locations in the United States, Canada and the Netherlands. On January 14, 2020, the Company registered its new subsidiary, Beyond Meat EU B.V., in the Netherlands. On April 28, 2020, the Company registered its new subsidiary, Beyond Meat (Jiaxing) Food Co., Ltd., in the Zhejiang Province in China. In the three months ended June 27, 2020, the Company acquired its first manufacturing facility in Europe located in Enschede, the Netherlands. This facility is expected to be operational by the end of 2020. In addition, in June 2020 the Company announced the official opening of a new co-manufacturing facility to be used for Beyond Meat production built by the Company’s distributor in the Netherlands.

The Company sells to a variety of customers in the retail and foodservice channels throughout the United States and internationally primarily through distributors who purchase, store, sell, and deliver the Company’s products. In addition, the Company sells directly to customers in the retail and foodservice channels who handle their own distribution. As of June 27, 2020, approximately 96% of the Company’s long-lived assets were located in the United States.

COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. The global spread and unprecedented impact of COVID-19 continues to create significant volatility, uncertainty and economic disruption. In the three months ended June 27, 2020, the Company’s operations in its facilities, and its financial results including net revenues, gross profit, gross margin and operating expenses were negatively impacted by COVID-19. The extent of COVID-19’s effect on the Company’s operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. As a result, it is not currently possible to ascertain the overall impact of COVID-19 on the Company’s business. While the ultimate health and economic impact of the COVID-19 pandemic is highly uncertain, the Company expects that its business operations and results of operations, including its net revenues, gross profit, gross margin, earnings and cash flows, will be adversely impacted for at least the balance of 2020.

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 27, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements include all adjustments

necessary, which are of a normal and recurring nature, for the fair presentation of the Company’s financial position and of the results of operations and cash flows for the periods presented. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2020 or for any other interim period or for any other future fiscal year. These condensed consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on March 19, 2020 (the “2019 10-K”). The condensed balance sheet as of December 31, 2019 has been derived from the audited financial statements at that date. There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2019 10-K, except as noted below.

Principles of Consolidation

The condensed consolidated financial statements for the periods ended June 27, 2020 include the accounts of the Company and its subsidiaries. All inter-company balances and transactions have been eliminated.

Management’s Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include trade promotion accruals; useful lives of property, plant and equipment; valuation of deferred tax assets; valuation of inventory; incremental borrowing rate used to determine operating lease right-of-use assets and operating lease liabilities; assessment of contract-based factors, asset-based factors, entity-based factors and market-based factors to determine the lease term impacting right-of-use assets and lease liabilities; and the valuation of the fair value of stock options used to determine share-based compensation expense. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.

Property, Plant and Equipment

Property, plant and equipment are carried at cost less accumulated depreciation and are depreciated using the straight-line method over the following estimated useful lives:

Land	Not amortized
Buildings	30 years
Leasehold improvements	Shorter of lease term or estimated useful life
Furniture and fixtures	3 years
Manufacturing equipment	5 to 10 years
Research and development equipment	5 to 10 years
Software and computer equipment	3 years
Vehicles	5 years

Leasehold improvements are depreciated on a straight-line basis over the lesser of the estimated useful life of the asset or the remaining lease term. When assets are sold or retired, the asset and related accumulated depreciation are removed from the respective account balances and any gain or loss on disposal is included in loss from operations. Expenditures for repairs and maintenance are charged directly to expense when incurred. See Note 6.

Foreign Currency

The Company’s foreign entities use their local currency as the functional currency. For these entities, the Company translates net assets into U.S. dollars at period end exchange rates, while revenue and expense accounts are translated at average exchange rates prevailing during the periods being reported. Resulting currency translation adjustments are included in accumulated other comprehensive loss and foreign currency transaction gains and losses are included in other, net. Transaction gains and losses on long-term intra-entity transactions are recorded as a component of other comprehensive loss. Transactions denominated in a currency other than the reporting entity’s functional currency may give rise to transaction gains and losses that impact the Company’s results of operations.

Unrealized translation losses, net of tax, reported as cumulative translation adjustments through other comprehensive loss were $0.2 million as of June 27, 2020. Foreign currency transaction gains included in other, net were $0.1 million during the three and six months ended June 27, 2020.

Fair Value of Financial Instruments

The fair value measurement accounting guidance creates a fair value hierarchy to prioritize the inputs used to measure fair value into three categories. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement, where Level 1 is the highest and Level 3 is the lowest.

The three levels are defined as follows:

•Level 1—Unadjusted quoted prices in active markets accessible by the reporting entity for identical assets or liabilities. Active markets are those in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

•Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which significant value drivers are observable.

•Level 3—Valuations derived from valuation techniques in which significant value drivers are unobservable.

The Company’s financial instruments include cash equivalents, accounts receivable, accounts payable, and accrued expenses, for which the carrying amounts approximate fair value due to the short-term maturity of these financial instruments. Based on the borrowing rates currently available to the Company for debt with similar terms, the carrying value of the Company’s revolving credit facility approximates fair value as well.

The Company had no financial instruments measured at fair value on a recurring basis as of June 27, 2020 and December 31, 2019, other than the liability classified share-settled obligation to one of the Company’s executive officers as discussed in Note 9 which represents a Level 1 financial instrument. There was no change in the fair value of the liability-classified share-settled obligation in the three and six months ended June 27, 2020. There were no transfers of financial assets or liabilities into or out of Level 1, Level 2 or Level 3 for the three and six months ended June 27, 2020.

Prior to the IPO, the stock warrant liability was measured at fair value using Level 3 inputs upon issuance and at each reporting date. Inputs used to determine the estimated fair value of the warrant liability as of the valuation date included expected term of the warrants, the risk-free interest rate, volatility, and the fair value of underlying shares.

The following table sets forth a summary of the changes in the fair value of the preferred and common stock warrant liabilities:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Beginning balance	$	—	$	2,677	$	—	$	1,918
Fair value of warrants issued during the period	—		—		—		—
Change in fair value of warrant liability	—		11,744		—		12,503
Reclassification of warrant liability to additional paid-in capital in connection with the IPO	—		(14,421)		—		(14,421)
Ending balance	$	—	$	—	$	—	$	—

The Company remeasured and reclassified the common stock warrant liability to additional paid-in-capital in connection with the IPO. The final re-measurement of the preferred stock warrant was based upon the publicly available stock price on the conversion date. Subsequent to the closing of the IPO, all outstanding warrants to purchase shares of common stock were cashless exercised and no warrants were outstanding as of June 29, 2019.

Revenue Recognition

Revenue is recognized at the point in which the performance obligation under the terms of a contract with the customer have been satisfied and control has transferred. The Company’s performance obligation is typically defined as the accepted purchase order, or the contract, with the customer which requires the Company to deliver the requested products at agreed upon prices at the time and location of the customer’s choice. The Company does not offer warranties or a right to return on the products it sells except in the instance of a product recall.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for fulfilling the performance obligation. Sales and other taxes the Company collects concurrent with the sale of products are excluded from revenue. The Company's normal payment terms vary by the type and location of its customers and the products offered. The time between invoicing and when payment is due is not significant. None of the Company's customer contracts as of June 27, 2020 contains a significant financing component.

The Company routinely offers sales discounts and promotions through various programs to its customers and consumers. These programs include rebates, temporary on shelf price reductions, buy-one-get-one-free programs, off invoice discounts, retailer advertisements, product coupons and other trade activities. Provision for discounts and incentives are recorded in the same period in which the related revenues are recognized. At the end of each accounting period, the Company recognizes a liability for estimated sales discounts that have been incurred but not paid which totaled $4.7 million and $1.6 million as of June 27, 2020 and December 31, 2019, respectively. The offsetting charge is recorded as a reduction of revenues in the same period when the expense is incurred.

The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. The incremental cost to obtain contracts was not material.

Presentation of Net Revenues by Channel

Effective January 1, 2020, the Company began presenting net revenues by geography and distribution channel as follows:

Distribution Channel	Description
U.S. Retail	Net revenues from retail sales to the U.S. market
U.S. Foodservice	Net revenues from restaurant and foodservice sales to the U.S. market
International Retail	Net revenues from retail sales to international markets, including Canada
International Foodservice	Net revenues from restaurant and foodservice sales to international markets, including Canada

Net revenues from sales to the Canadian market, previously included with net revenues from sales to the U.S. market, have been reclassified to International net revenues. Prior period amounts have been recast to conform to the current period presentation. The foregoing change in presentation had no impact on the Company’s net revenues, results of operations or cash flows.

Effective January 1, 2020, the Company also eliminated the presentation of net revenues by platform as it is no longer material to an understanding of the Company's financial results. Previously, the Company presented net revenues by platform for its “ready-to-cook” or fresh platform, and “ready-to-heat” or frozen platform. Gross revenues from sales of products in the Company's frozen platform were 5.5% of gross revenues in the year ended December 31, 2019, as compared to 16.3% of gross revenues in the year ended December 31, 2018.

The following table presents the Company’s net revenues by channel:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net revenues:
U.S.:
Retail	$	90,040	$	30,531	$	139,963	$	49,992
Foodservice	6,486		16,504		29,117		25,338
U.S. net revenues	96,526		47,035		169,080		75,330
International:
Retail	9,572		3,589		15,524		3,707
Foodservice	7,240		16,627		25,808		28,420
International net revenues	16,812		20,216		41,332		32,127
Net revenues	$	113,338	$	67,251	$	210,412	$	107,457

One distributor accounted for approximately 16% of the Company’s gross revenues in the three months ended June 27, 2020; and two distributors accounted for approximately 22% and 20%, respectively, of the Company’s gross revenues in the three months ended June 29, 2019. One distributor accounted for approximately 14% of the Company’s gross revenues in the six months ended June 27, 2020; and two distributors accounted for approximately 22% and 21%, respectively, of the Company’s gross revenues in the six months ended June 29, 2019. No other distributor or customer accounted for more than 10% of the Company’s gross revenues in the three and six months ended June 27, 2020 and June 29, 2019.

Shipping and Handling Costs

Outbound shipping and handling costs included in selling, general and administrative (“SG&A”) expenses in the three months ended June 27, 2020 and June 29, 2019 were $3.2 million and $2.6 million,

respectively. Outbound shipping and handling costs included in SG&A expenses in the six months ended June 27, 2020 and June 29, 2019 were $4.8 million and $3.9 million, respectively.

Recently Adopted Accounting Pronouncements

As an “emerging growth company” (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company will no longer qualify as an EGC as of the end of the fiscal year ending December 31, 2020, when it becomes a Large Accelerated Filer under Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Therefore, the Company has elected to use the adoption dates applicable to public companies beginning in the first quarter of 2020 and the adoption dates for the new accounting pronouncements disclosed below have been evaluated under such premise.

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842) (“ASU 2016-02”), which requires lessees to record most leases on their balance sheets but recognize the expenses on their income statements in a manner similar to Accounting Standards Codification (“ASC”) 840, “Leases” (“ASC 840”). ASU 2016-02 requires that a lessee recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term.

On January 1, 2020, the Company adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840. The Company also elected the package of practical expedients permitted under the transition guidance within ASU 2016-02, which among other things, permits the Company to not reassess under the new standard the Company’s prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight practical expedient or the practical expedient pertaining to land easements, the latter not being applicable to the Company. As part of this adoption, the Company elected not to record operating right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. Payments on those leases will be recognized on a straight-line basis through the Company’s condensed consolidated statements of operations over the lease term. The Company also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets. See Note 4.

On March 12, 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). The amendments in ASU 2020-04 provide temporary optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions to ease the potential accounting and financial reporting burden associated with transitioning away from reference rates that are expected to be discontinued, including the London Interbank Offered Rate (LIBOR). ASU 2020-04 is effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of ASU 2020-04 has not had and is not expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

New Accounting Pronouncements

On December 18, 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes (Topic 740)” (“ASU 2019-12”). ASU 2019-12 eliminates the need for an organization to analyze whether the following apply in a given period (1) exceptions to the incremental approach for intra-period tax allocation, (2) exceptions to accounting for basis differences when there are ownership changes in foreign investments, and (3) exceptions in interim period income tax accounting for year-to-date losses that exceed anticipated losses. ASU 2019-12 also is designed to improve financial statement preparers’ application of income tax-related guidance and simplify GAAP for (1) franchise taxes that are partially based on income, (2) transactions with a government that result in a step-up in the tax basis of goodwill, (3) separate financial statements of legal entities that are not subject to tax, and (4) enacted changes in

tax laws in interim periods. For public business entities, the amendments in ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption of the amendments is permitted, including adoption in any interim period for public business entities for periods for which financial statements have not yet been issued. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. ASU 2019-12 is effective for the Company beginning on January 1, 2021. Adoption of ASU 2019-12 is not expected to result in any material changes to the way the tax provision is prepared and is not expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

XML

Restructuring	6 Months Ended
	Jun. 27, 2020
Restructuring and Related Activities [Abstract]
Restructuring	RestructuringIn May 2017, management approved a plan to terminate the Company’s exclusive supply agreement (the “Agreement”) with one of its co-manufacturers, due to non-performance under the Agreement and on May 23, 2017, the Company notified the co-manufacturer of its decision to terminate the Agreement. In the three months ended June 27, 2020 and June 29, 2019, the Company recorded $1.5 million and $0.8 million, respectively, in restructuring expenses related to this dispute, which consisted primarily of legal and other expenses. In the six months ended June 27, 2020 and June 29, 2019, the Company recorded $3.9 million and $1.2 million, respectively, in restructuring expenses related to this dispute, which consisted primarily of legal and other expenses. See Note 10 for further information. As of June 27, 2020 and December 31, 2019, the Company had $2.3 million and $1.1 million, respectively, in accrued and unpaid restructuring expenses.

XML

Leases

6 Months Ended

Jun. 27, 2020

Leases [Abstract]

Leases

Leases

Leases are classified as either finance leases or operating leases based on criteria in ASC 842. The Company has operating leases for its corporate offices including its Manhattan Beach Innovation Center where the Company’s research and development facility is located, its manufacturing facilities, warehouses and vehicles, and finance leases for certain of the Company’s equipment. Such leases generally have original lease terms between two and 11 years, and often include one or more options to renew. Some leases also include early termination options, which can be exercised under specific conditions. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company currently considers its renewal options to be reasonably certain to be exercised. The Company does not have residual value guarantees or material restrictive covenants associated with its leases.

On January 1, 2020, the Company adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840.

Operating lease assets represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments at lease commencement. The Company calculates the present value of its operating leases using an estimated incremental borrowing rate, which requires judgment. The Company estimates the incremental borrowing rate for each operating lease based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. Certain leases contain variable payments, which are expensed as incurred and not included in the Company’s operating lease right-of-use assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance on the Company’s corporate, research and development, and manufacturing facilities and warehouse leases and are excluded from the present value of the Company’s lease obligations.

Previously designated capital leases under ASC 840 are now considered finance leases under ASC 842. The Company calculates the present value of its finance leases using the interest rate implicit in the lease agreement.

Upon adoption of ASU 2016-02, the Company recognized operating lease right-of-use assets of $11.9 million adjusted for $0.3 million previously recorded as deferred rent and $0.2 million previously recorded as prepaid rent on the Company’s condensed consolidated balance sheets. The Company also recorded $1.4 million in current operating lease liabilities and $10.6 million in operating lease liabilities, net of current portion.

As part of this adoption, the Company elected to not record operating lease right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.

The components of lease expense were as follows:

(in thousands)	Statement of Operations Location	Three Months Ended June 27, 2020		Six Months Ended June 27, 2020
Operating lease cost:
Lease cost	Cost of goods sold	$	468	$	652
Lease cost	Research and development expenses	158		283
Lease cost	Selling, general and administrative expenses	161		273
Variable lease cost (1)	Cost of goods sold	1		7
Operating lease cost		$	788	$	1,215
Short-term lease cost	Selling, general and administrative expenses	$	111	$	175
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	$	20	$	38
Interest on lease liabilities	Interest expense	3		7
Finance lease cost		$	23	$	45
Total lease cost		$	922	$	1,435

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

Supplemental balance sheet information as of June 27, 2020 related to leases are as follows:

(in thousands)	Balance Sheet Location	June 27, 2020
Assets
Operating leases	Operating lease right-of-use assets	$	13,793
Finance leases, net	Property, plant and equipment, net	249
Total lease assets		$	14,042
Liabilities
Current:
Operating lease liabilities	Current portion of operating lease liabilities	$	2,367
Finance lease liabilities	Current portion of finance lease liabilities	72
Long-term:
Operating lease liabilities	Operating lease liabilities, net of current portion	11,604
Finance lease liabilities	Finance lease obligations and other long-term liabilities	185
Total lease liabilities		$	14,228

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2020:

	June 27, 2020
(in thousands)	Operating Leases		Finance Leases
Remainder of 2020	$	1,335	$	43
2021	2,737		80
2022	2,664		71
2023	2,181		58
2024	1,395		30
2025	1,281		—
Thereafter	3,914		—
Total undiscounted future minimum lease payments	15,507		282
Less imputed interest	(1,536)		(25)
Total discounted future minimum lease payments	$	13,971	$	257

Weighted average remaining lease terms and weighted average discount rates were:

	June 27, 2020
	Operating Leases		Finance Leases
Weighted average remaining lease term (years)	7.4		3.7
Weighted average discount rate	2.9	%	5.4	%

A schedule of the future minimum rental commitments under the Company’s capital lease agreements and non-cancelable operating lease agreements with an initial or remaining term in excess of one year as of December 31, 2019, in accordance with ASC 840 were as follows:

(in thousands)	Capital Lease Obligations		Operating Lease Obligations
2020	$	86	$	1,878
2021	80		1,813
2022	71		1,817
2023	58		1,840
2024	30		1,353
Thereafter	—		5,167
Total minimum lease payments			$	13,868
Total minimum lease payments	$	325
Less: imputed interest (4.1% to 15.9%)	(34)
Total capital lease obligations	$	291
Less: current portion of capital lease obligations	(72)
Long-term capital lease obligations	$	219

Leases

Leases

Leases are classified as either finance leases or operating leases based on criteria in ASC 842. The Company has operating leases for its corporate offices including its Manhattan Beach Innovation Center where the Company’s research and development facility is located, its manufacturing facilities, warehouses and vehicles, and finance leases for certain of the Company’s equipment. Such leases generally have original lease terms between two and 11 years, and often include one or more options to renew. Some leases also include early termination options, which can be exercised under specific conditions. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company currently considers its renewal options to be reasonably certain to be exercised. The Company does not have residual value guarantees or material restrictive covenants associated with its leases.

On January 1, 2020, the Company adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840.

Operating lease assets represent the right to use an underlying asset for the lease term, and operating lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments at lease commencement. The Company calculates the present value of its operating leases using an estimated incremental borrowing rate, which requires judgment. The Company estimates the incremental borrowing rate for each operating lease based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. Certain leases contain variable payments, which are expensed as incurred and not included in the Company’s operating lease right-of-use assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance on the Company’s corporate, research and development, and manufacturing facilities and warehouse leases and are excluded from the present value of the Company’s lease obligations.

Previously designated capital leases under ASC 840 are now considered finance leases under ASC 842. The Company calculates the present value of its finance leases using the interest rate implicit in the lease agreement.

Upon adoption of ASU 2016-02, the Company recognized operating lease right-of-use assets of $11.9 million adjusted for $0.3 million previously recorded as deferred rent and $0.2 million previously recorded as prepaid rent on the Company’s condensed consolidated balance sheets. The Company also recorded $1.4 million in current operating lease liabilities and $10.6 million in operating lease liabilities, net of current portion.

As part of this adoption, the Company elected to not record operating lease right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.

The components of lease expense were as follows:

(in thousands)	Statement of Operations Location	Three Months Ended June 27, 2020		Six Months Ended June 27, 2020
Operating lease cost:
Lease cost	Cost of goods sold	$	468	$	652
Lease cost	Research and development expenses	158		283
Lease cost	Selling, general and administrative expenses	161		273
Variable lease cost (1)	Cost of goods sold	1		7
Operating lease cost		$	788	$	1,215
Short-term lease cost	Selling, general and administrative expenses	$	111	$	175
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	$	20	$	38
Interest on lease liabilities	Interest expense	3		7
Finance lease cost		$	23	$	45
Total lease cost		$	922	$	1,435

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

Supplemental balance sheet information as of June 27, 2020 related to leases are as follows:

(in thousands)	Balance Sheet Location	June 27, 2020
Assets
Operating leases	Operating lease right-of-use assets	$	13,793
Finance leases, net	Property, plant and equipment, net	249
Total lease assets		$	14,042
Liabilities
Current:
Operating lease liabilities	Current portion of operating lease liabilities	$	2,367
Finance lease liabilities	Current portion of finance lease liabilities	72
Long-term:
Operating lease liabilities	Operating lease liabilities, net of current portion	11,604
Finance lease liabilities	Finance lease obligations and other long-term liabilities	185
Total lease liabilities		$	14,228

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2020:

	June 27, 2020
(in thousands)	Operating Leases		Finance Leases
Remainder of 2020	$	1,335	$	43
2021	2,737		80
2022	2,664		71
2023	2,181		58
2024	1,395		30
2025	1,281		—
Thereafter	3,914		—
Total undiscounted future minimum lease payments	15,507		282
Less imputed interest	(1,536)		(25)
Total discounted future minimum lease payments	$	13,971	$	257

Weighted average remaining lease terms and weighted average discount rates were:

	June 27, 2020
	Operating Leases		Finance Leases
Weighted average remaining lease term (years)	7.4		3.7
Weighted average discount rate	2.9	%	5.4	%

A schedule of the future minimum rental commitments under the Company’s capital lease agreements and non-cancelable operating lease agreements with an initial or remaining term in excess of one year as of December 31, 2019, in accordance with ASC 840 were as follows:

(in thousands)	Capital Lease Obligations		Operating Lease Obligations
2020	$	86	$	1,878
2021	80		1,813
2022	71		1,817
2023	58		1,840
2024	30		1,353
Thereafter	—		5,167
Total minimum lease payments			$	13,868
Total minimum lease payments	$	325
Less: imputed interest (4.1% to 15.9%)	(34)
Total capital lease obligations	$	291
Less: current portion of capital lease obligations	(72)
Long-term capital lease obligations	$	219

XML

Inventories

6 Months Ended

Jun. 27, 2020

Inventory Disclosure [Abstract]

Inventories

Inventories

Major classes of inventory were as follows:

(in thousands)	June 27, 2020		December 31, 2019
Raw materials and packaging	$	80,848	$	36,884
Work in process	13,326		17,958
Finished goods	48,859		26,754
Total	$	143,033	$	81,596

XML

Property, Plant and Equipment

6 Months Ended

Jun. 27, 2020

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant, and equipment are stated at cost and finance lease assets are included. A summary of property, plant, and equipment as of June 27, 2020 and December 31, 2019, is as follows:

(in thousands)	June 27, 2020		December 31, 2019
Manufacturing equipment	$	51,559	$	37,939
Research and development equipment	9,643		8,933
Leasehold improvements	8,000		7,620
Building	1,600		—
Finance leases	287		1,108
Software	358		274
Furniture and fixtures	461		433
Vehicles	378		210
Land	1,120		—
Assets not yet placed in service	23,149		11,666
Total property, plant and equipment	$	96,555	$	68,183
Accumulated depreciation and amortization	(26,269)		(20,709)
Property, plant and equipment, net	$	70,286	$	47,474

Depreciation and amortization expense for the three months ended June 27, 2020 and June 29, 2019, was $3.3 million and $2.1 million, respectively. Of the total depreciation and amortization expense in the three months ended June 27, 2020 and June 29, 2019, $2.5 million and $1.4 million, respectively, were recorded in cost of goods sold, $0.7 million and $0.6 million, respectively, were recorded in research and development expenses, and $0.1 million and $12,000, respectively, were recorded in SG&A expenses in the Company’s condensed consolidated statements of operations.

Depreciation and amortization expense for the six months ended June 27, 2020 and June 29, 2019, was $5.9 million and $4.0 million, respectively. Of the total depreciation and amortization expense in the six months ended June 27, 2020 and June 29, 2019, $4.4 million and $2.8 million, respectively, were recorded in cost of goods sold, $1.4 million and $1.1 million, respectively, were recorded in research and development expenses, and $0.1 million and $22,000, respectively, were recorded in SG&A expenses, in the Company’s condensed consolidated statements of operations.

The Company no longer has any assets that meet the criteria for assets held for sale as of June 27, 2020. Amounts previously classified as assets held for sale were sold for amounts that approximated book value for which a note receivable of $5.2 million was recorded, of which $3.4 million is included in prepaid expenses and other current assets and $1.8 million is included in other non-current assets, net in the Company’s condensed consolidated balance sheet as of June 27, 2020.

XML

Debt

6 Months Ended

Jun. 27, 2020

Debt Disclosure [Abstract]

Debt

DebtOn April 21, 2020, the Company entered into a $150 million five-year secured revolving credit agreement (“2020 Credit Agreement”) by and among the Company, the lenders party thereto (the “Lenders”) and JPMorgan Chase Bank, N.A., as the administrative agent (the “Administrative Agent”). JPMorgan Chase Bank, N.A. and Silicon Valley Bank acted as joint bookrunners and joint lead arrangers under the 2020 Credit Agreement. The 2020 Credit Agreement includes an accordion feature for up to an additional $200 million. Capitalized terms used below but not defined have the meanings ascribed to such terms in the 2020 Credit Agreement.

Concurrently with the effectiveness of the 2020 Credit Agreement, on April 21, 2020, the Company terminated the SVB Credit Facilities (a revolving credit facility and a term loan facility with Silicon Valley Bank) and the Equipment Loan Facility (an equipment loan from Structural Capital), and incurred an aggregate of $1.2 million of termination, prepayment, and related fees in connection with such terminations.

Amounts available under the 2020 Credit Agreement are for working capital needs, for general corporate purposes and to refinance certain existing indebtedness, as the Company deems necessary. Borrowings under the 2020 Credit Agreement will bear interest, at the Company’s option, calculated according to an Alternate Base Rate or LIBO Rate, as the case may be, plus an applicable margin. Until the delivery to the Administrative Agent of the Company’s consolidated financial information for the fiscal quarter ending September 30, 2020, the applicable margin shall be 1.5% per annum for Alternate Base Rate loans and 2.5% per annum for LIBO Rate loans. Thereafter, the applicable margin for Alternate Base Rate loans will range from 1.25% to 1.75% per annum, and the applicable margin for LIBO Rate loans will range from 2.25% to 2.75% per annum, in each case, based on the Company’s total leverage ratio at the end of each quarter.

The Company is required to pay an unused commitment fee of 0.375% per annum, which shall accrue at the applicable rate on the daily amount of the undrawn portion of the commitment of each Lender. Letters of credit issued under the 2020 Credit Agreement are subject to customary letter of credit fees. The Company’s obligations under the 2020 Credit Agreement are secured by substantially all of its assets, subject to customary exceptions set forth in the 2020 Credit Agreement. In addition, to the extent the Company forms or acquires any domestic subsidiaries, such domestic subsidiaries will be required to guarantee the Company’s obligations under the 2020 Credit Agreement and provide a security interest over substantially all of their assets.

The 2020 Credit Agreement contains customary representations, warranties and covenants for a transaction of this type, including maintenance of (i) a maximum total leverage ratio of 3.00 to 1.00 and (ii) a minimum fixed charge coverage ratio of 1.25 to 1.00, in each case, tested on the last day of each fiscal quarter. The 2020 Credit Agreement also provides for customary events of default, including (among others) nonpayment, covenant defaults, breaches of representations or warranties, bankruptcy and insolvency events and a change of control. If an event of default occurs, the Administrative Agent shall, at the request of, or may, with the consent of, the required Lenders, declare the obligations under the 2020 Credit Agreement immediately due and payable and the commitments of the Lenders may be terminated. For certain events of default relating to insolvency, the commitments of the Lenders are automatically terminated and all outstanding obligations become due and payable.

The Company’s debt balances are detailed below:

(in thousands)	June 27, 2020		December 31, 2019
Revolving credit facility	$	50,000	$	—
Revolving credit line (SVB)	—		6,000
Term loan facility	—		20,000
Equipment financing loan	—		5,000
Debt issuance costs	—		(431)
Total debt outstanding	$	50,000	$	30,569
Less: current portion of long-term debt	—		11,000
Long-term debt	$	50,000	$	19,569

The Company records debt issuance costs on the revolving credit facility in other non-current assets, net in the accompanying condensed consolidated balance sheet as of June 27, 2020. Debt issuance costs on the revolving credit line and term loan, net of amortization, were recorded as a reduction of carrying value of the debt in the accompanying condensed consolidated balance sheet as of December

31, 2019. Debt issuance costs, net of amortization, totaled $1.2 million and $0.4 million as of June 27, 2020 and December 31, 2019, respectively. Debt issuance costs are amortized as interest expense over the term of the loan for which amortization of $57,000 and $20,000 was recorded during the three months ended June 27, 2020 and June 29, 2019, respectively, and $93,000 and $78,000 was recorded during the six months ended June 27, 2020 and June 29, 2019, respectively.

In the three months ended June 27, 2020 and June 29, 2019, the Company incurred $0.4 million and $0.5 million, respectively, in interest expense related to its bank credit facilities. In the six months ended June 27, 2020 and June 29, 2019, the Company incurred $0.9 million and $1.1 million, respectively, in interest expense related to its bank credit facilities. In the three months ended June 27, 2020 and June 29, 2019, the Company recorded $0.1 million and $0.2 million, respectively, in interest expense related to the Equipment Loan Facility. In the six months ended June 27, 2020 and June 29, 2019, the Company recorded $0.2 million and $0.3 million, respectively, in interest expense related to the Equipment Loan Facility.

The interest rate on the revolving credit facility under the 2020 Credit Agreement at June 27, 2020 was 3.5%. The Company is subject to compliance with the financial covenants in the 2020 Credit Agreement commencing with the fiscal quarter ending September 26, 2020.

XML

Stockholders’ Equity

6 Months Ended

Jun. 27, 2020

Equity [Abstract]

Stockholders’ Equity

Stockholders’ Equity

As of June 27, 2020, the Company’s shares consisted of 500,000,000 authorized shares of common stock, par value $0.0001 per share, of which 62,425,640 shares of common stock were issued and outstanding, and 500,000 authorized shares of preferred stock, par value $0.0001 per share, of which no shares were issued and outstanding.

As of December 31, 2019, the Company’s shares consisted of 500,000,000 authorized shares of common stock, par value $0.0001 per share, of which 61,576,494 shares were issued and outstanding, and 500,000 authorized shares of preferred stock, par value $0.0001 per share, of which no shares were issued and outstanding.

The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock.

XML

Share-Based Compensation

6 Months Ended

Jun. 27, 2020

Share-based Payment Arrangement [Abstract]

Share-Based Compensation

Share-Based Compensation

In 2019, the Company’s 2011 Equity Incentive Plan was amended, restated and re-named the 2018 Equity Incentive Plan (“2018 Plan”), and the remaining shares available for issuance under the 2011 Plan were added to the shares reserved for issuance under the 2018 Plan. As of January 1, 2020, the maximum aggregate number of shares that may be issued under the 2018 Plan increased to 16,626,877 shares.

As of June 27, 2020 and December 31, 2019, there were 4,562,663 and 5,170,976 shares, respectively, issuable under stock options outstanding, 287,439 and 149,004 shares, respectively, issuable under unvested RSUs outstanding, 6,722,897 and 5,864,738 shares, respectively, issued for stock option exercises, RSU settlement, and restricted stock grants, and 5,060,728 and 3,297,638 shares, respectively, available for grants under the 2018 Plan.

Stock Options

Following are the assumptions used in the Black-Scholes valuation model for options granted during the periods shown below:

	Three Months Ended		Six Months Ended
	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Risk-free interest rate	0.5%	2.3%	0.7%	2.3%
Average expected term (years)	7.0	6.0	7.0	6.0
Expected volatility	55.0%	55.0%	55.0%	55.0%
Dividend yield	—	—	—	—

Option grants to new employees in the six months ended June 27, 2020 and June 29, 2019 vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting monthly over the remaining three-year period, subject to continued employment through the vesting date. Option grants to continuing employees in the six months ended June 27, 2020 vest monthly over a 48-month period, subject to continued employment through the vesting date. Option grants to continuing employees in the six months ended June 29, 2019 vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting monthly over the remaining three-year period, subject to continued employment through the vesting date.

The following table summarizes the Company’s stock option activity during the six months ended June 27, 2020:

	Number of Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value (in thousands)(1)
Outstanding at December 31, 2019	5,170,976	$	14.28	7.5	$	329,879
Granted	251,170	$	97.72	—	$	—
Exercised	(825,965)	$	4.63	—	$	91,606
Cancelled/Forfeited	(33,518)	$	34.47	—	$	—
Outstanding at June 27, 2020	4,562,663	$	20.47	7.2	$	556,534
Vested and exercisable at June 27, 2020	2,470,346	$	7.84	6.0	$	331,568
Vested and expected to vest at June 27, 2020	3,932,836	$	15.73	6.9	$	497,871

__________

(1) Aggregate intrinsic value is calculated as the difference between the value of common stock on the transaction date and the exercise price multiplied by the number of shares issuable under the stock option.

During the three months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $3.6 million and $1.2 million, respectively, of share-based compensation expense related to options issued to employees and nonemployees. During the six months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $6.6 million and $1.8 million, respectively, of share-based compensation expense related to options issued to employees and nonemployees. The share-based compensation expense is included in cost of goods sold, research and development expenses, and SG&A expenses in the Company’s condensed consolidated statements of operations.

As of June 27, 2020, there was $15.7 million in unrecognized compensation expense related to nonvested stock option awards which is expected to be recognized over a weighted average period of 2.4 years.

Restricted Stock Units

RSU grants to new employees in the six months ended June 27, 2020 and June 29, 2019 vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting quarterly over the remaining three years of the award, subject to continued employment through the vesting date. RSU grants in the six months ended June 27, 2020 to continuing employees vest quarterly over 16 quarters, subject to continued employment through the vesting date. RSU grants to consultants in the six months ended June 27, 2020 vest quarterly over 8 quarters, subject to continued service through the vesting date. An RSU grant to a nonemployee brand ambassador in the six months ended June 27, 2020 vests 50% upon grant with the remainder vesting quarterly over 4 quarters commencing on October 1, 2020, subject to continued service through the vesting date.

The following table summarizes the Company’s RSU activity during the six months ended June 27, 2020:

	Number of Shares	Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2019	149,004	$	132.82
Granted	180,774	$	102.51
Vested(1)	(34,245)	$	137.82
Cancelled/Forfeited	(8,094)	$	—
Unvested at June 27, 2020	287,439	$	113.40

________

(1) Includes 8,902 shares of common stock that were withheld to cover taxes on the release of vested RSUs and became available for future grants pursuant to the 2018 Plan.

During the three months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $2.7 million and $89,000, respectively, of share-based compensation expense related to RSUs. During the six months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $4.3 million and $89,000, respectively, of share-based compensation expense related to RSUs. The share-based compensation expense is included in cost of goods sold, research and development expenses, and SG&A expenses in the Company’s condensed consolidated statements of operations.

As of June 27, 2020, there was $12.2 million in unrecognized compensation expense related to unvested RSUs which is expected to be recognized over a weighted average period of 2.2 years.

Share-Settled Obligation

Share-based compensation expense in the three and six months ended June 27, 2020 includes $0.9 million and $1.8 million, respectively, for a liability classified, share-settled obligation to an executive officer related to a sign-on award pursuant to the terms of the executive officer’s offer letter dated August 1, 2019 with the Company. There was no such expense in the three and six months ended June 29, 2019.

The share-based compensation expense related to this share-settled obligation is included in SG&A expenses in the Company’s condensed consolidated statements of operations. The liability classified award is considered unearned until the requirements for issuance of the shares are met and is included in accrued expenses and other current liabilities on the Company’s condensed consolidated balance sheets as of June 27, 2020 and December 31, 2019 in the amount of $2.8 million and $1.0 million, respectively. As of June 27, 2020, there was $4.2 million in unrecognized compensation expense related to this share-settled obligation which is expected to be recognized over 1.2 years.

Restricted Stock to Nonemployees

The following table summarizes the Company’s restricted stock activity during the six months ended June 27, 2020:

	Number of Shares of Restricted Stock	Weighted Average Remaining Contractual Life (Years)	Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2019	88,988	1.2	$	19.49
Granted	—	—	$	—
Vested/Released	(48,607)	—	$	19.39
Cancelled/Forfeited	—	—	$	—
Unvested at June 27, 2020	40,381	0.95	$	19.77

As of June 27, 2020, 40,381 shares of restricted stock had been purchased by nonemployee brand ambassadors which remained subject to vesting requirements and repurchase pursuant to restricted stock purchase agreements.

During the three months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $0.4 million and $0.5 million, respectively, of share-based compensation expense related to restricted stock issued to nonemployee brand ambassadors, which is included in SG&A expenses in the Company’s condensed consolidated statements of operations. During each of the six months ended June 27, 2020 and June 29, 2019, the Company recorded in aggregate $0.8 million of share-based compensation expense related to restricted stock issued to nonemployee brand ambassadors, which is included in SG&A expenses in the Company’s condensed consolidated statements of operations.

As of June 27, 2020, there was $0.8 million in unrecognized compensation expense related to unvested restricted stock, which is expected to be recognized over 0.8 years.

Employee Stock Purchase Plan

As of June 27, 2020, the maximum aggregate number of shares that may be issued under the 2018 Employee Stock Purchase Plan (“ESPP”) was 1,340,325 shares of common stock, including an increase of 536,130 shares effective January 1, 2020 under the terms of the ESPP. The 2018 ESPP is expected to be implemented through a series of offerings under which participants are granted purchase rights to purchase shares of the Company’s common stock on specified dates during such offerings. The administrator has not yet approved an offering under the 2018 ESPP.

XML

Commitments and Contingencies

6 Months Ended

Jun. 27, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Leases

On March 16, 2020, the Company amended an operating lease for its manufacturing facility in Columbia, Missouri, to extend the lease term for two years to June 30, 2022.

Effective May 22, 2020, the Company amended an operating lease for one of its leased manufacturing facilities to include land adjacent to the facility upon which the landlord will construct a parking lot.

Effective May 26, 2020, the Company entered into an agreement, assignment and assumption of lease and first amendment to lease pursuant to which the Company assumed an operating lease under which the Company is leasing certain real property and a building consisting of approximately 142,317 square feet in Columbia, Missouri, for a term expiring on April 30, 2023 with no renewal options. See Note 4.

Purchase Commitments

On January 10, 2020, the Company and Roquette Frères (“Roquette”) entered into a multi-year sales agreement pursuant to which Roquette will provide the Company with plant-based protein. The agreement expires on December 31, 2022; however it can be terminated after 18 months under certain circumstances. This agreement increases the amount of plant-based protein to be supplied by Roquette in each of 2020, 2021 and 2022 compared to the amount supplied 2019. The plant-based protein sourced under the supply agreement is secured on a purchase order basis regularly, per specified minimum monthly and semi-annual quantities, throughout the term. The Company is not required to purchase plant-based protein in amounts in excess of such specified minimum quantities; however the Company has the option to increase such minimum quantities for delivery in each of 2021 and 2022. The total annual amount purchased each year by the Company must be at least the minimum amount specified in the agreement, which totals in the aggregate $154.1 million over the term of the agreement. The Company also has the right to be indemnified by Roquette in certain circumstances.

As of June 27, 2020, the Company had committed to purchase pea protein inventory totaling $192.4 million, approximately $51.6 million in the remainder of 2020, $82.3 million in 2021, and $58.5 million in 2022.

In addition, as of June 27, 2020, the Company had approximately $17.8 million in purchase order commitments for capital expenditures primarily to purchase machinery and equipment. Payments for these purchases will be due within twelve months.

Litigation

Don Lee Farms

On May 25, 2017, Don Lee Farms, a division of Goodman Food Products, Inc., filed a complaint against the Company in the Superior Court of the State of California for the County of Los Angeles asserting claims for breach of contract, misappropriation of trade secrets, unfair competition under the California Business and Professions Code, money owed and due, declaratory relief and injunctive relief, each arising out of the Company’s decision to terminate an exclusive supply agreement between the Company and Don Lee Farms. The Company denied all of these claims and filed counterclaims on July 27, 2017, alleging breach of contract, unfair competition under the California Business and Professions Code and conversion. In October 2018, the former co-manufacturer filed an amended complaint that added one of the Company’s current contract manufacturers as a defendant, principally for claims arising from the current contract manufacturer’s alleged use of the former co-manufacturer’s alleged trade secrets, and for replacing the former co-manufacturer as one of the Company’s current co-manufacturers. The current contract manufacturer filed an answer denying all of Don Lee Farms’ claims and a cross-complaint against Beyond Meat asserting claims of total and partial equitable indemnity, contribution, and repayment. On March 11, 2019, Don Lee Farms filed a second amended complaint to add claims of fraud and negligent misrepresentation against the Company. On May 30, 2019, the judge denied the Company’s motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On June 19, 2019, the Company filed an answer denying Don Lee Farms' claims.

On January 24, 2020, a writ judge granted Don Lee Farms a right to attach in the amount of $628,689 on the grounds that Don Lee Farms had established a “probable validity” of its claim that the Company owes it money for a small batch of unpaid invoices.  This determination was not made by the trial judge.  The trial judge has yet to determine the legitimacy or merits of Don Lee Farms’ claims.

On January 27, 2020, Don Lee Farms filed a third amended complaint to add three individual defendants, all of whom are current or former employees of the Company, including Mark Nelson, the Company’s Chief Financial Officer and Treasurer, to Don Lee Farms’ existing fraud and negligent misrepresentation claims alleging that those individuals were involved in the alleged fraud and negligent misrepresentations. On June 23, 2020, the judge denied Beyond Meat and the individual defendants’ motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On July 6, 2020, the Company and the individual defendants filed an answer denying all of Don Lee Farms’ claims, including denying all allegations of fraud and negligent misrepresentation.

On August 11, 2020, the Company filed an amended cross-complaint against Don Lee Farms, its parent Goodman Food Products, Inc. and its owners and employees, Donald, Daniel, and Brandon Goodman. Among other claims, the amended cross-complaint alleges that Don Lee Farms defrauded Beyond Meat, misappropriated its trade secrets, and infringed its trademarks.

The previous trial date, February 8, 2021, was vacated. Trial is currently set for June 14, 2021.

Don Lee Farms is seeking from Beyond Meat, the individual defendants, and the current contract manufacturer unspecified compensatory and punitive damages, declaratory and injunctive relief, including the prohibition of Beyond Meat’s use or disclosure of the alleged trade secrets, and attorneys’ fees and costs. The Company is seeking from Don Lee Farms monetary damages, restitution of monies paid to Don Lee Farms, injunctive relief, including the prohibition of Don Lee Farms’ use or disclosure of Beyond Meat’s trade secrets and the prohibition of Don Lee Farms’ infringing use of Beyond Meat’s trademarks, and attorneys’ fees and costs. The current contract manufacturer is seeking indemnity, contribution, or repayment from the Company of any or all damages that the current contract manufacturer may be found liable to Don Lee Farms, and attorneys’ fees and costs.

The Company believes it was justified in terminating the supply agreement with Don Lee Farms, that the Company did not misappropriate Don Lee Farms’ alleged trade secrets, that the Company is not liable for the fraud or negligent misrepresentation alleged in the third amended complaint, that Don Lee Farms is liable for the conduct alleged in the Company’s amended cross-complaint, and that the Company is not liable to the current contract manufacturer for any indemnity, contribution, or repayment, including for any damages or attorneys’ fees and costs. Conversely, as alleged in the Company’s amended cross-complaint, the Company believes Don Lee Farms misappropriated the Company’s trade secrets, defrauded the Company, and ultimately has infringed the Company’s trademarks.

The Company is currently in the process of litigating this matter and intends to vigorously defend itself and its current and former employees against the claims and to prosecute the Company’s own claims. The Company cannot assure you that Don Lee Farms or the current contract manufacturer will not prevail in all or some of their claims against the Company or the individual defendants, or that the Company will prevail in some or all of its claims against Don Lee Farms. For example, if Don Lee Farms succeeds in the lawsuit, the Company could be required to pay damages, including but not limited to contract damages reasonably calculated at what the Company would have paid Don Lee Farms to produce the Company’s products through 2019, the end of the contract term, and Don Lee Farms could also claim some ownership in the intellectual property associated with the production of certain of the Company’s products or in the products themselves, and thus claim a stake in the value the Company has derived and will derive from the use of that intellectual property after the Company terminated its supply agreement with Don Lee Farms. Based on the Company’s current knowledge, the Company has determined that the amount of any material loss or range of any losses that is reasonably possible to result from this lawsuit is not estimable.

Securities Related Litigation

On January 30, 2020, Larry Tran, a purported shareholder of Beyond Meat, filed a putative securities class action lawsuit in the United States District Court for the Central District of California against Beyond Meat and two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act and is premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to the Company’s public disclosures regarding the

Company’s ongoing litigation with Don Lee Farms during the proposed class period of May 2, 2019 to January 27, 2020. The Court appointed a lead plaintiff and lead counsel on May 18, 2020, and a First Amended Complaint was filed on July 1, 2020. The First Amended Complaint names the same defendants, proposes the same class period, and similarly asserts claims under Sections 10(b) and 20(a) of the Exchange Act premised on allegedly false or misleading statements, and alleged non-disclosure of material facts, related to the Company’s public disclosures regarding the Company’s ongoing litigation with Don Lee Farms. The Company filed a motion to dismiss on behalf of all defendants on July 31, 2020. The motion to dismiss briefing will be completed by mid-September 2020. The Company believes the claims are without merit and intends to vigorously defend all claims asserted. 

On March 16, 2020, Eric Weiner, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement.  The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 16, 2020, and the securities case brought against the Company. 

On March 18, 2020, Kimberly Brink and Melvyn Klein, purported shareholders of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court for the Central District of California, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to March 18, 2020, and the securities case brought against the Company.

On April 1, 2020, the United States District Court for the Central District of California entered an order consolidating the Weiner action and the Brink action for all purposes and designated the consolidated case In re: Beyond Meat, Inc. Derivative Litigation. On April 13, 2020, the Court entered an order appointing co-lead counsel for the consolidated derivative action. On June 23, 2020, the Court entered an order approving a Joint Stipulation Regarding Stay of Actions. Under the terms of the stay approval order, all proceedings in the consolidated derivative case are stayed until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

On May 27, 2020, Kevin Chew, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 10(b) and 21D of the Exchange Act and claims of breaches of fiduciary duty, relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to May 27, 2020. On June 16, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On June 17, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

On June 17, 2020, James Janolek, a purported shareholder of Beyond Meat, filed a shareholder derivative lawsuit in the United States District Court of the District of Delaware, putatively on behalf of the Company, against two of the Company’s executive officers, the Company’s President and CEO, Ethan Brown, and the Company’s Chief Financial Officer and Treasurer, Mark Nelson, and each of the Company’s directors, including one former director, who signed the Company’s initial public offering registration statement. The lawsuit asserts claims under Sections 14(a) and 20(a) of the Exchange Act, claims of breaches of fiduciary duty as directors and/or officers of Beyond Meat, and claims of unjust enrichment and waste of corporate assets, all relating to the Company’s ongoing litigation with Don Lee Farms, related actions taken by Beyond Meat and the named individuals during the period of May 2, 2019 to June 17, 2020. On July 10, 2020, the Court entered an order staying all proceedings in the derivative action until (1) the securities class action is dismissed, with prejudice, and all appeals related thereto have been exhausted; or (2) any motion to dismiss the securities class action is denied in whole or in part. On July 10, 2020, the Court entered an order administratively closing the derivative case based on the stay order. Based on the early stages of this matter, the Company is unable to estimate potential losses, if any, related to this lawsuit.

TCPA Litigation

On March 18, 2020, Nazrin Massaro filed a putative class action lawsuit in the United States District Court for the Southern District of California against Beyond Meat and People for the Ethical Treatment of Animals, Inc. (“PETA”). The lawsuit asserts claims under the Telephone Consumer Protection Act and alleges that PETA sent unsolicited text message advertisements promoting the Company’s products to the putative class members in violation of consumers’ privacy rights. The lawsuit further alleges that PETA and Beyond Meat arranged for PETA to market Beyond Meat’s products in exchange for monetary contributions from Beyond Meat. The plaintiff seeks injunctive relief and damages on behalf of herself and the putative class members. On May 29, 2020, Beyond Meat moved to dismiss or in the alternative stay this lawsuit, and on June 8, 2020, the plaintiff voluntarily dismissed her claims against Beyond Meat without prejudice. The Company believes the claims asserted in this lawsuit are without merit.

The Company is involved in various other legal proceedings, claims, and litigation arising in the ordinary course of business. Based on the facts currently available, the Company does not believe that the disposition of such matters that are pending or asserted will have a material effect on its financial statements.

XML

Income Taxes

6 Months Ended

Jun. 27, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

For the three months ended June 27, 2020 and June 29, 2019, the Company recorded $16,000 and $21,000, respectively, in income tax expense, in its condensed consolidated statements of operations.

For the six months ended June 27, 2020 and June 29, 2019, the Company recorded $15,000 and $21,000, respectively, in income tax expense in its condensed consolidated statements of operations.

The Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized in the U.S. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against substantially all deferred tax assets. If the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets will be made and the adjustment would have the effect of increasing net income in the period such determination is made. 

As of June 27, 2020, the Company does not have any accrued interest or penalties related to uncertain tax positions. The Company’s policy is to recognize interest and penalties related to uncertain tax positions in income tax expense. The Company is subject to U.S. federal tax authority and U.S. state tax authority examinations for all years with respect to net operating loss and credit carryforwards.

On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”).  The CARES Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the U.S. economy and fund a nationwide effort to curtail the effect of COVID-19. While the CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions include removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. 

Due to the recent enactment of the CARES Act, the Company is currently evaluating the impact, if any, that the CARES Act will have on its financial position, results of operations or cash flows. Currently the Company does not expect the enactment of CARES Act will have a material impact on the Company’s financial position, results of operations or cash flows.

XML

Net Loss Per Share Available to Common Stockholders

6 Months Ended

Jun. 27, 2020

Earnings Per Share [Abstract]

Net Loss Per Share Available to Common Stockholders

Net Loss Per Share Available to Common Stockholders

The Company calculates basic and diluted net loss per share available to common stockholders in conformity with the two-class method required for companies with participating securities. Computation of net loss per share available to common stockholders for the three and six months ended June 27, 2020 excludes the dilutive effect of 4,562,663 option shares, 287,439 RSUs and 40,381 unvested restricted stock shares outstanding at June 27, 2020 because their inclusion would be anti-dilutive. Computation of net loss per share available to common stockholders for the three and six months ended June 27, 2020 also excludes adjustments under the two-class method relating to a liability classified, share-settled obligation to an executive officer to deliver a variable number of shares based on a fixed monetary amount because the shares to be delivered are not participating securities as they do not have voting rights and are not entitled to participate in dividends until they are issued. Computation of net loss per share available to common stockholders for the three and six months ended June 29, 2019 excludes the dilutive effect of 6,559,565 potential common shares outstanding at June 29, 2019 because their inclusion would be anti-dilutive.

(in thousands, except share and per share amounts)	Three Months Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Numerator:
Net loss available to common stockholders	$	(10,205)	$	(9,441)	$	(8,390)	$	(16,090)
Denominator:
Weighted average common shares outstanding—basic	62,098,861		39,081,359		61,904,360		23,206,203
Dilutive effect of shares issuable under stock options	—		—		—		—
Dilutive effect of RSUs	—		—		—		—
Dilutive effect of share-settled obligation	—		—		—		—
Weighted average common shares outstanding—diluted	62,098,861		39,081,359		61,904,360		23,206,203
Net loss per share available to common stockholders—basic and diluted	$	(0.16)	$	(0.24)	$	(0.14)	$	(0.69)

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 27, 2020

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements include all adjustments

necessary, which are of a normal and recurring nature, for the fair presentation of the Company’s financial position and of the results of operations and cash flows for the periods presented. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2020 or for any other interim period or for any other future fiscal year. These condensed consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on March 19, 2020 (the “2019 10-K”). The condensed balance sheet as of December 31, 2019 has been derived from the audited financial statements at that date.

Principles of Consolidation

Principles of ConsolidationThe condensed consolidated financial statements for the periods ended June 27, 2020 include the accounts of the Company and its subsidiaries. All inter-company balances and transactions have been eliminated.

Management’s Use of Estimates

Management’s Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include trade promotion accruals; useful lives of property, plant and equipment; valuation of deferred tax assets; valuation of inventory; incremental borrowing rate used to determine operating lease right-of-use assets and operating lease liabilities; assessment of contract-based factors, asset-based factors, entity-based factors and market-based factors to determine the lease term impacting right-of-use assets and lease liabilities; and the valuation of the fair value of stock options used to determine share-based compensation expense. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are carried at cost less accumulated depreciation and are depreciated using the straight-line method over the following estimated useful lives:

Land	Not amortized
Buildings	30 years
Leasehold improvements	Shorter of lease term or estimated useful life
Furniture and fixtures	3 years
Manufacturing equipment	5 to 10 years
Research and development equipment	5 to 10 years
Software and computer equipment	3 years
Vehicles	5 years

Leasehold improvements are depreciated on a straight-line basis over the lesser of the estimated useful life of the asset or the remaining lease term. When assets are sold or retired, the asset and related accumulated depreciation are removed from the respective account balances and any gain or loss on disposal is included in loss from operations. Expenditures for repairs and maintenance are charged directly to expense when incurred.

Foreign Currency

Foreign CurrencyThe Company’s foreign entities use their local currency as the functional currency. For these entities, the Company translates net assets into U.S. dollars at period end exchange rates, while revenue and expense accounts are translated at average exchange rates prevailing during the periods being reported. Resulting currency translation adjustments are included in accumulated other comprehensive loss and foreign currency transaction gains and losses are included in other, net. Transaction gains and losses on long-term intra-entity transactions are recorded as a component of other comprehensive loss. Transactions denominated in a currency other than the reporting entity’s functional currency may give rise to transaction gains and losses that impact the Company’s results of operations.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value measurement accounting guidance creates a fair value hierarchy to prioritize the inputs used to measure fair value into three categories. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement, where Level 1 is the highest and Level 3 is the lowest.

The three levels are defined as follows:

•Level 1—Unadjusted quoted prices in active markets accessible by the reporting entity for identical assets or liabilities. Active markets are those in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

•Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which significant value drivers are observable.

•Level 3—Valuations derived from valuation techniques in which significant value drivers are unobservable.

The Company’s financial instruments include cash equivalents, accounts receivable, accounts payable, and accrued expenses, for which the carrying amounts approximate fair value due to the short-term maturity of these financial instruments. Based on the borrowing rates currently available to the Company for debt with similar terms, the carrying value of the Company’s revolving credit facility approximates fair value as well.

The Company had no financial instruments measured at fair value on a recurring basis as of June 27, 2020 and December 31, 2019, other than the liability classified share-settled obligation to one of the Company’s executive officers as discussed in Note 9 which represents a Level 1 financial instrument. There was no change in the fair value of the liability-classified share-settled obligation in the three and six months ended June 27, 2020. There were no transfers of financial assets or liabilities into or out of Level 1, Level 2 or Level 3 for the three and six months ended June 27, 2020.

Prior to the IPO, the stock warrant liability was measured at fair value using Level 3 inputs upon issuance and at each reporting date. Inputs used to determine the estimated fair value of the warrant liability as of the valuation date included expected term of the warrants, the risk-free interest rate, volatility, and the fair value of underlying shares.

Revenue Recognition

Revenue Recognition

Revenue is recognized at the point in which the performance obligation under the terms of a contract with the customer have been satisfied and control has transferred. The Company’s performance obligation is typically defined as the accepted purchase order, or the contract, with the customer which requires the Company to deliver the requested products at agreed upon prices at the time and location of the customer’s choice. The Company does not offer warranties or a right to return on the products it sells except in the instance of a product recall.

Revenue is measured as the amount of consideration the Company expects to receive in exchange for fulfilling the performance obligation. Sales and other taxes the Company collects concurrent with the sale of products are excluded from revenue. The Company's normal payment terms vary by the type and location of its customers and the products offered. The time between invoicing and when payment is due is not significant. None of the Company's customer contracts as of June 27, 2020 contains a significant financing component.

The Company routinely offers sales discounts and promotions through various programs to its customers and consumers. These programs include rebates, temporary on shelf price reductions, buy-one-get-one-free programs, off invoice discounts, retailer advertisements, product coupons and other trade activities. Provision for discounts and incentives are recorded in the same period in which the related revenues are recognized. At the end of each accounting period, the Company recognizes a liability for estimated sales discounts that have been incurred but not paid which totaled $4.7 million and $1.6 million as of June 27, 2020 and December 31, 2019, respectively. The offsetting charge is recorded as a reduction of revenues in the same period when the expense is incurred.

The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. The incremental cost to obtain contracts was not material.

Recently Adopted and New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

As an “emerging growth company” (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company will no longer qualify as an EGC as of the end of the fiscal year ending December 31, 2020, when it becomes a Large Accelerated Filer under Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Therefore, the Company has elected to use the adoption dates applicable to public companies beginning in the first quarter of 2020 and the adoption dates for the new accounting pronouncements disclosed below have been evaluated under such premise.

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842) (“ASU 2016-02”), which requires lessees to record most leases on their balance sheets but recognize the expenses on their income statements in a manner similar to Accounting Standards Codification (“ASC”) 840, “Leases” (“ASC 840”). ASU 2016-02 requires that a lessee recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term.

On January 1, 2020, the Company adopted ASU 2016-02 using the modified retrospective approach, which permits application of this new guidance at the beginning of the period of adoption, with comparative periods continuing to be reported under ASC 840. The Company also elected the package of practical expedients permitted under the transition guidance within ASU 2016-02, which among other things, permits the Company to not reassess under the new standard the Company’s prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight practical expedient or the practical expedient pertaining to land easements, the latter not being applicable to the Company. As part of this adoption, the Company elected not to record operating right-of-use assets or operating lease liabilities for leases with an initial term of 12 months or less. Payments on those leases will be recognized on a straight-line basis through the Company’s condensed consolidated statements of operations over the lease term. The Company also elected to combine lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets. See Note 4.

On March 12, 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). The amendments in ASU 2020-04 provide temporary optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions to ease the potential accounting and financial reporting burden associated with transitioning away from reference rates that are expected to be discontinued, including the London Interbank Offered Rate (LIBOR). ASU 2020-04 is effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of ASU 2020-04 has not had and is not expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

New Accounting Pronouncements

On December 18, 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes (Topic 740)” (“ASU 2019-12”). ASU 2019-12 eliminates the need for an organization to analyze whether the following apply in a given period (1) exceptions to the incremental approach for intra-period tax allocation, (2) exceptions to accounting for basis differences when there are ownership changes in foreign investments, and (3) exceptions in interim period income tax accounting for year-to-date losses that exceed anticipated losses. ASU 2019-12 also is designed to improve financial statement preparers’ application of income tax-related guidance and simplify GAAP for (1) franchise taxes that are partially based on income, (2) transactions with a government that result in a step-up in the tax basis of goodwill, (3) separate financial statements of legal entities that are not subject to tax, and (4) enacted changes in

tax laws in interim periods. For public business entities, the amendments in ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption of the amendments is permitted, including adoption in any interim period for public business entities for periods for which financial statements have not yet been issued. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. ASU 2019-12 is effective for the Company beginning on January 1, 2021. Adoption of ASU 2019-12 is not expected to result in any material changes to the way the tax provision is prepared and is not expected to have a material impact on the Company’s financial position, results of operations, or cash flows.

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 27, 2020

Accounting Policies [Abstract]

Schedule of property, plant, and equipment

Property, plant and equipment are carried at cost less accumulated depreciation and are depreciated using the straight-line method over the following estimated useful lives:

Land	Not amortized
Buildings	30 years
Leasehold improvements	Shorter of lease term or estimated useful life
Furniture and fixtures	3 years
Manufacturing equipment	5 to 10 years
Research and development equipment	5 to 10 years
Software and computer equipment	3 years
Vehicles	5 years

A summary of property, plant, and equipment as of June 27, 2020 and December 31, 2019, is as follows:

(in thousands)	June 27, 2020		December 31, 2019
Manufacturing equipment	$	51,559	$	37,939
Research and development equipment	9,643		8,933
Leasehold improvements	8,000		7,620
Building	1,600		—
Finance leases	287		1,108
Software	358		274
Furniture and fixtures	461		433
Vehicles	378		210
Land	1,120		—
Assets not yet placed in service	23,149		11,666
Total property, plant and equipment	$	96,555	$	68,183
Accumulated depreciation and amortization	(26,269)		(20,709)
Property, plant and equipment, net	$	70,286	$	47,474

Schedule of changes in fair value

The following table sets forth a summary of the changes in the fair value of the preferred and common stock warrant liabilities:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Beginning balance	$	—	$	2,677	$	—	$	1,918
Fair value of warrants issued during the period	—		—		—		—
Change in fair value of warrant liability	—		11,744		—		12,503
Reclassification of warrant liability to additional paid-in capital in connection with the IPO	—		(14,421)		—		(14,421)
Ending balance	$	—	$	—	$	—	$	—

Schedule of disaggregation of revenue

Effective January 1, 2020, the Company began presenting net revenues by geography and distribution channel as follows:

Distribution Channel	Description
U.S. Retail	Net revenues from retail sales to the U.S. market
U.S. Foodservice	Net revenues from restaurant and foodservice sales to the U.S. market
International Retail	Net revenues from retail sales to international markets, including Canada
International Foodservice	Net revenues from restaurant and foodservice sales to international markets, including Canada

The following table presents the Company’s net revenues by channel:

	Three Months Ended				Six Months Ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Net revenues:
U.S.:
Retail	$	90,040	$	30,531	$	139,963	$	49,992
Foodservice	6,486		16,504		29,117		25,338
U.S. net revenues	96,526		47,035		169,080		75,330
International:
Retail	9,572		3,589		15,524		3,707
Foodservice	7,240		16,627		25,808		28,420
International net revenues	16,812		20,216		41,332		32,127
Net revenues	$	113,338	$	67,251	$	210,412	$	107,457

XML

Leases (Tables)

6 Months Ended

Jun. 27, 2020

Leases [Abstract]

Components of lease and supplemental cash flow information

The components of lease expense were as follows:

(in thousands)	Statement of Operations Location	Three Months Ended June 27, 2020		Six Months Ended June 27, 2020
Operating lease cost:
Lease cost	Cost of goods sold	$	468	$	652
Lease cost	Research and development expenses	158		283
Lease cost	Selling, general and administrative expenses	161		273
Variable lease cost (1)	Cost of goods sold	1		7
Operating lease cost		$	788	$	1,215
Short-term lease cost	Selling, general and administrative expenses	$	111	$	175
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	$	20	$	38
Interest on lease liabilities	Interest expense	3		7
Finance lease cost		$	23	$	45
Total lease cost		$	922	$	1,435

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

Weighted average remaining lease terms and weighted average discount rates were:

	June 27, 2020
	Operating Leases		Finance Leases
Weighted average remaining lease term (years)	7.4		3.7
Weighted average discount rate	2.9	%	5.4	%

Schedule of assets and liabilities related to operating and finance leases

Supplemental balance sheet information as of June 27, 2020 related to leases are as follows:

(in thousands)	Balance Sheet Location	June 27, 2020
Assets
Operating leases	Operating lease right-of-use assets	$	13,793
Finance leases, net	Property, plant and equipment, net	249
Total lease assets		$	14,042
Liabilities
Current:
Operating lease liabilities	Current portion of operating lease liabilities	$	2,367
Finance lease liabilities	Current portion of finance lease liabilities	72
Long-term:
Operating lease liabilities	Operating lease liabilities, net of current portion	11,604
Finance lease liabilities	Finance lease obligations and other long-term liabilities	185
Total lease liabilities		$	14,228

Schedule of future maturities of operating lease liabilities

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2020:

	June 27, 2020
(in thousands)	Operating Leases		Finance Leases
Remainder of 2020	$	1,335	$	43
2021	2,737		80
2022	2,664		71
2023	2,181		58
2024	1,395		30
2025	1,281		—
Thereafter	3,914		—
Total undiscounted future minimum lease payments	15,507		282
Less imputed interest	(1,536)		(25)
Total discounted future minimum lease payments	$	13,971	$	257

Schedule of future maturities of finance lease liabilities

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2020:

	June 27, 2020
(in thousands)	Operating Leases		Finance Leases
Remainder of 2020	$	1,335	$	43
2021	2,737		80
2022	2,664		71
2023	2,181		58
2024	1,395		30
2025	1,281		—
Thereafter	3,914		—
Total undiscounted future minimum lease payments	15,507		282
Less imputed interest	(1,536)		(25)
Total discounted future minimum lease payments	$	13,971	$	257

Schedule of future maturities of operating lease liabilities (Topic 840)

A schedule of the future minimum rental commitments under the Company’s capital lease agreements and non-cancelable operating lease agreements with an initial or remaining term in excess of one year as of December 31, 2019, in accordance with ASC 840 were as follows:

(in thousands)	Capital Lease Obligations		Operating Lease Obligations
2020	$	86	$	1,878
2021	80		1,813
2022	71		1,817
2023	58		1,840
2024	30		1,353
Thereafter	—		5,167
Total minimum lease payments			$	13,868
Total minimum lease payments	$	325
Less: imputed interest (4.1% to 15.9%)	(34)
Total capital lease obligations	$	291
Less: current portion of capital lease obligations	(72)
Long-term capital lease obligations	$	219

Schedule of future maturities of capital lease liabilities (Topic 840)

A schedule of the future minimum rental commitments under the Company’s capital lease agreements and non-cancelable operating lease agreements with an initial or remaining term in excess of one year as of December 31, 2019, in accordance with ASC 840 were as follows:

(in thousands)	Capital Lease Obligations		Operating Lease Obligations
2020	$	86	$	1,878
2021	80		1,813
2022	71		1,817
2023	58		1,840
2024	30		1,353
Thereafter	—		5,167
Total minimum lease payments			$	13,868
Total minimum lease payments	$	325
Less: imputed interest (4.1% to 15.9%)	(34)
Total capital lease obligations	$	291
Less: current portion of capital lease obligations	(72)
Long-term capital lease obligations	$	219

XML

Inventories (Tables)

6 Months Ended

Jun. 27, 2020

Inventory Disclosure [Abstract]

Schedule of major classes of inventory

Major classes of inventory were as follows:

(in thousands)	June 27, 2020		December 31, 2019
Raw materials and packaging	$	80,848	$	36,884
Work in process	13,326		17,958
Finished goods	48,859		26,754
Total	$	143,033	$	81,596

XML

Property, Plant and Equipment (Tables)

6 Months Ended

Jun. 27, 2020

Property, Plant and Equipment [Abstract]

Schedule of property, plant, and equipment

Property, plant and equipment are carried at cost less accumulated depreciation and are depreciated using the straight-line method over the following estimated useful lives:

Land	Not amortized
Buildings	30 years
Leasehold improvements	Shorter of lease term or estimated useful life
Furniture and fixtures	3 years
Manufacturing equipment	5 to 10 years
Research and development equipment	5 to 10 years
Software and computer equipment	3 years
Vehicles	5 years

A summary of property, plant, and equipment as of June 27, 2020 and December 31, 2019, is as follows:

(in thousands)	June 27, 2020		December 31, 2019
Manufacturing equipment	$	51,559	$	37,939
Research and development equipment	9,643		8,933
Leasehold improvements	8,000		7,620
Building	1,600		—
Finance leases	287		1,108
Software	358		274
Furniture and fixtures	461		433
Vehicles	378		210
Land	1,120		—
Assets not yet placed in service	23,149		11,666
Total property, plant and equipment	$	96,555	$	68,183
Accumulated depreciation and amortization	(26,269)		(20,709)
Property, plant and equipment, net	$	70,286	$	47,474

XML

Debt (Tables)

6 Months Ended

Jun. 27, 2020

Debt Disclosure [Abstract]

Schedule of debt balances

The Company’s debt balances are detailed below:

(in thousands)	June 27, 2020		December 31, 2019
Revolving credit facility	$	50,000	$	—
Revolving credit line (SVB)	—		6,000
Term loan facility	—		20,000
Equipment financing loan	—		5,000
Debt issuance costs	—		(431)
Total debt outstanding	$	50,000	$	30,569
Less: current portion of long-term debt	—		11,000
Long-term debt	$	50,000	$	19,569

XML

Share-Based Compensation (Tables)

6 Months Ended

Jun. 27, 2020

Share-based Payment Arrangement [Abstract]

Schedule of fair value assumptions

Following are the assumptions used in the Black-Scholes valuation model for options granted during the periods shown below:

	Three Months Ended		Six Months Ended
	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Risk-free interest rate	0.5%	2.3%	0.7%	2.3%
Average expected term (years)	7.0	6.0	7.0	6.0
Expected volatility	55.0%	55.0%	55.0%	55.0%
Dividend yield	—	—	—	—

Schedule of stock option activity

The following table summarizes the Company’s stock option activity during the six months ended June 27, 2020:

	Number of Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value (in thousands)(1)
Outstanding at December 31, 2019	5,170,976	$	14.28	7.5	$	329,879
Granted	251,170	$	97.72	—	$	—
Exercised	(825,965)	$	4.63	—	$	91,606
Cancelled/Forfeited	(33,518)	$	34.47	—	$	—
Outstanding at June 27, 2020	4,562,663	$	20.47	7.2	$	556,534
Vested and exercisable at June 27, 2020	2,470,346	$	7.84	6.0	$	331,568
Vested and expected to vest at June 27, 2020	3,932,836	$	15.73	6.9	$	497,871

__________

(1) Aggregate intrinsic value is calculated as the difference between the value of common stock on the transaction date and the exercise price multiplied by the number of shares issuable under the stock option.

Schedule of RSU activity

The following table summarizes the Company’s RSU activity during the six months ended June 27, 2020:

	Number of Shares	Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2019	149,004	$	132.82
Granted	180,774	$	102.51
Vested(1)	(34,245)	$	137.82
Cancelled/Forfeited	(8,094)	$	—
Unvested at June 27, 2020	287,439	$	113.40

________

(1) Includes 8,902 shares of common stock that were withheld to cover taxes on the release of vested RSUs and became available for future grants pursuant to the 2018 Plan.

Schedule of restricted stock activity

The following table summarizes the Company’s restricted stock activity during the six months ended June 27, 2020:

	Number of Shares of Restricted Stock	Weighted Average Remaining Contractual Life (Years)	Weighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2019	88,988	1.2	$	19.49
Granted	—	—	$	—
Vested/Released	(48,607)	—	$	19.39
Cancelled/Forfeited	—	—	$	—
Unvested at June 27, 2020	40,381	0.95	$	19.77

XML

Net Loss Per Share Available to Common Stockholders (Tables)

6 Months Ended

Jun. 27, 2020

Earnings Per Share [Abstract]

Schedule of basic and diluted net loss per common share

(in thousands, except share and per share amounts)	Three Months Ended				Six Months Ended
	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Numerator:
Net loss available to common stockholders	$	(10,205)	$	(9,441)	$	(8,390)	$	(16,090)
Denominator:
Weighted average common shares outstanding—basic	62,098,861		39,081,359		61,904,360		23,206,203
Dilutive effect of shares issuable under stock options	—		—		—		—
Dilutive effect of RSUs	—		—		—		—
Dilutive effect of share-settled obligation	—		—		—		—
Weighted average common shares outstanding—diluted	62,098,861		39,081,359		61,904,360		23,206,203
Net loss per share available to common stockholders—basic and diluted	$	(0.16)	$	(0.24)	$	(0.14)	$	(0.69)

XML

Introduction (Details)	6 Months Ended
	Jun. 27, 2020
Geographic Concentration Risk | Long-Lived Assets | United States
Concentration Risk [Line Items]
Concentration risk	96.00%

XML

Summary of Significant Accounting Policies - Schedule of property, plant and equipment (Details)	6 Months Ended
	Jun. 27, 2020
Building
Property, Plant and Equipment [Line Items]
Useful life	30 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life	3 years
Manufacturing equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life	5 years
Manufacturing equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life	10 years
Research and development equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life	5 years
Research and development equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life	10 years
Software
Property, Plant and Equipment [Line Items]
Useful life	3 years
Vehicles
Property, Plant and Equipment [Line Items]
Useful life	5 years

XML

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 31, 2019	Dec. 31, 2018
Class of Warrant or Right [Line Items]
Cumulative foreign translation adjustments, net of tax	$ 200		$ 200
Foreign currency transaction gain	100		100
Warrants outstanding (in shares)		0		0
Liability for estimated sales discounts	4,700		4,700		$ 1,600
Cost of goods sold	79,687	$ 44,510	139,070	$ 73,945
Shipping and Handling
Class of Warrant or Right [Line Items]
Cost of goods sold	$ 3,200	$ 2,600	$ 4,800	$ 3,900
Product Concentration Risk | Revenue | Frozen
Class of Warrant or Right [Line Items]
Concentration risk					5.50%	16.30%
Distributor One | Customer Concentration Risk | Revenue
Class of Warrant or Right [Line Items]
Concentration risk	16.00%	22.00%	14.00%	22.00%
Distributor Two | Customer Concentration Risk | Revenue
Class of Warrant or Right [Line Items]
Concentration risk		20.00%		21.00%

XML

Summary of Significant Accounting Policies - Summary of changes in fair value (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 0	$ 2,677	$ 0	$ 1,918
Fair value of warrants issued during the period	0	0	0	0
Change in fair value of warrant liability	0	11,744	0	12,503
Reclassification of warrant liability to additional paid-in capital in connection with the IPO	0	(14,421)	0	(14,421)
Ending balance	$ 0	$ 0	$ 0	$ 0

XML

Summary of Significant Accounting Policies - Schedule of disaggregation of revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Disaggregation of Revenue [Line Items]
Net revenues	$ 113,338	$ 67,251	$ 210,412	$ 107,457
U.S. net revenues
Disaggregation of Revenue [Line Items]
Net revenues	96,526	47,035	169,080	75,330
U.S. net revenues | Retail
Disaggregation of Revenue [Line Items]
Net revenues	90,040	30,531	139,963	49,992
U.S. net revenues | Foodservice
Disaggregation of Revenue [Line Items]
Net revenues	6,486	16,504	29,117	25,338
International net revenues
Disaggregation of Revenue [Line Items]
Net revenues	16,812	20,216	41,332	32,127
International net revenues | Retail
Disaggregation of Revenue [Line Items]
Net revenues	9,572	3,589	15,524	3,707
International net revenues | Foodservice
Disaggregation of Revenue [Line Items]
Net revenues	$ 7,240	$ 16,627	$ 25,808	$ 28,420

XML

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 31, 2019
Restructuring and Related Activities [Abstract]
Restructuring expenses	$ 1,509	$ 847	$ 3,882	$ 1,241
Accrued unpaid liabilities, contract termination	$ 2,300		$ 2,300		$ 1,100

XML

Leases - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 27, 2020	Jan. 01, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accounting standards update	us-gaap:AccountingStandardsUpdate201602Member
Operating lease right-of-use assets	$ 13,793
Current portion of operating lease liabilities	2,367
Operating lease liabilities, net of current portion	$ 11,604
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Lease, initial term	2 years
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Lease, initial term	11 years
ASU 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets		$ 11,900
Decrease in deferred rent		300
Decrease in prepaid rent		200
Current portion of operating lease liabilities		1,400
Operating lease liabilities, net of current portion		$ 10,600

XML

Leases - Components of expense and supplemental cash flow information (Details) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 27, 2020 USD ($)	Jun. 27, 2020 USD ($)
Lease Cost
Variable lease cost	$ 1	$ 7
Operating lease cost	788	1,215
Short-term lease cost	111	175
Amortization of right-of use assets	20	38
Interest on lease liabilities	3	7
Finance lease cost	23	45
Total lease cost	$ 922	$ 1,435
Operating Leases
Weighted average remaining lease term (years)	7 years 4 months 24 days	7 years 4 months 24 days
Weighted average discount rate	2.90%	2.90%
Finance Leases
Weighted average remaining lease term (years)	3 years 8 months 12 days	3 years 8 months 12 days
Weighted average discount rate	5.40%	5.40%
Cost of goods sold
Lease Cost
Lease cost	$ 468	$ 652
Research and development expenses
Lease Cost
Lease cost	158	283
Selling, general and administrative expenses
Lease Cost
Lease cost	$ 161	$ 273

XML

Leases - Schedule of assets and liabilities related to leases (Details) $ in Thousands	Jun. 27, 2020 USD ($)
Assets
Operating lease right-of-use assets	$ 13,793
Finance leases, net	249
Total lease assets	14,042
Current:
Current portion of operating lease liabilities	2,367
Current portion of finance lease liabilities	72
Long-term:
Operating lease liabilities, net of current portion	11,604
Finance lease liabilities	185
Total lease liabilities	$ 14,228

XML

Leases - Schedule of future maturities of lease liabilities (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Dec. 31, 2019
Operating Leases
Remainder of 2020	$ 1,335
2021	2,737
2022	2,664
2023	2,181
2024	1,395
2025	1,281
Thereafter	3,914
Total undiscounted future minimum lease payments	15,507
Less imputed interest	(1,536)
Total discounted future minimum lease payments	13,971
Finance Leases
Remainder of 2020	43
2021	80
2022	71
2023	58
2024	30
2025	0
Thereafter	0
Total undiscounted future minimum lease payments	282
Less imputed interest	(25)
Total discounted future minimum lease payments	$ 257
Capital Lease Obligations
2020		$ 86
2021		80
2022		71
2023		58
2024		30
Thereafter		0
Total minimum lease payments		325
Less: imputed interest (4.1% to 15.9%)		(34)
Total capital lease obligations		291
Less: current portion of capital lease obligations		(72)
Long-term capital lease obligations		219
Operating Lease Obligations
2020		1,878
2021		1,813
2022		1,817
2023		1,840
2024		1,353
Thereafter		5,167
Total minimum lease payments		$ 13,868
Minimum
Capital Lease Obligations
Lease discount rate		4.10%
Maximum
Capital Lease Obligations
Lease discount rate		15.90%

XML

Inventories (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials and packaging	$ 80,848	$ 36,884
Work in process	13,326	17,958
Finished goods	48,859	26,754
Total	$ 143,033	$ 81,596

XML

Property, Plant and Equipment - Summary of property, plant, and equipment (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Total property, plant and equipment		$ 68,183
Finance leases	$ 287
Total property, plant and equipment	96,555
Accumulated depreciation and amortization	(26,269)
Accumulated depreciation and amortization		(20,709)
Property, plant and equipment, net	70,286
Property, plant and equipment, net		47,474
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	51,559	37,939
Research and development equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	9,643	8,933
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	8,000	7,620
Building
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	1,600	0
Finance leases
Property, Plant and Equipment [Line Items]
Total property, plant and equipment		1,108
Software
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	358	274
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	461	433
Vehicles
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	378	210
Land
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	1,120	0
Assets not yet placed in service
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 23,149	$ 11,666

XML

Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	$ 3,300	$ 2,100	$ 5,855	$ 3,957
Note receivable, net	5,200		5,200
Prepaid expenses and other current assets
Property, Plant and Equipment [Line Items]
Note receivable, net	3,400		3,400
Other non-current assets
Property, Plant and Equipment [Line Items]
Note receivable, net	1,800		1,800
Cost of goods sold
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	2,500	1,400	4,400	2,800
Research and development expenses
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	700	600	1,400	1,100
Selling, general and administrative expenses
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	$ 100	$ 12	$ 100	$ 22

XML

Debt - Narrative (Details)		3 Months Ended		6 Months Ended
	Apr. 21, 2020 USD ($)	Jun. 27, 2020 USD ($)	Jun. 29, 2019 USD ($)	Jun. 27, 2020 USD ($)	Jun. 29, 2019 USD ($)	Dec. 31, 2019 USD ($)
Debt Instrument [Line Items]
Debt issuance costs		$ 0		$ 0		$ 431,000
Amortization of debt issuance costs		57,000	$ 20,000	93,000	$ 78,000
Other non-current assets
Debt Instrument [Line Items]
Debt issuance costs		1,200,000		1,200,000
Line of Credit
Debt Instrument [Line Items]
Early termination fee amount	$ 1,200,000
Interest expense		$ 400,000	500,000	$ 900,000	1,100,000
Line of Credit | Revolving credit facility
Debt Instrument [Line Items]
Debt, face amount	$ 150,000,000
Debt term	5 years
Maximum additional borrowing capacity	$ 200,000,000
Unused commitment fee	0.375%
Maximum leverage ratio	3.00
Minimum fixed charge coverage ratio	1.25
Interest rate		3.50%		3.50%
Line of Credit | Revolving credit facility | Fiscal quarter ending September 30, 2020 | Alternate Base Rate
Debt Instrument [Line Items]
Variable annual interest rate	1.50%
Line of Credit | Revolving credit facility | Fiscal quarter ending September 30, 2020 | LIBOR
Debt Instrument [Line Items]
Variable annual interest rate	2.50%
Line of Credit | Revolving credit facility | Fiscal quarters thereafter | Alternate Base Rate | Minimum
Debt Instrument [Line Items]
Variable annual interest rate	1.25%
Line of Credit | Revolving credit facility | Fiscal quarters thereafter | Alternate Base Rate | Maximum
Debt Instrument [Line Items]
Variable annual interest rate	1.75%
Line of Credit | Revolving credit facility | Fiscal quarters thereafter | LIBOR | Minimum
Debt Instrument [Line Items]
Variable annual interest rate	2.25%
Line of Credit | Revolving credit facility | Fiscal quarters thereafter | LIBOR | Maximum
Debt Instrument [Line Items]
Variable annual interest rate	2.75%
Line of Credit | Equipment financing loan
Debt Instrument [Line Items]
Interest expense		$ 100,000	$ 200,000	$ 200,000	$ 300,000

XML

Debt - Schedule of debt balances (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt issuance costs	$ 0	$ (431)
Total debt outstanding	50,000	30,569
Less: current portion of long-term debt	0	11,000
Long-term debt	50,000	19,569
Revolving credit facility | Line of Credit
Debt Instrument [Line Items]
Debt, outstanding balance	50,000	0
Revolving credit facility | Line of Credit | SVB Credit Facilities
Debt Instrument [Line Items]
Debt, outstanding balance	0	6,000
Term loan facility | Line of Credit
Debt Instrument [Line Items]
Debt, outstanding balance	0	20,000
Equipment financing loan | Line of Credit
Debt Instrument [Line Items]
Debt, outstanding balance	$ 0	$ 5,000

XML

Stockholders’ Equity (Details) - $ / shares	Jun. 27, 2020	Dec. 31, 2019	Jun. 29, 2019	Mar. 30, 2019	Dec. 31, 2018
Equity [Abstract]
Common stock, authorized (in shares)	500,000,000	500,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, issued (in shares)	62,425,640	61,576,494
Common stock, outstanding (in shares)	62,425,640	61,576,494
Convertible preferred stock, authorized (in shares)	500,000	500,000
Convertible preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Convertible preferred stock, issued (in shares)	0	0
Convertible preferred stock, outstanding (in shares)	0	0	0	41,562,111	41,562,111

XML

Share-Based Compensation - Narrative (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 01, 2020	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance	16,626,877
Stock options outstanding (in shares)		4,562,663		4,562,663		5,170,976
Shares issued for stock option exercises (in shares)				6,722,897		5,864,738
Shares available for grant (in shares)		5,060,728		5,060,728		3,297,638
RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issuable (in shares)		287,439		287,439		149,004
Share-based compensation expense		$ 2,700,000	$ 89,000	$ 4,300,000	$ 89,000
Unrecognized compensation expense, period of recognition				2 years 2 months 12 days
Unrecognized share-based compensation expense		12,200,000		$ 12,200,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense		3,600,000	1,200,000	6,600,000	1,800,000
Unrecognized compensation expense		15,700,000		$ 15,700,000
Unrecognized compensation expense, period of recognition				2 years 4 months 24 days
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense, period of recognition				1 year 2 months 12 days
Unrecognized share-based compensation expense		4,200,000		$ 4,200,000
Accrual for share-settled obligation		900,000	0	1,800,000	0
Share-settled obligation liability		$ 2,800,000		$ 2,800,000		$ 1,000,000.0
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issuable (in shares)		40,381		40,381		88,988
Share-based compensation expense		$ 400,000	$ 500,000	$ 800,000	$ 800,000
Unrecognized compensation expense, period of recognition				9 months 18 days
Unrecognized share-based compensation expense		$ 800,000		$ 800,000
Shares of restricted stock purchased by nonemployees (in shares)		40,381		40,381
Employee Stock | 2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance		1,340,325		1,340,325
Number of additional shares authorized per year	536,130
Non-employee | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				2 years
Executive Officer | Employee | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				4 years
Executive Officer | Employee | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				48 months
Brand Ambassador | Non-employee | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				1 year
First Anniversary | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				25.00%	25.00%
First Anniversary | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				25.00%	25.00%
Thereafter | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years	3 years
Thereafter | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years	3 years
Upon Grant | Brand Ambassador | Non-employee | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				50.00%

XML

Share-Based Compensation - Schedule of fair value assumptions (Details)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Share-based Payment Arrangement [Abstract]
Risk-free interest rate	0.50%	2.30%	0.70%	2.30%
Average expected term (years)	7 years	6 years	7 years	6 years
Expected volatility	55.00%	55.00%	55.00%	55.00%
Dividend yield	0.00%	0.00%	0.00%	0.00%

XML

Share-Based Compensation - Schedule of stock option activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 27, 2020	Dec. 31, 2019
Number of Stock Options
Outstanding, beginning balance (in shares)	5,170,976
Granted (in shares)	251,170
Exercised (in shares)	(825,965)
Cancelled/Forfeited (in shares)	(33,518)
Outstanding, ending balance (in shares)	4,562,663	5,170,976
Vested and exercisable (in shares)	2,470,346
Vested and expected to vest (in shares)	3,932,836
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 14.28
Granted (in dollars per share)	97.72
Exercised (in dollars per share)	4.63
Cancelled/Forfeited (in dollars per share)	34.47
Outstanding, ending balance (in dollars per share)	20.47	$ 14.28
Vested and exercisable (in dollars per share)	7.84
Vested and expected to vest (in dollars per share)	$ 15.73
Weighted Average Remaining Contractual Life (Years)
Outstanding	7 years 2 months 12 days	7 years 6 months
Vested and exercisable	6 years
Vested and expected to vest	6 years 10 months 24 days
Aggregate Intrinsic Value
Outstanding, beginning balance	$ 329,879
Exercised	91,606
Outstanding, ending balance	556,534	$ 329,879
Vested and exercisable	331,568
Vested and expected to vest	$ 497,871

XML

Share-Based Compensation - Schedule of restricted stock and RSU activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 27, 2020	Dec. 31, 2019
RSU
Number of Shares
Outstanding, beginning balance (in shares)	149,004
Granted (in shares)	180,774
Vested (in shares)	(34,245)
Cancelled/Forfeited (in shares)	(8,094)
Outstanding, ending balance (in shares)	287,439	149,004
Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share)	$ 132.82
Granted (in dollars per share)	102.51
Vested (in dollars per share)	137.82
Cancelled/Forfeited (in dollars per share)	0
Ending balance (in dollars per share)	$ 113.40	$ 132.82
Restricted Stock
Number of Shares
Outstanding, beginning balance (in shares)	88,988
Granted (in shares)	0
Vested (in shares)	(48,607)
Cancelled/Forfeited (in shares)	0
Outstanding, ending balance (in shares)	40,381	88,988
Weighted Average Remaining Contractual Life (Years)
Weighted Average Remaining Contractual Life (Years)	11 months 12 days	1 year 2 months 12 days
Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share)	$ 19.49
Granted (in dollars per share)	0
Vested (in dollars per share)	19.39
Cancelled/Forfeited (in dollars per share)	0
Ending balance (in dollars per share)	$ 19.77	$ 19.49
Common Stock | RSU
Weighted Average Grant Date Fair Value Per Share
Common stock withheld to cover taxes (in shares)	8,902

XML

Commitments and Contingencies (Details)					1 Months Ended
	May 26, 2020 ft² contract	Jan. 27, 2020 defendant	Jan. 24, 2020 USD ($)	Jan. 10, 2020 USD ($)	Oct. 31, 2018 defendant	Jun. 27, 2020 USD ($)	Mar. 16, 2020
Loss Contingencies [Line Items]
Lease extended term							2 years
Area leased | ft²	142,317
Number of renewal options | contract	0
Purchase commitment term				18 months
Purchase commitments				$ 154,100,000		$ 192,400,000
Purchase commitments, due remainder of 2019						51,600,000
Purchase commitments, due 2021						82,300,000
Purchase commitments, due 2022						58,500,000
Former Co-manufacturer Complaint | Pending Litigation
Loss Contingencies [Line Items]
Number of defendants | defendant		3			1
Damages sought, value			$ 628,689
Machinery and equipment
Loss Contingencies [Line Items]
Purchase order commitment						$ 17,800,000

XML

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Income Tax Disclosure [Abstract]
Income tax expense	$ 16,000	$ 21,000	$ 15,000	$ 21,000
Accrued interest or penalties related to uncertain tax positions	$ 0		$ 0

XML

Net Loss Per Share Available to Common Stockholders - Narrative (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation	4,562,663		4,562,663
RSU
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation	287,439		287,439
Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation	40,381		40,381
Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation		6,559,565		6,559,565

XML

Net Loss Per Share Available to Common Stockholders - Schedule of basic and diluted net loss per common share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Numerator:
Net loss available to common stockholders	$ (10,205)	$ (9,441)	$ (8,390)	$ (16,090)
Denominator:
Weighted average common shares outstanding—basic (in shares)	62,098,861	39,081,359	61,904,360	23,206,203
Weighted average common shares outstanding—diluted (in shares)	62,098,861	39,081,359	61,904,360	23,206,203
Net loss per share available to common stockholders—basic and diluted (in dollars per share)	$ (0.16)	$ (0.24)	$ (0.14)	$ (0.69)
Stock Options
Denominator:
Dilutive effect (in shares)	0	0	0	0
RSU
Denominator:
Dilutive effect (in shares)	0	0	0	0
Common Stock
Denominator:
Dilutive effect (in shares)	0	0	0	0